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Preface
Many of the model equations and results included in Chapters 6 and 7 have been previously
published in Farr and David [54]. Authors publishing in the Journal of Theoretical Biology and
other Elsevier Journals retain the rights to publish their work in a thesis1. As this journal article
was written in conjunction with my supervisor, Prof Tim David, I have included a co-authorship
form with this thesis.
Verification of the model described in Chapters 6 and 7 was performed by Kristina Raba, a
summer scholarship student in the BlueFern High Performance Computing Research Group at
the University of Canterbury. She has kindly given permission for her work to be discussed in
Chapter 7 of this thesis.
1See [2] for further information.
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β -amyloid see amyloid-β .
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20-HETE 20-hydroxy-eicosatetraenoic acid.
20-hydroxy-eicosatetraenoic acid 20-HETE; arachidonic acid derivative which acts as a vaso-
constrictor.
AA arachidonic acid.
actin protein involved in muscle contraction; contraction occurs due to the interdigitation of
myosin “heads” with actin filaments.
action potential “a momentary reversal in the potential difference across a plasma membrane
that occurs when a cell has been activated by a stimulus [112]”.
AD Alzheimer’s disease.
adaptive methods numerical methods of solving differential equations which adapt the step
size at each iteration to maintain accuracy of the solution.
adenosine plays an important role in energy transfer (as adenosine triphosphate (ATP) and
adenosine diphosphate (ADP)), as well as in signal transduction (as cyclic adenosine
monophosphate (cAMP)); it is also an inhibitory neurotransmitter.
adenosine triphosphate ATP; “a phosphorylated molecule composed of adenosine and three
phosphate groups that supplies energy for many biochemical cellular processes by un-
dergoing enzymatic hydrolysis to ADP [112]”.
xx
afferent “bearing or conducting inward; specifically : conveying impulses toward the central
nervous system [112]”.
agonist “a chemical substance (as a drug) capable of combining with a receptor on a cell and
initiating the same reaction or activity typically produced by the binding of an endoge-
nous substance [112]”.
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amyloid-β the main constituent of the plaques characteristic of Alzheimer’s disease.
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anterior “situated before or toward the front [112]”.
APP amyloid precursor protein.
aquaporins proteins embedded in the cell membrane that regulate the flow of water.
arachidonic acid AA; second messenger molecule; precursor to prostaglandins and other molecules
that can act as vasomodulators.
arteriole “any of the small terminal twigs of an artery that ends in capillaries [112]”.
artery any of the tubular branching muscular- and elastic-walled vessels that carry blood from
the heart through the body [112].
astrocyte star-shaped glial cell involved in the control of vascular tone and the maintenance of
the neuronal environment.
atherosclerosis inflammation or “hardening” of the walls of the arteries.
ATP adenosine triphosphate.
atrophy “decrease in size or wasting away of a body part or tissue [112]”.
autocrine “of, relating to, promoted by, or being a substance secreted by a cell and acting on
surface receptors of the same cell – compare paracrine [112]”.
autoregulation the process by which blood vessels in the brain adjust their calibre to maintain
adequate blood supply to brain tissue.
xxi
axon structure that extends from the neuron cell body and transmits signals to other neurons.
basal tone the degree of tension or constriction the smooth muscle of a blood vessel has at
rest.
BBB blood-brain barrier.
BK “big” or “large” conductance voltage- and calcium- gated potassium channel.
blood-brain barrier tightly packed endothelial cell lining of the blood vessels that keeps un-
wanted chemical substances from reaching the neuronal environment.
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calculus the study of change; a branch of mathematics focused on derivatives and integrals.
calmodulin “an abbreviation for CALcium-MODULated proteIN; also CaM; a calcium-binding
protein that mediates cellular metabolic processes (as muscle-fiber contraction) by regu-
lating the activity of specific calcium-dependent enzymes [112]”.
CaM calmodulin.
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cell membrane a fatty, semipermeable membrane that surrounds the content that resides within
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cerebral “of, relating to, affecting, or being the cerebrum [112]”.
cerebral amyloid angiopathy deposition of amyloid-β -peptide found in the blood vessels of
a brain affected by Alzheimer’s disease.
cerebral cortex outer part of the cerebrum.
cerebrovascular “of or involving the cerebrum and the blood vessels supplying it [112]”.
xxii
cerebrovascular autoregulation mechanisms which counteract normal fluctuations in arterial
pressure and shear stress by adjusting the calibre of cerebral arterioles.
cerebrovasculature blood vessels of the brain.
cerebrum “an enlarged anterior or upper part of the brain; especially: the expanded anterior
portion of the brain that in higher mammals overlies the rest of the brain, consists of cere-
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mental processes [112]”.
cGMP cyclic guanosine monophosphate.
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cognitive “of, relating to, or being conscious intellectual activity (as thinking, reasoning, re-
membering, imagining, or learning words) [112]”.
compressive stress acts to compress a deformable body.
conceptual models models based on mathematical descriptions of underlying physical pro-
cesses.
conductance “the power, readiness, or capacity to conduct something; the readiness with
which a conductor transmits an electric current expressed as the reciprocal of electrical
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coronary “of, relating to, or being the coronary arteries or veins of the heart; broadly: of or
relating to the heart [112]”.
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ing depression.
cotransporter a protein residing in the cell membrane that helps to transport molecules or ions
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xxiii
current “a flow of electric charge [112]”.
cyclic guanosine monophosphate cGMP; second messenger molecule important for NO-mediated
vasodilation mechanism.
cytoplasm “the organized complex of inorganic and organic substances external to the nuclear
membrane of a cell and including the cytosol and membrane-bound organelles [112]”.
cytosol “the fluid portion of the cytoplasm exclusive of organelles and membranes [112]”.
dementia “a usually progressive condition marked by the development of multiple cognitive
deficits [112]”.
dendrite structure that extends from the neuron cell body and receives signals from other
neurons.
dendritic spine protrusion from a dendrite that receives input from an axon.
depolarization “loss of polarization; especially: loss of the difference in charge between the
inside and outside of the plasma membrane of a muscle or nerve cell due to a change in
permeability and migration of ions [112]”; change in cell membrane potential to a less
negative value.
derivative a mathematical expression that describes a rate of change; for example, the rate of
change of quantity a with respect to quantity t as the quantity t approaches zero.
DHET dihydroxyeicosatrienoic acid.
diabetes mellitus “a variable disorder of carbohydrate metabolism caused by a combination of
hereditary and environmental factors and usually characterized by inadequate secretion
or utilization of insulin, by excessive urine production, by excessive amounts of sugar in
the blood and urine, and by thirst, hunger, and loss of weight [112]”.
differential equation “an equation containing differentials or derivatives of functions [112]”.
diffusion the movement of particles from an area of higher concentration to that of a lower
one.
dihydroxyeicosatrienoic acid DHET; derivative of EET (which is a derivative of AA); acts as
a vasodilator.
dissociation constant “a constant that depends upon the equilibrium between the dissociated
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xxiv
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imal [112]”.
distensible “capable of being distended, extended, or dilated [112]”.
E. coli “an enterobacterium (Escherichia coli) that is used in medicine and genetics as a re-
search organism [112]”.
EC endothelial cell.
ECS extracellular space.
EET epoxyeicosatrienoic acid.
elastic modulus “the ratio of the stress in a body to the corresponding strain [112]”.
electrochemical “pertaining to electrochemistry, a science that deals with the relation of elec-
tricity to chemical changes and with the interconversion of chemical and electrical energy
[112]”.
endfoot the end of an astrocyte branch that surrounds neighbouring neurons or blood vessels.
endogenous “growing from or on the inside [112]”.
endoplasmic reticulum “a system of interconnected vesicular and lamellar cytoplasmic mem-
branes that functions especially in the transport of materials within the cell and that is
studded with ribosomes in some places [112]”; cell “stores”.
endothelial cells thin, flat cells that line the lumen of blood vessels.
endothelial nitric oxide synthase enzyme found in endothelial cells that is capable of produc-
ing vasodilatory nitric oxide.
eNOS endothelial nitric oxide synthase.
epoxyeicosatrienoic acid EET; arachidonic acid derivative which acts as a vasodilator.
ER endoplasmic reticulum.
erythrocytes see red blood cells.
expression as in gene expression; the process by which information from a gene is used to
produce a cellular structure, such as an ion channel.
xxv
fibrous astrocyte astrocytes with long, thin, unbranched processes [114].
fMRI functional magnetic resonance imaging.
forepaw stimulation experimental method where neuronal activation is initiated in the cortex
by first stimulating the forepaw of the experimental animal.
functional hyperaemia the mechanism by which increased neuronal activity is matched by a
rapid and regional increase in blood supply [54].
functional magnetic resonance imaging fMRI; an MRI procedure that estimates the amount
of brain activity by detecting changes in blood oxygen.
G-protein “any of a class of cell membrane proteins that are coupled to cell surface receptors
and upon stimulation of the receptor by an extracellular molecule (a hormone or neuro-
transmitter) bind to GTP to form an active complex which mediates an intracellular event
[112]”.
gap junction “an area of contact between adjacent cells characterized by modification of the
plasma membranes for intercellular communication or transfer of low molecular-weight
substances [112]”.
gK(Ca) voltage- and calcium- gated potassium channel.
glia “supporting tissue intermingled with the essential elements of nervous tissue especially in
the brain, spinal cord, and ganglia [112]”.
glial “of, relating to, or constituting glia [112]”.
glutamate neurotransmitter released by active neurons.
gray matter “neural tissue especially of the brain and spinal cord that contains cell bodies as
well as nerve fibres, has a brownish-gray colour, and forms most of the cortex and nuclei
of the brain, the columns of the spinal cord, and the bodies of ganglia called also gray
substance [112]”.
GTP guanosine-5’-triphosphate.
guanosine-5’-triphosphate “an energy-rich nucleotide analogous to ATP that is composed of
guanine linked to ribose and three phosphate groups and is necessary for peptide bond
formation during protein synthesis [112]”.
haemorrhage “copious discharge of blood from the blood vessels [112]”.
xxvi
heterocellular coupling gap junction coupling between different cell types.
Hill equation mathematical expression that describes the binding of a ligand to a receptor.
histology “a branch of anatomy that deals with the minute structure of animal and plant tissues
as discernible with the microscope [112]”.
homocellular coupling gap junction coupling between the same cell type.
hyperaemia see functional hyperaemia.
hypercholesterolaemia “the presence of excess cholesterol in the blood [112]”.
hyperglycaemia high blood sugar.
hyperpolarization “to produce an increase in potential difference across (a biological mem-
brane) [112]”; change in cell membrane potential to a more negative value.
hypertension abnormally high blood pressure.
hypotension abnormally low blood pressure.
infinitesimal “taking on values arbitrarily close to but greater than zero; immeasurably or
incalculably small [112]”.
innervated supplied by nerve fibres.
inositol triphosphate molecule important for cell signalling.
integration anti-differentiation.
interstitial clefts the space that surrounds the cells of a given tissue.
intima “the innermost coat of an organ (as a blood vessel) consisting usually of an endothelial
layer backed by connective tissue and elastic tissue – called also tunica intima [112]”.
inwardly rectifying potassium channel KIR channel; despite their name, “inwardly rectify-
ing” potassium channels can actually pass potassium ions both in and out of the cell; they
are just able to pass ions into the cell more readily (i.e., with less resistance).
ion channel “a cell membrane channel that is selectively permeable to certain ions [112]”.
ion pump a cell membrane protein that uses ATP to provide energy to move ions across the
membrane against their concentration gradient.
xxvii
ionotropic type of neurotransmitter receptor that forms a ion channel pore; when activated, a
ionotropic receptor allows ions to flow through it.
ischaemia “deficient supply of blood to a body part (as the heart or brain) that is due to ob-
struction of the inflow of arterial blood (as by the narrowing of arteries by spasm or
disease) [112]”.
Kelvin-Voigt type of viscoelastic model formed by a dashpot and a spring connected in paral-
lel.
kinetics “the mechanism by which a physical or chemical change is effected [112]”.
KIR inwardly rectifying potassium channel.
knockout “having all or part of a gene eliminated or inactivated by genetic engineering; for
example, knockout mice predisposed to diabetes mellitus serve as animal models in the
study of human diabetes [112]”.
L-Arginine basic amino acid.
Laplace’s Law if you have a larger vessel radius, you will need a larger wall tension to with-
stand a given internal fluid pressure.
ligand small molecule that can form complexes with cellular proteins.
lumen “the cavity of a tubular organ or part [112]”.
mathematical model a physical system described using mathematical language.
mechanism “a piece of machinery; a bodily process or function; the fundamental physical or
chemical processes involved in or responsible for an action, reaction, or other natural
phenomenon [112]”.
media “the middle coat of the wall of a blood or lymph vessel consisting chiefly of circular
muscle fibres – called also tunica media [112]”.
membrane potential “the potential difference between the interior of a cell and the interstitial
fluid beyond the membrane [112]”.
metabolic autoregulation regulation of blood flow according to the degree of metabolism
occurring in the neighbouring tissue.
xxviii
metabotropic “relating to or being a receptor for glutamate that when complexed with G-
protein triggers increased production of certain intracellular messengers [112]”.
metabotropic glutamate receptors astrocyte glutamate receptor; involved in neurovascular
coupling.
mGluR metabotropic glutamate receptors.
Michaelis-Menten kinetics model of enzyme kinetics; relates the reaction rate v to [S], the
concentration of a substrate S.
MLCK myosin light chain kinase.
MLCP myosin light chain phophatase.
myogenic mechanism vascular mechanism that acts to counteract the normal fluctuations in
arterial pressure that occur during normal activities.
myosin protein involved in muscle contraction; contraction occurs due to the interdigitation of
myosin “heads” with actin filaments.
myosin light chain a subunit of myosin.
myosin light chain kinase MLCK; enzyme that phosphorylates the light chain (a subunit) of
myosin, enabling the molecular interaction of myosin with actin.
myosin light chain phosphatase MLCP; enzyme that dephosphorylates the light chain (a sub-
unit) of myosin, enabling the disruption of the molecular interaction of myosin with actin.
N-methyl-d-aspartate receptors neuronal ionotropic glutamate receptor; involved in NO-mediated
neurovascular coupling.
Nernst potential reversal potential.
neuritic plaques plaques of amyloid-β -peptide found in the neuronal tissue of a brain affected
by Alzheimer’s disease.
neurodegenerative “relating to or marked by degeneration of nervous tissue [112]”.
neurofibrillary tangle accumulation of abnormally formed tau protein that occurs in the neu-
rons of those with Alzheimer’s disease.
neuron “one of the cells that constitute nervous tissue, that have the property of transmitting
and receiving nervous impulses [112]”.
xxix
neuronal nitric oxide synthase enzyme found in neurons that is capable of producing va-
sodilatory nitric oxide.
neurotransmitter “a substance that transmits nerve impulses across a synapse [112]”.
neurovascular coupling NVC; the intercellular communication system between cells com-
prising the neurovascular unit [54].
neurovascular signalling see neurovascular coupling.
neurovascular unit NVU; functional unit comprised of neurons, astrocytes and vascular cells.
nitric oxide NO; vasodilatory molecule; produced by neuronal nitric oxide synthase (nNOS)
in neurons and endothelial nitric oxide synthase (eNOS) in endothelial cells.
NMDAR N-methyl-d-aspartate receptors.
nNOS neuronal nitric oxide synthase.
NO nitric oxide.
non-dimensionalization the process of removing units from a system of equations by making
a series of substitutions for the variables; can be used to help uncover characteristic
properties of the system (such as characteristic times or lengths) or to determine which
terms of the equations significantly affect system behaviour.
normal “perpendicular to a tangent at a point of tangency [112]”.
normal stress stress component normal to a surface.
numerical solution solution found by numerical mathematical methods.
NVC neurovascular coupling.
NVU neurovascular unit.
ODE ordinary differential equation.
oedema “an abnormal infiltration and excess accumulation of serous fluid in connective tissue
or in a serous cavity – called also dropsy [112]”.
Ohm’s Law V=IR; “a law in electricity: the strength of a direct current is directly propor-
tional to the potential difference and inversely proportional to the resistance of the circuit
[112]”.
xxx
ohmic of, or relating to Ohm’s law, or a system component that is governed by Ohm’s law.
ordinary differential equation ODE; a differential equation in which there is only one inde-
pendent variable.
osmotic shrinkage shrinkage of one compartment due to the osmotic movement of water to a
neighbouring compartment that has a higher solute (ionic) concentration.
overexpression “excessive expression of a gene by producing too much of its effect or product
[112]”.
paracrine “of, relating to, promoted by, or being a substance secreted by a cell and acting on
adjacent cells – compare autocrine [112]”.
parameter any of a set of physical properties whose values determine the characteristics or
behavior of something [112].
partial derivative a derivative of a function of several variables.
partial differential equation PDE; “an equation containing at least one partial derivative [112]”.
pathogenic “causing or capable of causing disease [112]”.
pathology “the structural and functional deviations from the normal that constitute disease or
characterize a particular disease [112]”.
pathophysiology “the physiology of abnormal states; specifically: the functional changes that
accompany a particular syndrome or disease [112]”.
PDE partial differential equation.
PDEs phosphodiesterases.
perfusion “to force a fluid through (an organ or tissue) especially by way of the blood vessels
[112]”.
pericyte glial cell capable of altering the calibre of capillaries.
perivascular “of, relating to, occurring in, or being the tissues [or space] surrounding a blood
vessel [112]”.
PG prostaglandins.
pharmacological treatments drugs.
xxxi
phenomenological models models formed by fitting equations to observed behaviour.
phosphatidylinositol 4 5 bisphosphate molecule from which many important signalling pro-
teins are derived.
phosphodiesterases more specifically: cyclic nucleotide phosphodiesterases; a group of en-
zymes that degrade the phosphodiester bond in the second messenger molecules cAMP
and cGMP.
Phospholipase C PLC; enzyme that cleaves PIP2 to produce IP3.
phosphorylate “to cause (an organic compound) to take up or combine with phosphoric acid
or a phosphorus-containing group [112]”.
physiological “characteristic of or appropriate to an organism’s healthy or normal functioning
[112]”.
pial arteries arteries on the outside of the brain.
plasma membrane see cell membrane.
PLC Phospholipase C.
Poisson effect the effect observed when a deformable body is stretched in one direction: it
tends to get thinner in the other two directions.
Poisson’s ratio measure of the Poisson effect; it is the ratio of the strain in one direction to the
strain in another direction.
posterior “situated behind [112]”.
prostaglandins PG; arachidonic acid derivative which acts as a vasodilator.
protoplasmic astrocyte astrocytes with many branching processes [114].
proximal “next to or nearest the point of attachment or origin, a central point, or the point of
view – compare distal [112]”.
red blood cells “any of the haemoglobin-containing cells that carry oxygen to the tissues and
are responsible for the red colour of vertebrate blood [112]”.
reperfusion “restoration of the flow of blood to a previously ischaemic tissue or organ (as the
heart or brain) [112]”.
xxxii
resistance “the opposition offered by a body or substance to the passage through it of a steady
electric current [112]”.
reversal potential the membrane potential at which there is no net flow from one side of the
membrane to the other.
RK Runge-Kutta.
RKSUITE a robust mathematical solver that uses an embedded RK-45 method.
Runge-Kutta numerical method for finding a numerical solution that approximates the ana-
lytical solution of a differential equation.
SAC stretch-activated calcium ion channel.
sarcoplasmic reticulum “the endoplasmic reticulum of [muscle] that functions especially as
a storage and release area for calcium [112]”; special form of “smooth” ER.
SD spreading depression.
sGC soluble guanylate cyclase.
shear stress stress component tangential to a surface.
sigmoidal behaviour behaviour that exhibits a progression from a small value that increases
quickly and approaches a plateau over time; “S-shaped” behaviour; used to describe the
opening of ion channels, among other things.
SMC smooth muscle cell.
smooth muscle cells cell that constitutes smooth muscle, a type of muscle that is a major com-
ponent of arterial and arteriolar walls.
soluble guanylate cyclase intracellular receptor that binds nitric oxide; involved in NO-mediated
vasodilation.
soma cell body.
spatial buffering mechanism for the regulation of extracellular potassium concentration by
astrocytes.
spine see dendritic spine.
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spreading depression SD; a slow spreading wave of depolarization of neurons and glial cells
that is accompanied by changes in vascular tone, blood flow and metabolism [34].
SR sarcoplasmic reticulum.
strain a normalized measure of the size of the deformation/displacement of particles within a
body relative to an initial or reference body size.
stress forces acting within a deformable body.
stress tensor mathematical grouping of stress components, usually into an array or matrix.
stroke cerebral infarction; where the blood supply to a part of the brain is interrupted by the
rupture (haemorrhagic stroke) or the blocking (ischaemic stroke) of a blood vessel.
subarachnoid haemorrhage “haemorrhage situated or occurring under the arachnoid mem-
brane in the brain [112]”.
synapse “the place at which a nervous impulse passes from one neuron to another [112]”.
synaptic cleft “the space between neurons at a nerve synapse across which a nerve impulse is
transmitted by a neurotransmitter – called also synaptic gap [112]”.
tangential “acting along or lying in a tangent [112]”.
tensile stress acts to stretch a deformable body.
tone as in muscular “tonus;” see vascular tone.
transmural across the wall (of a blood vessel).
vascular relating to blood vessels.
vascular cells cells lining the lumen of blood vessels; these include smooth muscle cells and
endothelial cells.
vascular tone the degree of tension or constriction the smooth muscle of a blood vessel has;
muscular “tonus”.
vasoconstriction constriction of a blood vessel.
vasoconstrictor “an agent (as a sympathetic nerve fibre or a drug) that induces or initiates
vasoconstriction [112]”.
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vasodilation dilation of a blood vessel.
vasodilator “an agent (as a parasympathetic nerve fibre or a drug) that induces or initiates
vasodilation [112]”.
vasomodulator agent capable of modulating (inducing changes in) vascular tone.
vasomotion diameter oscillations of the arteries.
viscoelastic having both viscous and elastic properties.
viscoelastic model mathematical model consisting of springs (that represent the elastic re-
sponse) and dashpots (that represent the viscous response) arranged in series and/or par-
allel.
VOCC voltage operated calcium channel.
voltage “electric potential or potential difference expressed in volts [112]”.
VSM vascular smooth muscle.
VSMC vascular smooth muscle cell/s.
wall shear stress stress exerted on the vessel wall by flowing blood.
white matter “neural tissue especially of the brain and spinal cord that consists largely of
myelinated nerve fibres bundled into tracts, has a whitish colour, and typically underlies
the grey matter [112]”.
WSS wall shear stress.
Young’s modulus “the ratio of the tensile stress in a material to the corresponding tensile
strain [112]”.
Abstract
Functional hyperaemia is an important mechanism by which increased neuronal activity is
matched by a rapid and regional increase in blood supply. This mechanism is facilitated by a
process known as “neurovascular coupling” – the orchestrated communication system involv-
ing the cells that comprise the neurovascular unit (neurons, astrocytes and the smooth muscle
and endothelial cells lining arterioles). Blood flow regulation and neurovascular coupling are
altered in several pathological states including hypertension, diabetes, Alzheimer’s disease,
cortical spreading depression and stroke.
By adapting and extending other models found in the literature, we create, for the first
time, a mathematical model of the entire neurovascular unit that is capable of simulating two
separate neurovascular coupling mechanisms: a potassium- and EET-based and a NO-based
mechanism. These models successfully account for several observations seen in experiment.
The potassium/EET-based mechanism can achieve arteriolar dilations similar in magnitude
(3%) to those observed during a 60-second neuronal activation (modelled as a release of potas-
sium and glutamate into the synaptic cleft). This model also successfully emulates the para-
doxical experimental finding that vasoconstriction follows vasodilation when the astrocytic cal-
cium concentration (or perivascular potassium concentration) is increased further. We suggest
that the interaction of the changing smooth muscle cell membrane potential and the changing
potassium-dependent resting potential of the inwardly rectifying potassium channel are respon-
sible for this effect. Furthermore, our simulations demonstrate that the arteriolar behaviour is
profoundly affected by depolarization of the astrocytic cell membrane, and by changes in the
rate of perivascular potassium clearance or the volume ratio between the perivascular space and
astrocyte.
In the modelled NO-based neurovascular coupling mechanism, NO exerts its vasodila-
tory effects via neuronal and endothelial cell sources. With both sources included, the model
achieves a 1% dilation due to a 60-second neuronal activation. When the endothelial con-
tribution to NO production is omitted, the arteriole is more constricted at baseline. Without
the endothelial NO contribution, the arteriolar change in diameter during neuronal activity is
greater (6%). We hypothesize that NO has a dual purpose in neurovascular coupling: 1) it di-
xxxvi
rectly mediates neurovascular coupling through release by neuronal sources, and 2) it indirectly
modulates the size of the neurovascular coupling response by determining the baseline tone.
Our physiological models of neurovascular coupling have allowed us to replicate, and ex-
plain, some of the phenomena seen in both neurovascular coupling-oriented and clinically-
oriented experimental research. This project highlights the fact that physiological modelling
can be used as a tool to understand biological processes in a way that physical experiment can-
not always do, and most importantly, can help to elucidate the cellular processes that induce or
accompany our most debilitating diseases.
Chapter 1
Introduction
1.1 Overview
The human brain consumes an extraordinary 20% of the energy that is produced by the body. It
receives a continuous supply of fuel and oxygen from blood, but if cerebral blood flow (CBF)
is disrupted, brain function will cease within seconds and permanent damage to the cellular
structures will occur within minutes [78]. Conversely, if blood supply is too plentiful, the brain
will experience oedema (swelling). The brain therefore requires neither too much nor too little
blood. To ensure that it receives just the right amount of blood, it has evolved a collection of
protective, automatically regulated mechanisms.
A phenomenon known as cerebrovascular autoregulation constitutes one line of defence
[78]. Arteries and arterioles within the brain make compensatory changes in radius in response
to normal fluctuations in blood pressure and wall shear stress. When arterial pressure rises,
arteries will constrict (their diameter will decrease) to counteract the increase in blood flow
caused by the pressure rise. When arterial pressure drops, arteries will relax (their diameter
will increase), allowing the passage of more blood. This process – termed myogenic regulation
– ensures that a constant CBF can be maintained.
Another protective mechanism involves the distribution of blood according to the func-
tional activity of different brain regions – a mechanism known as functional hyperaemia. Func-
tional hyperaemia is essentially the process by which increased neuronal activity is matched by
a rapid and regional increase in blood supply. Those familiar with fMRI will understand this
in terms of the coloured “activated” areas overlaid on brain slices. Although investigations into
functional hyperaemia began with the work of Roy and Sherrington [136] over 200 years ago, it
is still unknown exactly what chemical species and cellular machinery are involved. However,
a growing body of evidence indicates that neurons, astrocytes and vascular cells constitute an
important entity (termed the neurovascular unit or NVU), which maintains homeostasis in the
brain in a variety of different ways. It is believed that functional hyperaemia is achieved through
2“neurovascular coupling” – the intercellular communication system between cells comprising
the NVU [78].
The breakdown of the cell machinery that powers these defensive autoregulatory mecha-
nisms leads to dysregulated cerebral blood flow and perfusion, which in turn leads to cellular
injury, brain dysfunction and disease [78]. It is now believed that this cerebrovascular dysreg-
ulation is not only implicated in the development of cerebrovascular disease, such as stroke
and atherosclerosis (hardening of the arteries), but also in neurodegenerative disorders, such as
Alzheimer’s disease (AD) [53, 59, 78] and cortical spreading depression (CSD) [98].
1.2 Motivations
Understandably, neuronal abnormalities have been the focus for neurodegenerative disease re-
search for decades [107]. However, recent research into the nature and causes of neurological
(and other) disorders has highlighted the importance of vascular pathology.
Impaired cerebrovascular autoregulation, as well as impaired autoregulation by functional
hyperaemia, has been seen in “Alzheimer mice” (mice that overproduce the amyloid precursor
protein, APP) [59, 119, 120, 122]. In light of such evidence, it has been hypothesized that vas-
cular damage may actually precede the formation of the amyloid-β plaques and neurofibrillary
tangles indicative of AD [78, 133]. It has also been shown that atherosclerosis and high choles-
terol – essentially “bad” vascular health – increases the risk of developing AD [134, 148]. Other
studies have localised neurodegenerative mechanisms down to specific defective ion channels
in astrocytes or smooth muscle cells [108, 153, 165]. Finally, astrocytes (an integral part of
the NVU) have also been implicated as major players in the progression of neurodegenerative
diseases [107, 116]. Astrocytes – also known as the “housekeepers” of the brain – are known
to “clean up” neuron-derived amyloid β material, which can eventually cause astrocytic cell
injury and death [107].
The pathogenic gap between cerebrovascular disorders and other common diseases is also
narrowing. AD [78], cortical spreading depression (CSD)[34] and diabetes [39, 156] all have
a vascular component in their pathology. These vascular changes are not necessarily a side or
secondary effect of the disease; vascular responses can play an integral part in the initiation,
propagation or degeneration of the disease itself. Understanding the interplay between vas-
cular and other components of a disease, and indeed developing new therapies to target these
components, relies on the discovery and analysis of very complex and coupled cellular pro-
cesses. Mathematical models that can describe cellular-level processes in detail will aid in this
understanding and can provide a platform for predicting the effects that new pharmacological
treatments could have [143]. Mathematical modelling has been used for hundreds of years
3to help biological scientists better understand the mechanisms underlying their experimental
results. These models have not only been used to validate existing hypotheses, but have also
helped guide the creation of new and testable experimental pathways [155]. However, the pro-
cess, and indeed the benefits, of creating a mathematical model are not well understood by the
general scientific community. Care must be taken to ensure that they are presented in such
a way that they can provide maximum value. Models need to be understood in terms of their
scope, scale, strengths and limitations, and need to be presented so that every member of the in-
terdisciplinary biological science community (experimentalists, clinicians and mathematicians)
can understand the terminology [144]. This thesis must therefore include sufficient background
information regarding physiological, clinical and mathematical concepts so that a person with
knowledge only in one area could still understand this work as a whole.
1.3 Objective
The overall objective of this project is to build a mathematical model of neurovascular coupling
and investigate the model’s response to known physiological (and pathological) changes. In
order to achieve these overall objectives, the following key goals were identified:
1. Conduct a review of the current neurovascular (smooth muscle, endothelial and astrocyte
cell) models in the literature
2. Construct a working model of the neurovascular unit using previous cell models and
additional physiological information
3. Analyze the contributions of two known neurovascular coupling mechanisms to blood
flow regulation as a whole; namely, 1) a K+- and EET- based mechanism and 2) a NO-
based mechanism
4. Ensure that the model and its results are communicated in a format that is accessible
to all members of the biological science community (experimentalists, clinicians and
mathematicians)

Chapter 2
The Physics and Mathematics of Physiology
2.1 Introduction
The earliest physiological investigations were explorations into physical forces. They sought
to understand “how chemical, electrical and mechanical forces are transmitted, transduced and
processed in and around living organisms [19].” Or in other words:
“La vie . . . n’est autre chose qu’un phenomen physique.”
—Lamarck [95]
Essentially: “Physiology is physics.”
Physiology is a form of physics and physics can be translated into the language of mathe-
matics. It is therefore natural to develop a mathematical approach to physiological study.
The aim of this project is to translate the physiology of neurovascular coupling into math-
ematical terms in the hope that the mathematics will help reveal the physiology. The following
chapter endeavours to outline this translation process, beginning with very basic mathematical
principles. Because this research sits evenly in the interstices between complex mathematics
and complex physiology, it seemed important to describe both of these aspects so that a reader
unknowledgeable in one aspect could understand the work as a whole. To this end, many of the
mathematical ideas have been explained from very simple first principles (that is, assuming the
reader has little training in mathematics). Furthermore, before we can explore the modelling
that has already been done in the field of microvasculature research (Chapter 5), we must first
understand what modelling is and how it adds value and insights to the research. Thus, it is use-
ful to 1) explain the reasons why we make an effort to create mathematical (or “theoretical”)
models and 2) to outline the differences between various different kinds of theoretical models.
62.2 Calculus and Differential Equations
Some scientific principles give information about the value of a variable at a given instant.
Examples include Ohm’s Law (V = IR) or Hooke’s Law for Springs (F = kx). However, some
laws of science do not provide direct information about the value of the variable which you
want to measure. Take Newton’s second law, for example:
∑F = ma
Translated out of the language of mathematics this says: “The sum (∑) of all the forces (F) act-
ing on an object is equal to the mass (m) of that object multiplied by its acceleration (a).” You
might be interested in the object’s speed or its position in space, but the equation only gives
you information about the acceleration. If you want to know about the velocity or position,
you need a way to describe and manipulate change – that is, you need calculus, derivatives and
differential equations. Things change. It is therefore important to have a mathematical way of
talking about change. This is why differential equations appear throughout many branches of
science – in physics, chemistry, economics, and, importantly (for the purposes of this project),
physiology. The relationships between change, derivatives, differential equations and integra-
tion are outlined below.
2.2.1 Change
We can describe large changes and small changes. Let’s start with large changes:
change in a
change in b
=
∆a
∆b
(2.1)
Equation 2.1 describes how much a changes with b. We can say that this is the change in a with
respect to b.
Often we are interested in changes with respect to time. A change in the value of a variable
K for a given time interval ∆t is:
change in K
change in time
=
∆K
∆t
(2.2)
We are sometimes interested in changes across space. A change in the value of K with
respect to its position x is described similarly:
change in K
change in x
=
∆K
∆x
(2.3)
7Returning now to acceleration: the change in velocity with time (acceleration) can be de-
scribed by:
average acceleration over a time interval =
change in velocity
change in time
=
∆v
∆t
(2.4)
This equation will give us the average change in velocity (acceleration) in the time interval
measured. If we want the acceleration at a given instant (the “instantaneous acceleration”),
however, we must consider the change in velocity that occurs over the time interval of an
“instant.” To calculate this perfectly using perfect mathematics, we consider what the rate of
change of velocity would “tend to” over a infinitesimal time interval (an interval so small it
is almost zero: an “instant”). We compute the rate of change as the “limiting value of the
ratio of the differences ∆v∆t as ∆t becomes infinitesimally small.” Differentiation is a method of
finding what the rate of change “tends to” at any given instant. The notation used to denote a
very small (almost zero) change is d (this is sensible notation (as invented by mathematician
Gottfried Leibniz) as the lowercase d is a “small” version of the uppercase greek “D”, ∆). In
Leibniz’s notation, such an infinitesimal change in t is denoted by dt, and the derivative of v
with respect to t is written:
instantaneous acceleration =
dv
dt
(2.5)
where dvdt is an example of a first order derivative.
As we know, velocity is another value that can be expressed in terms of change (it de-
scribes the change in position, x, with time). Velocity can therefore be expressed as a first order
derivative itself:
instantaneous value of velocity =
dx
dt
(2.6)
A second order derivative arises when we want to express acceleration in a different way:
in terms of the position, x, rather than the velocity, v. If acceleration is the change in velocity
with time, and velocity is the change in position with time, acceleration is the change in the
change of position with respect to time, and is therefore given by:
acceleration =
d2x
dt2
(2.7)
the second order derivative (demonstrated by the power of 2).
When first or second (or even higher order) derivatives are used in an equation, you have a
differential equation. Differential equations involving derivatives of position and velocity with
respect to time can be used in physiological or anatomical modelling to describe changes in the
8position (displacement) of limbs, organs, vessels, muscles or cells. Other differential equations
used in physiological modelling involve the changes in the chemical/ionic concentration inside
or outside a cell with time. These equations appear when a mass balance is performed on the
closed system of the cell. Mass balances are explained in the following section.
2.2.2 Mass Balances
“The Law of the Conservation of Mass: Although matter may change its form
or shape, its mass always remains the same.”
— Antoine-Laurent Lavoisier, French chemist (1743–1794)
In other words: The mass that enters a system must, by conservation of mass, either leave the
system or accumulate within the system. In an equation:
Input = Output+Accumulation (2.8)
Or, in the case where there is a chemical reaction or a change in state:
Input+Generation = Output+Consumption+Accumulation (2.9)
Rearranging the simple balance (Equation 2.8) gives:
Accumulation = Input−Output (2.10)
In the situation where we have a flow of mass entering and a flow of mass leaving a closed
compartment, we can rewrite this equation as:
change in mass inside the system per unit time=mass flowrate in−mass flowrate out (2.11)
This is shown graphically in Figure 2.1.
In physiological modelling, we are often concerned with the changing concentrations of
ions and other chemical species inside the cell with time. We can write a mass balance for a
specific ion or chemical (denoted by K) by replacing the accumulation or “change term” with
a differential term. We get the following differential equation (DE):
Accumulation of K with time =
dK
dt
= Fin−Fout (2.12)
where t denotes time and where Fin and Fout are shorthand representations of the flowrate of
9Figure 2.1 Accumulation of material inside a closed compartment. A flowrate of 5 dots per unit time in minus
a flowrate of two dots per unit time out gives an accumulation in the system of 3 dots per unit time.
substance K in and out of the cell, respectively. Accumulation can actually be positive or
negative. If positive, then Input is greater than Output, and K will literally “accumulate” in the
cell. If the Accumulation term is negative, then Output is greater than the Input, and K will be
“depleted” in the cell.
Note that sometimes the value of a variable changes with position and with time. This
complicates the maths, and requires the use of partial derivatives (recognisable by the curly
‘∂ ’ as opposed to the ‘d’ of an ordinary derivative). To simplify a model so that it is the type
involving only ordinary derivatives, we can assume that variables do not change with their
position in space. In the case of a model of a chemical K in a cell: if we assume the cell
acts as a “well-mixed” compartment, we can assume that the value of the variable K is the
same throughout the entire cell at a given instant. If a differential equation describes a change
with respect to only one variable (like time t in Equation 2.12), then it is called an ordinary
differential equation or ODE.
2.2.3 “Undoing” Differential Equations using Integration
To obtain the solution from a differential equation (that is, to find the value of the variable
itself as opposed to the value of the change of the variable), you must “undo” the derivative
using the process of anti-differentiation (or integration, for short). There are many different
mathematical techniques involved in integration; the type of technique used depends on the
particular mathematics used in the differential equation. In many situations, there will not be
a technique available that is able to undo the differential equation perfectly. In this case, we
would say that the analytical (or exact) solution cannot be found.
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2.2.4 Solving Differential Equations Numerically
The physiological phenomena modelled in our system are complex and non-linear by nature;
sigmoidal and exponential behaviour is very common in physiology. In addition, many of the
equations that we use are coupled with other equations (certain variables depend on the values
of other variables (for example: the membrane potential of a cell might depend on the concen-
trations of potassium K+ and calcium Ca2+)). Finally, the different physiological processes
we are trying to model operate on vastly different timescales (for example, the binding of the
chemical glutamate at a receptor would occur much faster than muscle contraction would); this
property creates what is known as a “stiff” system. Analytical solutions are not usually pos-
sible for complex, coupled or non-linear systems of differential equations (like those used in
physiological modelling). Numerical integration techniques must therefore be used to find a
solution that approximates the actual analytical solution. There are many numerical integra-
tion techniques that can be used; the choice of method depends on the nature of the equation
set (“stiff” systems need certain techniques), the amount of error that can be tolerated and the
computational expense of the method. In practice, higher order Runge-Kutta (RK) methods are
used to solve such problems because of their superior convergence and stability features. 4th
order explicit RK methods are commonly used. A brief description of these methods, in the
context of a system of ODEs, follows.
Say we have a collection of variables that describe our physiological system (let’s assume
the variables we are interested in are called y1, y2, y3 and y4). Rather than describe each variable
and its corresponding differential equation separately, we can collect these variables together
as an array – a collection of variables. This will help simplify the explanation. So our array
would be y =
[
y1 y2 y3 y4
]
or y(t) =
[
y1(t) y2(t) y3(t) y4(t)
]
. Therefore, all the
ODEs in our set (or system) will be of the form:
dy
dt
= f (t,y(t)) (2.13)
Here, the change in any one of the variables in the array y (i.e., y1, y2, y3 or y4) with respect to
time t is described by a mathematical function f that could depend on the value of time t itself
and/or the value of any one of the variables in the array y at time t. So, for example, the change
in the variable y1 may depend on time t and the components of the array y(t) in the following
way:
dy1
dt
= f (t,y(t)) = 3y1(t)2+2y2(t)+6y3(t−4)+ y4(t)3 (2.14)
Note that y1(t), y2(t), y3(t), y4(t) and t don’t all have to be involved in the DE. For example,
the change in the variable y1 at a certain time t may only depend on its own value, like in
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Equation 2.15 below:
dy1
dt
= f (t,y(t)) = 7y1(t)2+20 (2.15)
We can think of t as some time between t0 and t f (the start and finish time of a time interval
of interest, respectively). Let us assume that we know all the initial values (y0) of all of the
variables in y(t) at the start time (t0). That is:
y(t0) = y0 (2.16)
If we know the initial value of all the variables, then the system of ODEs can be described as
an initial value problem.
To find a numerical solution that approximates the analytical solution for this set of ODEs,
we can first split the time interval of interest into N sections, each consisting of a small time
step h. To solve an initial value problem like the one in Equations 2.13 and 2.16 you would
take one variable at a time (starting with y1) and use an explicit “sth” order RK method which
would use the present value of the variable y at time step t (i.e., y(t)) to approximate y(t +h),
the value of y at the next time step (t+h) using this general formula:
y(n+1) = yn+b1k1+b2k2+b3k3+ · · ·bsks = yn+
s
∑
i=1
biki
tn+1 = tn+h (2.17)
where
k1 = h f (tn,yn)
k2 = h f (tn+ c2h,yn+a21k1)
...
ks = h f (tn+ csh,yn+as1k1+ · · ·+as,s−1ks−1) (2.18)
n is the nth, or previous, timestep; (n+ 1) is the (n+ 1)th, or next/current, timestep; s is the
number of stages (or the order of the RK method); the function f is the same function described
in the system of ODEs (Equation 2.13), but different values are substituted into it (as shown)
for each of k1, k2 and so on, up until ks. Note that
s
∑
i=1
biki is a shorthand representation meaning
“evaluate biki at all the values of i (starting at 1 and stopping at s), then add them all together.”
ai j (for 1 ≤ j < i ≤ s), bi (for i = 1,2, . . . ,s) and ci (for i = 2,3, . . . ,s) are special coefficients
specific to the order of the method (found from a special mnemonic device known as a “Butcher
Tableau” (Figure 2.2) – named after John C. Butcher, Emeritus Professor at the University of
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Auckland, New Zealand).
Figure 2.2 Butcher Tableau. Adapted from [1].
The Butcher Tableau for a fourth order RK method (RK4) is shown in Figure 2.3.
Figure 2.3 Butcher Tableau for RK4 method. Adapted from [1].
Obviously, it is less “expensive” (in terms of computational time) to have fewer, larger time
steps. However, a larger step size (h) will produce a less accurate result. Ideally, you want the
largest step size you can without allowing the solution to diverge from the actual solution (here
you can define an acceptable error tolerance for your problem). This step size may need to
be smaller or larger at different stages in a simulation or for equations with widely different
timescales (stiff systems). Adaptive RK methods are used in these circumstances.
Adaptive methods produce an estimate of the local truncation error at a single step and
then use that estimate to adjust the step size for the next iteration. The actual error between
the calculated numerical solution and the actual solution cannot be calculated (as the actual
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solution is not known). For the purposes of adaptive step size calculations, the exact solution
is instead estimated as the solution gained using a RK method one order higher. An RK-45
method is a fourth order method that uses the fifth order calculation to help adjust the step size.
This is done by having two methods in the tableau, one with order s and one with order (s−1).
The lower-order step (labelled using an *) is calculated:
y∗n+1 = y∗n+
s
∑
i=1
b∗i ki (2.19)
where the ki are the same as for the higher order method and b∗i can be found from an extended
version of the Butcher Tableau for this method.
The estimated error (at any given step) can be calculated as follows:
en+1 = yn+1− y∗n+1 = h
s
∑
i=1
(bi−b∗i )ki (2.20)
Now, if h1 is the step taken by the solver to produce an error ε1, then the step size h0 that
would have produced an error ε0 can be calculated by
h0 = h1
∣∣∣∣ε0ε1
∣∣∣∣1/s (2.21)
Here ε0 represents the desired accuracy or tolerance – this is decided before we begin. Thus,
if ε1 > ε0 Equation 2.21 will calculate how much h0 should decrease by, and if ε0 > ε1, it will
calculate how much it should increase by. In this way, as solution progresses, the solver will
adjust to smaller step sizes when the solution exhibits stiffness, and adjust to larger ones as the
solution exhibits smoother behaviour.
In practice, systems of ODEs are solved using these types of numerical algorithms imple-
mented on a computer system.
2.3 Sigmoidal Behaviour
Many natural processes, including the opening of ion channels in a cell, exhibit a progression
from a small value that increases quickly and approaches a plateau over time. This “S-shaped”
behaviour can be described by a sigmoidal function – Figure 2.4.
There are many ways to mathematically represent a sigmoidal function; some use the expo-
nential function (exp(x)) and some use the hyperbolic tan (tanh) function. For more information
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Figure 2.4 Example of sigmoidal behaviour: the fraction of open channels at different cell membrane potentials.
about these representations and how ion channels are represented by sigmoidal functions, see
Appendix C.
2.4 Binding and the Hill Equation
The binding of a ligand to a receptor can be enhanced if there are already other ligands bound
on the same receptor; this phenomenon is known as cooperative binding. The Hill equation
can be used to characterize such binding behaviour (as a function of ligand concentration). It
can be easily derived from the binding scheme below in which n molecules of ligand L bind to
a receptor R [162]:
R+nL
k f


kb
RLn (2.22)
or
R+nL
Kd
 RLn (2.23)
where the dissociation constant, which describes the tendency of a larger object to “break up”
into smaller pieces, is given as Kd ≡ kbk f . The Hill Equation is as follows:
bound
total
=
[L]n
Kd +[L]n
(2.24)
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n (the Hill coefficient) provides a way to quantify the cooperativity of the binding. A coefficient
greater than 1 indicates “positive cooperation” (that is, once one ligand is bound, the enzyme’s
affinity for other ligands increases). A coefficient less than 1 describes the opposite (that is, the
affinity decreases). A coefficient equal to 1 indicates a “non-cooperative reaction” where the
affinity is independent of prior ligand binding.
It is important to note that the reaction scheme (Equation 2.23) that gives rise to the Hill
equation is a convenient mathematical simplification of binding that implies “simultaneous”
binding; in reality, however, binding will occur in a sequential or independent fashion (Fig-
ure 2.5).
Figure 2.5 Schematic representation of a sequential vs. an independent ligand binding mechanism. L, ligand;
R, receptor. Adapted from [162].
2.5 Michaelis-Menten Kinetics
“Michaelis-Menten kinetics” (named after German biochemist Leonor Michaelis and Canadian
physician Maud Menten) can be used to describe enzyme and protein-protein interactions. The
model consists of a single equation which describes the rate of an enzymatic reaction by relating
the reaction rate V to [S], the concentration of a substrate S. Its formula is given by:
V =
Vmax[S]
Km+[S]
(2.25)
Vmax is the maximum rate achieved by the system at maximum (saturating) substrate concen-
trations. Km is the substrate concentration at which the reaction rate reaches half of Vmax. A
small Km indicates that the substrate has a high affinity for the enzyme, so the reaction rate will
approach Vmax more quickly. As shown in Figure 2.6 below, the reaction rate increases with
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substrate concentration [S], and tends to its maximum rate Vmax when all the enzyme is bound
to the substrate.
Figure 2.6 Michaelis-Menten kinetics and parameters. Adapted from [8].
2.6 Electrical Math
Cells in the human body are “powered” by electricity (Figure 2.7). This electricity has many
similarities to the electricity that flows through the wires of an electrical appliance; therefore,
with some adjustments, we can use the same equations for cell electricity as those used for
standard electrical circuits. First: the definition of important terms and equations. Then: how
to use them in the context of cell electricity.
Current (I) is the flow of electric charge through a medium. Commonly, we think of elec-
trical charge travelling through a wire as negatively charged electrons, but electrical charge can
travel in and out of cells as positively charged ions also. Voltage (V , also called electromotive
force) is the potential difference between two points in an electrical field. As cells are usually
more negative inside the cell membrane than they are outside, they have a membrane voltage
(or membrane potential). The greater the voltage, the greater the flow of electrical current
through a conducting medium for a given resistance (R) to that flow. This can be summarised
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Figure 2.7 The origin of the electrical equivalent circuit of the cell membrane. Adapted from [21].
in Ohm’s Law, the first important equation needed for cell electrical analysis:
V = IR (2.26)
Capacitance (C) refers to the ability of a system (in this case, a cell membrane) to store
electrical charge. It can be quantified as the ratio of charge (Q) to potential (V ). Charge is not
a useful measure for these purposes and it can instead be written in terms of current (as current
(I) is the rate of change of charge (Q) with time (t)). That is:
I =
dQ
dt
(2.27)
As C = Q/V (or Q = CV ), a small change in Q (δQ) will yield a corresponding small
change in V (δV ) to give:
δQ =CδV (2.28)
Combining Equations 2.27 and 2.28 to obtain a more useful (and differential) form of the
capacitance law gives:
C
dV
dt
= I (2.29)
As there are many ion channels present in a cell membrane, there are many different cur-
rents. We therefore rewrite Equation 2.29 in terms of the sum of all the currents of ions through
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all the membrane’s N ion channels (Equation 2.30).
C
dV
dt
=
N
∑
i=1
Ii (2.30)
The current IA through a generalized “A” ion channel can be expressed by a special form of
Ohm’s Law (Equation 2.31). Here, conductance gA – the ease by which the channel conducts
charge – is used instead of its reciprocal, resistance (a measure of how much the channel resists
flow).
Ohm’s Law: I =
V
R
⇒ IA = gAa(V −VA) (2.31)
where gA is the maximum conductance for all “A” ion channels in the cell, a is the fraction of
open “A” channels, V is the membrane potential of the cell, and VA is the reversal potential (or
Nernst potential). The reversal potential (VA) is the membrane potential at which there is no net
flow of an ion from one side of the membrane to the other (an equilibrium state). Therefore,
the terms (V −VA) constitute the “driving force” for ionic flow.
If an ion channel type selective to one species of ion dominates within the membrane of a
cell (perhaps because this type is present in greater densities or because other ion channels are
closed), then the cell’s membrane potential will tend to equilibrate to the reversal potential for
that ion.
2.7 Fluid Flow and Electricity
When a fluid in a pipe is subjected to a pressure gradient, it will flow along the pipe. The rate
at which the fluid flows (Q) is proportional to the pressure gradient (∆P) driving that flow. So,
Q ∝ ∆P (2.32)
This flow will be met with a resistance (R), which gives:
Q =
∆P
R
(2.33)
The flow of fluid through a pipe and the flow of charge through a circuit can be described
in a similar way using the language of mathematics. In fact, the relationship between fluid flow
and pressure in the pipe is analogous to Ohm’s Law for electrical circuits:
I =
∆V
R
(2.34)
19
Here, the flow of electrical current (I) is driven by a difference in electrical potential or voltage
(∆V ) and is resisted by the resistance (R) of the electrical components in the circuit.
The resistance to fluid flow in a pipe results from 1) the friction between particles in the
fluid (this is reflected in the viscosity of the fluid), and 2) the friction between the fluid and the
pipe wall (which is determined by the pipe’s length and radius). Resistance can therefore be
represented mathematically by:
R =
8µL
pir4
(2.35)
where L is the length of pipe, µ is the viscosity, and r is the radius.
Equation 2.35 demonstrates that changes in the radius of the pipe can have a profound
effect on fluid flow as the resistance to flow is inversely proportional to the fourth power of the
radius. For example, halving the radius of a pipe increases the resistance to fluid movement by
a factor of 16.
The combination of Equations 2.35 and 2.33 gives Poiseuille’s Law:
∆P =
8µLQ
pir4
(2.36)
In the context of blood flow autoregulation modelling, we are interested in the relationship
between compensatory blood vessel radius changes and the corresponding change in blood
flow delivery to the tissue. In a rearrangement of Poiseuille’s Law, the radius of a vessel r and
the blood flow through that vessel Q, can be shown to be related by:
Q =
∆Ppir4
8µL
=
∆Ppi
8µL
r4 = Kr4 (2.37)
Here we simplify this relationship by assuming all the other components are constant and
“lumping” them together as one term, K.
We are interested in the changes in r and Q and how they relate to one another and so we
need to use derivatives of r and Q. They are related as follows:
δQ =
∂Q
∂ r
δ r (2.38)
Differentiating Equation 2.37 with respect to r and substituting the result into Equation 2.38
yields Equation 2.39 below.
δQ =
∂Q
∂ r
δ r = 4Kr3δ r = 4Kr4
δ r
r
(2.39)
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As Q = Kr4, Equation 2.39 becomes:
δQ
Q
= 4
δ r
r
(2.40)
This means that the expected relative or percentage change in blood flow (δQQ ) will be four
times the percentage change in radius (δ rr ) that causes it. For example, a 1% change in radius
corresponds to a 4% change in blood flow through that vessel.
2.8 Muscles as Machines
Muscle converts the chemical fuel that we obtain from our food into the force and power needed
to move parts of our body (like our legs, arms and importantly, the walls of our blood ves-
sels). Our “muscle machinery” is comprised of myosin and actin proteins and the chemical
fuel “burned” is in the form of ATP. Neither myosin nor actin has the ability to contract by
itself. Contraction instead comes from the “interdigitation of myosin and actin [159]” which
allows the filaments to ratchet along each other. This ratcheting action is analogous to hauling
something toward you by pulling a long rope, arm over arm [159]. The “arms” here are thick
protrusions from myosin filaments that attach (in a crossbridge), swing through an arc, detach
and then reattach farther along the actin filaments. The swinging movement that occurs when
they are attached is the motion that accomplishes contraction. The following questions remain:
• How do we quantify the movement of contraction?
• Are there other forces at play other than the active force of contraction?
• What equation/s are needed to describe these?
• How do we work with the cylindrical geometry of the smooth muscle layer in the arteri-
ole?
The answers to these questions are not obvious, nor are they definite. In fact, different
modellers use different models and/or model parameters depending on 1) their understanding
of the mechanism involved, 2) the experimental data on which their contraction information is
based, and 3) the assumptions and simplifications they define as part of the model development.
One method of modelling vascular smooth muscle cell contraction begins by first considering
a section of the arteriolar wall as a viscoelastic material (that is, a material that has both elastic
and “viscous” (damped) properties), and then applying a force balance to it.
The active force that is provided by the crossbridges in the smooth muscle is not the only
force that we need to consider. There is also the force provided by the pressure of blood acting
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on the wall, the wall shear stress exerted by the flowing blood, and the viscoelastic forces
exerted by the components of the wall. It helps to first have an understanding of the forces
involved in this situation. The following sections describe the concepts and definitions needed
to develop a model of muscle contraction (which we will do in Chapter 6).
2.8.1 Stress σ
A deformable body is a physical object that can be deformed; i.e., it will change its shape
when an external force acts upon it. Stress is a measure of the internal forces acting within the
body which are reactions to external forces applied on the body. Tensile stress acts to stretch
while compressive stress acts to compress. Stress can be quantitatively described as the average
internal force applied per unit area of a surface within the body. Therefore, the dimension of
stress is that of pressure and has the (SI) unit of a pascal (symbol Pa). It is important to note
here that although stress has the dimension of pressure, the external forces that act on the body
do not have to be perpendicular (or normal) to the surface of the object. Forces can also be
applied tangential to the body, as will be shown in a later section.
2.8.2 Strain ε
When a body is deformed, particles within the body are displaced from their original position.
A strain is a normalized measure of the size of the deformation/displacement relative to an
initial or reference body size. Strains are relative measures and are thus dimensionless. They
are usually expressed as a decimal fraction, as a percentage, or in “parts-per” notation.
2.8.3 Measures of Stretchiness (Elasticity)
The relationship between tensile stress and strain in a deformable body is unique for each
material and can be measured using a tensile test, where the amount of deformation (strain)
is measured at known levels of stress. This data can be represented as a stress-strain curve
(Figure 2.8). The elastic modulus of the body is the slope of this curve in the elastic deformation
region (the region in which the body will still “spring back” to its initial shape after the force is
removed). A stiffer material will have a higher elastic modulus. In the case of tensile elasticity,
the elastic modulus is called the Young’s modulus (E).
There are also other measures to describe elasticity. For example, when a body is stretched
it tends to get longer in the direction of the stretch, but thinner in the other two directions
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Figure 2.8 A stress-strain curve. The elastic modulus is the slope in the initial (elastic deformation) region.
Adapted from [10].
(Figure 2.9). This phenomenon is the Poisson effect, which is quantified by Poisson’s ratio, ν .
The Poisson ratio is the ratio of the fraction of expansion divided by the fraction of compression.
Figure 2.9 A cube with a Poisson’s ratio of 0.5 and sides of length L is stretched along the x axis. The trans-
formed cube is expanded in the x direction by ∆L and contracted in the y and z directions by ∆L′. Adapted from
artwork released into the public domain [3].
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2.8.4 The Stress Tensor
One cannot describe a stress without first specifying the direction on which it acts. Stresses
acting on a body can be resolved (split up) into three orthogonal (perpendicular) components:
one component is normal to the surface and represents normal or direct stress and the other
two components are tangential to the surface and represent shear stresses. Direct stresses will
change the volume of the body; shear stresses will change the shape of the body, but the volume
will remain unchanged.
In Cartesian (“xyz”) coordinates, the stress at a single point inside the body can be rep-
resented by an infinitesimally tiny cube with the three stress components on each of its sides
(one direct and two shear components for the top/bottom, left/right and front/back sides) – Fig-
ure 2.10. These nine components can be organized into a matrix:
 σxx σxy σxzσyx σyy σyz
σzx σzy σzz

Figure 2.10 The nine stress components in a Cartesian coordinate system. Adapted from [5].
This special way of grouping the components together is known as the stress tensor.
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Sometimes, the Cartesian coordinate system described above is not the most useful system
to use. For example, the force applied to an arteriole wall can be decomposed more easily
into components parallel to the cylindrical coordinates: r, z, and θ (Figure 2.11). These forces
induce corresponding stresses within the body: radial stress, axial stress and hoop (or circum-
ferential) stress, respectively.
Figure 2.11 The nine stress components in a cylindrical coordinate system. Adapted from [7].
In both cases, there are nine possible stresses that can act on any internal point within the
body. The sum of these stresses will determine how the body “deforms” (changes shape).
2.8.5 Models of Viscoelasticity
Several viscoelastic models exist and they are comprised of combinations of two main ele-
ments:
• a dashpot with viscosity η which obeys the relation σ = η · dεdt
• a spring with elastic modulus E which obeys the relation σ = E · ε
These elements are shown schematically in Figure 2.12.
Common viscoelastic models include the Kelvin-Voigt and the Maxwell models (Fig-
ures 2.13 and 2.14, respectively).
We can then make mathematical statements about the stresses (and strains) in the model of
our choice. Let’s take the Kelvin-Voigt model (Figure 2.13) as an example:
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(a) dashpot
(b) spring
Figure 2.12 A dashpot with viscosity η and a spring with elastic modulus E
Figure 2.13 The Kelvin-Voigt model, which consists of a dashpot and a spring connected in parallel
Figure 2.14 The Maxwell model, which consists of a dashpot and a spring connected in series
The two components of the model are arranged in parallel; as such, the strains in each
component are identical:
εtotal = εdashpot = εspring (2.41)
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Similarly, the total stress will be the sum of the stress in each component (that is, the applied
load is borne by the spring and the dashpot):
σtotal = σdashpot +σspring (2.42)
From these equations and the two relations σ = η · dεdt and σ = E · ε , we deduce, that in
a Kelvin-Voigt material, stress σ , strain ε and their rates of change with respect to time t are
determined by Equation 2.43:
σ(t) = Eε(t)+η
dε
dt
(2.43)
2.8.6 Laplace’s Law for Thin-Walled Vessels
Laplace’s Law states that if you have a larger vessel radius, you will need a larger wall tension
to withstand a given internal fluid pressure. Arteries can be viewed as cylindrical thin-walled
vessels and can be modelled by the Law of Laplace:
T =
pr
h
(2.44)
where T =wall tension, p=pressure, r=radius, and h=wall thickness.
For a given internal fluid pressure, a larger vessel radius requires a larger wall thickness
to accommodate a stable wall tension. Further, increases in the pressure load inside the vessel
will necessitate an increase in the vessel wall thickness.
2.9 Mathematical Models
2.9.1 What Are Mathematical Models?
Mathematical modelling helps scientists better understand the mechanics and dynamics that
underlie their experimental observations [155]. Simply put, a mathematical (or theoretical)
model is a description of a physical system using mathematical language. Generally, a mathe-
matical model includes a set of variables and a set of equations that relates the variables to one
another.
Mathematical models can take many forms and can be classified in many ways. They can:
• be linear or non-linear
• have coupled or uncoupled variables
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• be deterministic (with variables uniquely defined by parameters and initial values) or
stochastic (with variables represented by probability distributions)
• be static or dynamic (a static model does not account for the element of time, while a
dynamic model does)
Physiological models “specify how the concentrations of biochemical substances change
in time, in and around cells, when influenced by the presence or absence of other molecules
[155]”. These models are comprised of a set of differential equations which encompass a
variety of parameters, such as rate constants and thresholds, which need to be determined using
appropriate experimental data [155].
2.9.2 Why Make Models?
“The purpose of [mathematical] models is not to fit the data but to sharpen the
questions.”
— Samuel Karlin, mathematician
It is easy to assume that the purpose of mathematical models is to simply calculate values
that are in fitting with experimental data. However, fitting data is not particularly difficult and
it provides little information. In fact, modelling is meaningless unless its value or its goal is
explicitly stated at the outset. The first step to take in any modelling study is to therefore define
the goals that are to be achieved. Bailey [16] provides the following collection of possible goals
that arise from the question: Why make models?
• “to organize disparate information into a coherent whole
• to think (and calculate) logically about what components and interactions are important
in a complex system
• to discover new strategies
• to make important corrections to the conventional wisdom
• to understand the essential qualitative features [16] ”
So, why should we make physiological models? Because physiological modelling, in conjunc-
tion with experimental work, has the potential to overcome the difficulties we have in under-
standing multiplex physiological systems such as our circulatory system. Several hypothesized
mechanisms can be integrated into a singular framework which can then be used to predict or
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understand the overall behaviour of a larger system or behaviours at a lower level (cell, cells,
segment, or segments level, in the case of blood flow regulation models). Further, the relative
contributions of particular biological pathways can be assessed by removing them from the
model, just as it is commonly done in experiment (except in a model, we are creating “mathe-
matical knockouts” instead of physical ones) [143]. Essentially, models help us to organize our
confused thoughts about complex biological phenomena. Indeed:
“The essence of mathematics is not to make simple things complicated, but to
make complicated things simple.”
— Stanley Gudder, mathematician
2.9.3 Types of Theoretical Models
Models can be roughly divided into two types: conceptual and phenomenological. Conceptual
models are based on mathematical descriptions of underlying physical processes, whereas phe-
nomenological models are formed by fitting equations to observed behaviour [144]. A brief
description of the uses, benefits and weaknesses of these two model types follows.
2.9.3.1 Phenomenological Models
These models are not built upon descriptions of the underlying physical, mechanical or chem-
ical processes. As such, these models cannot be used for simulations outside of the specific
process or data set modelled. However, framing the data in a succinct mathematical construct
in the making of these models can help to simplify complex data sets and can help to reveal
statistical patterns [144].
2.9.3.2 Conceptual Models
These models are based on a conceptual understanding of the underlying physical mechanism
that governs the behaviour. Some model parameters can be known a priori or can be scav-
enged from experimental data. Model results can be compared qualitatively or quantitatively to
experimental observations for appropriate values of any unknown parameters. Discrepancies
between model and observed behaviour could mean that the mechanism is not valid or that it
has been poorly represented by its parameters. If there is agreement, the parameters can be opti-
mized so that the model can obtain the best fit to experimental data. Parameter values outputted
from this optimization can then be analyzed in terms of what they could mean in terms of the
proposed mechanism. Those unfamiliar with theoretical modelling may judge the success of a
model by the nearness of its fit to experimental data [144]. It is important to be aware that it is
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not necessarily the case; in fact, a close fit to a set of experimental data does not guarantee the
correctness of the proposed mechanism. A failure to achieve a close fit can reveal more to the
modeller: the discrepancy can point out the areas in which an incorrect assumption has been
made or may make it clear that not enough detail was included [144].
If we are fortunate enough to be modelling a system where the underlying mechanisms
are well understood and well characterized, we can build a theoretical model where all the
equations and parameters are known. The completed model can be validated against known
experimental data, and can then be used to predict results in a computational “experiment.” Of-
ten, a modeller’s ultimate goal is the development of a model that can be extensively validated
(compared) against experimental data. However, the value of a predictive sort of model ex-
ceeds this limited goal of merely reproducing what has been done before. A successful model
could form a constituent of a larger multiscale project [144] or suggest novel experiments that
could be used to help advance or reform the model [155]. Even better, it can be used to predict
behaviours in conditions that have not yet been studied – or are difficult to study – experimen-
tally. Many and varied computational experiments can be simulated in the time it would take
to formulate and undertake a single physical experiment and can be performed without once
lifting a scalpel.
2.10 Summary
Physiology is Physics. To understand physiology is to understand how chemical, electrical and
mechanical forces are involved with the functioning of living cells and organisms.
Chemical reactions in the body occur in dependence upon the binding of substrates to
enzymes. Chemical species can also bind to receptors on cells, initiating further chemical
reactions. Differing concentrations of charged ions create a potential difference (voltage) across
the membrane, fluxes of charged ions become electrical flux (or current), and the cell membrane
itself acts as a capacitor. Mechanical stresses are exerted on deformable vascular walls by
flowing blood, by myosin-actin crossbridges, and by viscoelastic wall components. All of
these physiological phenomena can be simplified and be more easily understood using the
mathematics. In fact, a physiological model is simply a description of a physiological system
using mathematical language. Physiological models help us to organize and simplify complex
information, think logically about what components are important in a system, and sharpen our
research questions.

Chapter 3
Anatomy and Physiology
3.1 Introduction
“The brain is the great receiving and distributing reservoir of vital electricity,
just as the heart is the receiving and distributing reservoir of the blood.”
— Edward B. Foote, Medical Common Sense, 1866
The problem of the brain and its blood supply is a multiscale one, with scales spanning
from the entire brain organ down to the level of ions and proteins that move within and between
neuronal and glial cells. Macroscale events can affect systems in the microscale and microscale
events can affect macroscale systems. The following chapter gives a brief overview of the
important small and big “things” pertinent to this project. I will start with the big (brains and
blood vessels) and progress to the small (cells, ions and proteins). A detailed description of the
physiological processes involved in blood flow autoregulation and neurovascular coupling will
then be given.
3.2 Blood Flow to the Brain – The “Big Things”
3.2.1 The Brain
The nervous system has three main functions: it 1) takes sensory inputs, 2) collates and pro-
cesses them, and 3) provides motor output to muscle cells. The central nervous system (CNS)
is responsible for integrating the information, while the network of nerves in the peripheral
nervous system (PNS) transports sensory and motor signals between the CNS and the rest of
the body.
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3.2.1.1 Brain Regions
The brain is separated into two halves (the left and right hemispheres) which communicate
through the corpus callosum, a thick band of nerve fibres. There are many parts of the brain
(Figure 3.1) and each part is in charge of certain functions.
Figure 3.1 Main parts of the brain. Adapted from [12].
The brainstem (medulla oblongata, pons and midbrain) relays data and controls automatic
activities essential for survival, such as heart rate, breathing and swallowing. The cerebel-
lum controls movement and balance. The diencephalon consists mainly of two structures: the
thalamus, which relays sensory input to the cerebral cortex, and the hypothalamus, which is
responsible, among other things, for controlling the autonomic nervous system. The cerebrum
interprets sensory impulses and controls conscious motor activity, emotion and intellectual pro-
cesses. It folds in on itself, creating bulges (gyri) and crevices (sulci). The outer part of the
cerebrum (known as the cerebral cortex) is made of gray matter, and the inner part is made of
white matter. Gray matter is gray because it consists mainly of unmyelinated nerve cell bodies;
white matter is white because it mainly consists of myelin-coated nerve cell fibre. The cerebral
cortex can be further divided into four lobes: the frontal, parietal, occipital, and temporal lobes
(Figure 3.2).
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Figure 3.2 Lobes of the brain. Adapted from [12].
3.2.2 The Major Arteries of the Brain and the Circle Of Willis (CoW)
Blood flow to the brain is important, and as such, the brain is a highly vascularised organ. In
fact, the brain is the only organ in the body that is supplied by four arteries: the two Vertebral
Arteries (VAs) and the two Internal Carotid Arteries (ICAs). The VAs join together to form
the Basilar Artery (BA) before they meet the ICAs in a ring-like structure called the Circle of
Willis (CoW). The blood that enters the CoW is then distributed by the Anterior Cerebral Ar-
teries (ACA), Middle Cerebral Arteries (MCA), and Posterior Cerebral Arteries (PCA). These
arteries then bifurcate into smaller arterial branches. The Circle of Willis, with its ring-like
conformation of branches, allows flow to be maintained in the case of impaired or blocked flow
in one of the major afferent arteries. Essentially, as long as the “CoW is complete”, if one artery
is blocked, blood can still reach the brain tissue through an alternative CoW route. However,
this “back-up system” is heavily dependent on the presence and/or size of all the CoW vessels
and not everyone has a complete CoW (Figure 3.3). In fact, approximately half of the popula-
tion has an incomplete CoW [89] – a fact that may not cause problems for a healthy individual,
but may be very important for a person with cerebrovascular disease (see Chapter 4).
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Figure 3.3 Arteries that surround and constitute the Circle of Willis in the brain. Image on left adapted from [6]
and images on right adapted from [89].
3.2.3 Moving Down The Vascular Tree – From Arteries to Arterioles to
Capillaries to the Tissue
From the heart to the tissue, blood vessels undergo repeated branching to progressively smaller
sizes and increasing numbers. Blood vessels can be classified into arteries, arterioles, capil-
laries, venules and veins. For this study, we focus on the delivery of blood to the cerebral tissue
and not its journey back to the heart via the venous system; as a result, we focus only on the
structure and function of the arteries, arterioles and capillaries.
Blood flow velocity decreases significantly in the arterioles and is slowest in the capillaries
due to the increase in total cross-sectional area that these vessel groups contribute. Blood
pressure is the force exerted on the wall of the vessel and is determined in part by the pressure
supplied by the heart, but also by the peripheral resistance of the arterioles, the “bottlenecks”
of the circulatory system [32] – Figure 3.4.
The structure of a blood vessel (that is, the composition of its wall components) changes
as we travel down the vascular tree. These structural differences correlate with their different
functions. All vessels in the body, including the capillaries, have a tightly coupled endothe-
lial cell layer that lines the lumen. Arteries, arterioles and veins have additional outer layers
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Figure 3.4 Blood pressure and velocity in, and the total cross-sectional area and resistance contribution of, the
arteries, capillaries and veins of the circulatory system. Adapted from Figure 14.6 in [27].
composed of smooth muscle, elastic fibres and connective tissue (Figure 3.5).
Arteries have the thickest, strongest and springiest (most elastic) walls, so they can with-
stand the high blood pressure and fast blood flow that occurs there [32] (Figure 3.4). The
transfer of nutrients between blood and the interstitial fluid surrounding tissue occurs across
the thin walls of the capillaries – the low flowrates through the capillaries enhance this ex-
change (Figure 3.4). Capillary walls consist only of a single layer of endothelial cells and a
basement membrane. The supply of blood to different organ and tissue regions is primarily
governed by the variable constriction of sections of the arteriolar tree and by the closing and
opening of sphincters that surround precapillary vessels.
The arterioles have relatively thick walls compared to their diameter as they have many
layers of smooth muscle. The presence of large amounts of smooth muscle allows these ves-
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Figure 3.5 Structural differences between arteries, arterioles and capillaries. Adapted from Figure 14.4 in [27].
sels to significantly regulate their diameter and therefore change the resistance to blood flow
[32]. For this reason, these vessels are often termed resistance vessels. Arterioles range from
approximately 40 µm to as small as 9 µm in diameter, and have one to two layers of smooth
muscle cells in their wall. Arterioles can, with their high cumulative resistance, be responsible
for the majority of the control of the total vascular resistance of the tree [32].
The capillaries are the smallest vessels in the vasculature (about 7–9µm in diameter) and
their purpose is to deliver nutrients to, and remove wastes from, the tissue. Red blood cells
flow through most capillaries in a single file and frequently are folded and squeezed as they
pass through the smaller diameter capillaries. Capillaries do not function independently; they
form interconnected networks called capillary beds. Fat-soluble substances, such as oxygen
and carbon dioxide, as well as small water-soluble molecules readily diffuse through the plasma
membrane. Larger water-soluble substances must pass through the fenestrae or “gaps” between
the endothelial cells. The tightly arranged endothelial cells form a barrier to the red blood cells
themselves and to harmful substances. When people refer to the blood-brain barrier (BBB) they
are referring to the tightly packed endothelial cells that act as permeability barriers to certain
substances [32]. The BBB protects the brain from attack from harmful substances, but can also
make it difficult to treat neurological diseases, as drugs must be capable of passing the barrier
in order to have an effect on the diseased tissue.
Neurons are closely affiliated with cerebral blood vessels [46]. Pial arteries (those on
the outside of the brain) are densely innervated (supplied) by nerve fibres that contain many
vasodilators and constrictors. Small arteries and arterioles are generally innervated to a greater
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extent than other blood vessel types and are contacted by neural processes that originate from
local interneurons [78]. Local conditions in the neuronal tissue effect changes in the calibre
(diameter) of the arterioles, adjusting the resistance of the tree, and hence altering the delivery
of blood flow to that region. This local control (“autoregulation”) ensures that there is adequate
blood supply to meet the demand. The physiological processes involved in autoregulation are
outlined later in this chapter.
3.3 Cells and Other Important “Small Things”
3.3.1 Cells
3.3.1.1 Major Cell Components
All cells are encapsulated by a selectively permeable membrane which is comprised of lipids
and proteins. This membrane (also known as a plasma membrane) protects the cell’s contents
and allows an electrical potential to be maintained. It also facilitates the transport of important
molecules in and out of the cell. Organelles (“miniature organs”) can be found within the
interior environment of the cell, the cytoplasm. There are many types of organelles (Figure 3.6)
and each one has a specific role to play.
Figure 3.6 Organelles in an animal cell. Adapted from [4].
The cell nucleus is the cell’s library – it holds all of the information the cell needs. This
is where the cell’s genetic material is stored and where most of DNA replication and RNA
synthesis occurs. Mitochondria are responsible for generating the cell’s energy by oxidative
phosphorylation, using oxygen to release energy stored in cellular fuel (normally glucose) to
generate ATP, a coenzyme capable of performing cellular work. The endoplasmic reticulum
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(ER) constitutes the cell’s “stores” or “holding area”. It holds molecules requiring modification
or transport. The ER has two forms: the rough ER and the smooth ER. The sarcoplasmic
reticulum (SR) is a special type of smooth ER found in muscle. It is concerned only with
calcium sequestration and release, processes that play a major role in muscle contraction (more
on this in a later section).
3.3.1.2 Cells and Electricity
The human body runs on electricity. Electrical signals within cells are driven by ions (charged
atoms). Some of the important ions in cellular biology are sodium Na+, potassium K+, calcium
Ca2+ and chlorine Cl−.
All animal cells maintain a voltage difference across the cell’s plasma membrane; this is
called the membrane potential. At rest, a cell has a negative membrane potential, meaning
that there are more positive ions outside than there is inside. When the membrane potential
undergoes a change in which it becomes less negative, this is called a depolarization. When
the voltage becomes more negative, this is called a hyperpolarization. A change back to resting
state after hyper- or depolarization is termed a repolarization. These different levels of polar-
ization result from the operation of ion channels and ion pumps: protein structures that are
embedded in the membrane.
Ion pumps use cellular energy (ATP) to continuously move ions in and out of the cell. They
create concentration differences (between the inside and outside of the cell) by transporting
ions against their concentration gradients (from regions of low concentration to regions of high
concentration). Ion channels, on the other hand, transport ions “down” their concentration
gradients (that is, from regions of high concentration to regions of low concentration). Ion
pumps provide continuous transport, whereas ion channel fluxes are noncontinuous: they are
“gated” by (open and close in response to) chemical and electrical (voltage) signals.
Ion channels are specially shaped proteins that contain a pore through which ions can
travel. They are categorised by how they respond to signals from their environment. For
example, there are voltage-gated channels which open and close in response to the voltage
across the membrane. Ligand-gated channels open and close in response to the binding of a
ligand (signal-triggering) molecule, such as a neurotransmitter. Some channels can be both
ligand- and voltage- gated. Ion channels can also open and close in response to mechanical
forces, such as pressure or shear stress.
Most channels are specific for one ion, even though cell ions can be approximately the
same size and charge (like potassium (K+) and sodium (Na+), for example). A channel may
have several different states (corresponding to different conformations of the protein), but each
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such state is either open or closed. When we create equations to describe the behaviour of
ion channels, we refer to the probability distribution of channels in an open state. It is called
a probability distribution because it describes the proportion of channels that are likely to be
open at a given voltage. These distributions can be shifted due to the presence of ligands and
also due to ionic concentrations inside or outside the cell.
The resting (equilibrium or Nernst) potential of an ion channel is the potential at which
no ions feel compelled to pass through it (that is, the electric force generated by diffusional
movement of the charged ion down its concentration gradient becomes equal to the molecular
force of that diffusion). The equilibrium potential for any ion can be calculated using the Nernst
equation.
Like an electrical circuit, the cell membrane has a capacitance, which is a measure of
how much charge must be passed across the membrane in order to produce a given change in
membrane potential. Each different ion channel has a different electrical resistance associated
with it. In physiological modelling, it is common to use conductance (the inverse of resistance)
to describe the “difficulty” by which open ion channels pass charge in and out. The size of
the ionic flux through an open channel is determined by the maximum channel conductance
and the electrochemical driving force for that ion (the difference between the actual membrane
potential and the resting potential) – see Chapter 2 for further explanation.
Another important electrical cellular event is known as the action potential, which involves
the transport of Na+ and K+ across the membrane. Action potentials occur in many different
types of animal cells, but they exist in neurons as a mechanism for cell-cell communication. An
action potential (or “depolarizing wave”) in the neuron is a “transient (<1 millisecond) reversal
in the polarity of the membrane potential which then moves from its point of initiation, down
the axon, to the axon terminals [17]”.
3.3.2 Cells in the Brain
Brain tissue is composed of neurons and supporting cells (glia). Neurons create and transmit
signals. Glia support, insulate and protect neurons. We are particularly interested in the glial
cell called the astrocyte, as it is known to have an important role in the control of vascular tone
(the degree of tension/constriction an arteriole possesses).
Vascular tissue (also found in the brain, in the blood vessels that perfuse brain tissue)
contains endothelial cells (ECs) and smooth muscle cells (SMCs).
Finally, blood, a connective tissue, circulates through the lumen (inside) of brain blood
vessels, and contains a collection of ions and proteins, nutrients, metabolic waste products,
hormones, and respiratory gases.
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3.3.2.1 Neurons
A neuron (Figure 3.7) consists of a cell body (or soma), dendrites, and an axon. An axon is
a part of the neuron that extends out like a thin strand from a lump at the cell body (the axon
hillock). Dendrites are also filaments (strands) that protrude from the cell body. They branch
extensively, giving rise to a complex dendritic “tree.” A dendritic spine (or simply spine) is a
small protrusion from a neuron’s dendrite that typically receives input from a single synapse
of an axon. A neuron can have many dendrites, but only one axon. Axons are commonly
surrounded by myelin sheaths. The sheaths are formed by glial cells, and they enable action
potentials to travel faster whilst using less energy. The myelin sheath is interrupted at intervals
by nodes of Ranvier which contain a high density of voltage-gated ion channels [32].
Figure 3.7 A neuron. Adapted from [9].
Chemical signaling between neurons occurs via synapses. Signals from one neuron to oth-
ers are transmitted from the axon to the soma and dendrites. A synapse, therefore, is the place
at which the axon of one neuron comes into contact with the dendrite or soma of another. The
process of synaptic communication begins with an action potential (described earlier). When
an action potential reaches the axon terminal, it opens voltage-gated calcium channels, allow-
ing calcium ions to enter the terminal. Calcium causes vesicles (membranous bubbles) filled
with neurotransmitter molecules to fuse with the membrane, releasing their contents into the
synaptic cleft [32]. The neurotransmitters diffuse across the synaptic cleft and activate recep-
tors on the postsynaptic neuron (neuron at the opposing end of the synapse) or on neighbouring
glia.
Neurotransmitter receptors can be classified into ionotropic or metabotropic receptors.
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Ionotropic receptors form an ion channel pore; when they are activated, they allow ions to
flow. A metabotropic receptor does not form a channel pore; instead, when a metabotropic
receptor is activated, a series of events involving intracellular second messenger chemicals is
triggered. These events can culminate in ion channel opening but do so indirectly, through
signal transduction pathways (often involving G-proteins).
No neuron is like another; they come in a wide variety of shapes and sizes and have diverse
electrochemical properties [32]. They also tend to specialise in a particular task. For exam-
ple, sensory neurons respond to stimuli (like light, sound and touch) and send signals to the
spinal cord and brain. Motor neurons work in the opposite direction; they receive signals from
the brain and spinal cord and cause muscle contractions and changes in glands. Interneurons
connect neurons to other neurons.
3.3.2.2 Glia – Astrocytes and Pericytes
Historically, astrocytes, as well as other glia, were believed to be structural cells [107]; that is,
their main function was to “glue” the neurons in place. It is now known, however, that astro-
cytes serve many functions and are responsible for maintaining the neuronal environment. This
includes clearing away excess potassium and neurotransmitters, providing important support
molecules to synapses, and contributing to the health of the BBB (blood brain barrier) [160].
Astrocytes also regulate cerebral blood flow in periods of changing neuronal metabolism [107];
in other words, they are involved in “neurovascular coupling” – the process that is investigated
in this thesis.
Astrocytes were once viewed as a largely homogeneous cell population defined by their
characteristic “star-shape.” They were divided only into two subpopulations based on their lo-
cation and morphology: fibrous and protoplasmic for astrocytes in the white and gray matter,
respectively [114] (Figure 3.8). Protoplasmic astrocytes were thought to have many branching
processes that surround synapses with endfeet that impinge upon blood vessels, and fibrous as-
trocytes: long, thin, unbranched processes whose endfeet envelop nodes of Ranvier. However,
this nomenclature (fibrous and protoplasmic) is not sufficient to describe the vast anatomical
diversity seen in astrocytes. Advanced electrophysiological, molecular, and genetic tools have
now revealed that astrocytes represent a “complex and diverse population of cells with numer-
ous functions [160]. ”
The astrocyte’s plasma membrane folds into both complex lamellae (thin flat layers) and
fibre (thread-like) forms, which arrange themselves around networks of neural synapses (Fig-
ure 3.9). The degree at which the astrocytes wrap around these forms depends on their location
in the brain. For example, in the hippocampus, only 57% of the synapses have astrocytic pro-
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Figure 3.8 Glial cells are morphologically diverse; some are more fibrous (have long, thread-like branches) and
some are more protoplasmic (have many branches). Adapted from [11].
cesses positioned around them. In the cerebellum, the special neurons known as Purkinje cells,
can be surrounded 67% or 94% of the time, depending on the type of neuron that provides
their excitatory input [160]. The complex contortion of the astrocytic membrane results in the
presence of glial microdomains (spatially exclusive regions), which have been observed in cere-
bellar and hippocampal astrocytes using electron microscopy [30, 63, 68]. These compartments
consist of thin membrane sheets, as well as mitochondria. It is possible that an astrocyte may
consist of hundreds of separate compartments, each capable of independently interacting with
the synapses that it surrounds. These microdomains can restrict the spread of Ca2+ waves in
response to neuronal stimulation [63]. Mature astrocytes are also organised in non-overlapping
domains and make contacts with many thousand synapses [30, 67]. This allows a one astrocyte
to one synapse communication, which inhibits the problem of information mismatch.
It has long been assumed that neurovascular coupling could only be effected by the change
in tone (tension/constriction) of smooth muscle that surrounds the arterioles. Capillaries –
with their lack of smooth muscle – were never thought to be able to contribute. However,
it has recently been discovered that pericytes – glial cells present at regular intervals along
capillaries – can adjust the calibre of the capillary due to the contractile proteins that they
possess [69]. The importance of pericyte capillary control for regulating cerebral blood flow
is yet to be determined, as it has not yet been demonstrated in vivo in physiological conditions
[69] (although it does occur after ischaemia [172]). The importance of the pericyte effect also
depends on the fraction of the total vascular resistance that the capillaries actually contribute
(this could be between between 16% and 70% [102, 103]).
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Figure 3.9 Astrocytes arrange themselves around synapses and blood vessels. They also can communicate with
each other via gap junctions.
3.3.2.3 Smooth Muscle Cells and Smooth Muscle Contraction
Layers of smooth muscle cells (SMCs) line the walls of various organs and ‘tubes’ in the
body. These cells are ‘smooth’ because they lack the striations (stripes) of skeletal and cardiac
muscle. Furthermore, unlike skeletal muscle, the level of tone in smooth muscle is not under
voluntary control – it is instead controlled by hormones and other chemical signals. A change
in membrane potential, for example, often triggers contraction [161].
Smooth muscle contains thick and thin filaments. Thin filaments consist of a ‘rope’ made
of actin strands and regulatory protein, while thick filaments are arrays of myosin molecules
[32]. During contraction, thick and thin filaments form cycling crossbridges, which act to
progressively “ratchet” the smooth muscle together, causing the filaments to slide past one
another, shortening the muscle.
Contraction of smooth muscle is first initiated with a change in Ca2+. Cytosolic Ca2+ in-
creases due to Ca2+ release from intracellular stores (the sarcoplasmic reticulum) as well as
entry from extracellular space through Ca2+ channels (which is often instigated by the changes
in membrane potential mentioned above). This additional Ca2+ combines with the protein
calmodulin to form a complex which activates the enzyme myosin light chain kinase (MLCK)
to phosphorylate (add a phosphate group to) the “light chain” (a subunit) of myosin, enabling
myosin to form a molecular ‘bridge’ with actin. The cycling of these bridges provides con-
traction. Therefore, the degree of contraction in smooth muscle is directly determined by the
degree of phosphorylation of the myosin light chains. In some smooth muscle cells, the phos-
44
phorylation state is maintained at a low level in the absence of stimuli [161]. This essentially
means that the smooth muscle is always slightly constricted – this is known as “basal tone.”
It is important to note that the action of muscle is always to contract. Muscles can only
extend passively [32], by “relaxation.” Smooth muscle relaxation occurs either as a result of 1)
the removal of a contracting stimulus or 2) by the action of a substance that actually inhibits the
contractile machinery (i.e., a vasodilator). Either way, relaxation is dependent on a decreased
cytosolic Ca2+ concentration, and the increased activity of myosin light chain phosphatase
(MLCP, an enzyme that dephosphorylates the myosin light chain). Again, membrane Ca2+
channels facilitate the decrease in Ca2+ [161].
3.3.2.4 Blood
Blood is a type of tissue consisting of several kinds of cells suspended in a liquid, plasma. The
three main types of cells contained in blood are erythrocytes (or red blood cells – used to help
transport oxygen and carbon dioxide), leukocytes (or white blood cells – necessary for defense
and immunity) and platelets (for blood clotting). Plasma is essentially a carrier fluid that is
made up mostly of water, but which also contains ions and proteins, nutrients, waste products,
hormones, and respiratory gases (oxygen and carbon dioxide).
3.3.2.5 The Neurovascular Unit (NVU)
Neurons, astrocytes, and the endothelial and smooth muscle cells surrounding blood vessels
comprise what is known as the neurovascular unit (NVU). Figure 3.10 demonstrates their po-
sitions in the cerebrovasculature.
3.4 The Physiology of Autoregulation
The brain demands a constant supply of oxygenated blood. Changes within the brain must
not affect the supply of blood reaching the brain tissue. Blood vessels within the brain are
known to make compensatory changes in radius in response to local changes by several au-
toregulation mechanisms. These mechanisms include blood pressure, wall shear stress and
metabolic-mediated mechanisms [47].
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Figure 3.10 Cells comprising the neurovascular unit.
3.4.1 Cerebrovascular Autoregulation – Myogenic (Pressure) and Wall
Shear Stress Mechanisms
The myogenic (pressure-based) mechanism counteracts the effects of the normal fluctuations
in arterial pressure that occur during everyday activities (like moving from sitting to standing).
Cerebral arteries relax to counteract arterial pressure decreases, and constrict to combat arterial
pressure rises [78]. This mechanism is effected by stretch activated channels in the SMCs
that “sense” the increases in pressure and flow and effect ionic changes in the cell that induce
contraction. The flowrate through the vessel at varying blood pressures is demonstrated below
(Figure 3.11). Note that not all vessels are able to react to changes in pressure. For those vessels
that do, there exists a range or “autoregulated region” of normal physiological blood pressures
for which these mechanisms work; however, these processes do not function in the pathological
ranges of hypotension (low blood pressure) and hypertension (high blood pressure).
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Figure 3.11 Autoregulation of blood flow with changing pressure. Some vessels, such as those in the brain and
the kidneys, have the ability to autoregulate, whereas others do not. Adapted from Figure 14.13 in [27].
Vascular smooth muscle tone also depends on the shear stress exerted on vascular walls by
flowing blood. Increased wall shear stress initiates the synthesis of vasodilatory nitric oxide
(NO) by the enzyme endothelial NO synthase (eNOS). It is believed that while heightened
blood pressure causes arterial smooth muscle to contract, higher wall shear stress acts as a
counterbalance to this response, causing arterial walls to dilate [38, 128].
3.4.2 Metabolic Autoregulation Mechanisms
Our understanding of metabolic autoregulation is changing constantly. Historically, it was be-
lieved that a negative feedback system existed, where activated neurons generated a metabolic
signal (such as a fall in O2 or ATP or a rise in CO2 concentration) which then triggered a
rise in CBF that would rectify the metabolic signal by supplying the required metabolite (Fig-
ure 3.12(a)). This hypothesis was supported by results such as those in Yaksh and Anderson
[168], where exogenous CO2 caused vasodilations. Several investigations (reviewed in [13])
have since shown that tissue O2, glucose and CO2-based mechanisms do not regulate blood
flow in a negative feedback process.
Metabolic signals don’t need to be tissue-based; they can arise from the lumen “side”, and
not the tissue “side”, of the vessel wall. In a recent review, Ellsworth et al. [50] argue that ery-
throcytes, through their oxygen-dependent release of the vasodilator ATP, can act as metabolic
sensors and effectors of changes in vascular tone. Figure 3.13 details the basic pathways by
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(a) Negative-feedback hypothesis (b) Feedforward hypothesis
Figure 3.12 Metabolic autoregulation – feedback or feedforward? Adapted from [13].
which erythrocytes can increase CBF. In short, the entrance of erythrocytes into tissue regions
with a high oxygen demand (characterised by a decreased oxygen tension (PO2)) results in dif-
fusion of oxygen to the tissue and a decrease in the oxygen saturation (SO2) of the haemoglobin
within erythrocytes. This decrease in SO2 stimulates the release of ATP, which interacts with
endothelial receptors, resulting in the production of mediators that initiate vasodilation in the
nearby SMCs. This vasodilation is conducted upstream along the blood vessel, resulting in
increased blood flow to the areas of increased oxygen demand.
The feedback and metabolic signal-based pathways described have recently been super-
seded by a feedforward hypothesis (Figure 3.12(b)) following the discovery that glutamate, a
neurotransmitter released by active neurons, is capable of regulating blood flow via a signaling
pathway involving neurons and astrocytes (the mechanism known as neurovascular coupling).
This signal is capable of increasing or decreasing blood flow depending on the local O2 concen-
tration. A metabolic signal (i.e., the O2 concentration) is still involved in the process; however,
it is not that which actually initiates the request for changes in CBF. In this feedforward mech-
anism, activation itself is the initiating signal, not the changing tissue metabolism associated
with the activation. The next section provides a more detailed description of neurovascular
coupling.
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Figure 3.13 Erythrocytes as oxygen sensors and effectors of vasodilation. Adapted from [50]. Note that, for
simplicity, many of the intermediate pathways have not been shown in detail and are instead represented schemat-
ically by coloured circles.
3.4.2.1 Neurovascular Coupling – Astrocytic and Neuronal Control of Blood Flow
The processes, major cells and chemical species known to be involved in the neurovascular
coupling (NVC) mechanisms described are shown in Figure 3.14.
Synaptically released glutamate acts on both neurons and astrocytes. In neurons, glutamate
attaches to N-methyl-d-aspartate receptors (NMDAR) to raise neuronal Ca2+, causing neuronal
nitric oxide synthase (nNOS) to release NO, which acts via sGC and cGMP in SMCs to dilate
vessels. Raised Ca2+ may also generate arachidonic acid (AA), which is converted to vasodila-
tory prostaglandins (PG). In astrocytes, glutamate raises Ca2+ by activating metabotropic glu-
tamate receptors (mGluR), generating arachidonic acid and three types of AA metabolite (Fig-
ure 3.15): PGs and EETs in astrocytes, which dilate vessels, and 20-HETE in smooth muscle,
which constricts vessels.
There is a high expression of voltage-dependent, calcium-activated potassium ( or “BK”)
channels in astrocytic endfeet processes, with higher densities in areas close to synapses and
blood vessels. These channels are also activated by EETs [73]. Activation of these channels
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Figure 3.14 Neurovascular coupling: an overview. Adapted from Attwell et al. [13].
following glutamate-induced calcium and EET increases results in the rapid efflux of potassium
into the perivascular space [55]. Increases in extracellular potassium concentration ([K+]) can
lead to vasodilation (and in higher concentrations, paradoxically, vasoconstriction) [31, 48, 60,
94, 111]. Filosa et al. [56] and others [37, 81, 84, 117] have proposed that the release of K+ ions
from astrocyte endfeet and the subsequent activation of inwardly rectifying potassium (KIR)
channels on vascular SMCs comprises a rapid mechanism of arteriolar dilation.
It is difficult to assess the relative contributions of these signalling pathways to functional
hyperaemia, as they all interact with each other: NO, O2, lactate and adenosine concentrations
affect neurovascular coupling at low O2 concentrations [13], NO inhibits the production of both
vasoconstricting 20-HETE and vasodilating EET [135], and O2 is needed for the synthesis of
NO as well as the vasomodulatory AA metabolites [70].
It is also important to note that the collection of possible NVC pathways shown in Fig-
ure 3.14 is not exhaustive. The exact interactions between pathways are also not well un-
derstood. Peng et al. [127] studied changes in CBF in rats (induced by forepaw stimulation)
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Figure 3.15 Metabolites of arachidonic acid (AA). Adapted from Fleming [57].
whilst blocking the NO and K+/EET pathways. Blocking either pathway reduces the increase
in cerebral blood flow (CBF) by about 60%. Paradoxically, when both pathways are blocked
the decrease is still 60%. Shi et al. [145] also examine the effect of blocking K+/EET and mea-
sure a 50% decrease in CBF response. They also observe a similar, non-additive, effect when
blocking metabotropic glutamate receptors (mGluRs) and adenosine A2B receptors, where the
CBF response still only decreases by 50%.
3.5 Summary
The problem of the brain and its blood supply is a multiscale one, with scales spanning from
the big to the very small. This thesis focuses on the blood flow autoregulation mechanism
known as neurovascular coupling: the system by which neuronal activity triggers a rapid and
regional increase in blood supply. Although the exact pathways of neurovascular coupling are
still not completely understood, it is known that the neurotransmitter glutamate operates in a
feedforward manner to generate activity-induced blood flow and that astrocytes mediate this
blood flow control. Glutamate released by active neurons acts on both neighbouring neurons
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and astrocytes, initiating the production of various vasomodulatory compounds including NO,
EETs, PGs, 20-HETE, and K+.

Chapter 4
Neurovascular Coupling in Disease
4.1 Introduction
The process of neurovascular coupling is altered in several pathological conditions. These
alterations disrupt the delivery of blood and nutrients to, and impair the removal of waste and
toxic products from, active brain cells. Subsequent disruptions to the brain’s microenvironment
can lead to neurodegeneration, disability, and death. In this section, we will focus on the
cerebrovascular, astrocytic and neuronal dysfunction that occurs in diseases and disorders such
as hypertension, diabetes, Alzheimer’s disease (AD), spreading depression (SD) and stroke.
4.2 Neurovascular Changes in Normal Aging
Aging is known to affect the structure and mechanics of cerebral blood vessels. In aged rats, it
has been shown that during aging, cerebral arterioles undergo atrophy (waste away) and have
reduced distensibility (capacity to stretch or dilate) [66].
4.3 Stroke and Ischaemia
A stroke, or cerebral infarction, is an event where the blood supply to a part of the brain is
interrupted by the rupture (haemorrhagic stroke) or the blocking (ischaemic stroke) of a blood
vessel. The lack of blood supply to the brain (cerebral ischaemia) not only causes damage to
neuronal tissue, but can exert profound effects on normal blood flow regulation.
After ischaemia, and during reperfusion of the affected tissue area, there is a transient in-
crease in flow, followed by a period of reduced flow. During this time, the cerebral circulation
abides in paralysis. In addition, the reactivity to vasomodulatory stimuli changes, autoregula-
tion is impaired and the process of functional hyperaemia is compromised [59]. Certain cell
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componentry important for vasomodulation can also be damaged following stroke: vascular
KIR and BK channel function is impaired in ischaemia/reperfusion [108] and subarachnoid
haemorrhage conditions [88], respectively.
4.4 Hypertension
Hypertension (high blood pressure) is a medical condition that causes many deleterious effects
on circulation in the brain. It affects vascular structure causing enlargement and remodelling
of the cells in the vascular wall, which reduces the maximum dilatation of cerebral arterioles
[52]. Major causes of stroke are also associated with hypertension. These include increased
blood coagulability and occlusion of the larger cerebral arteries due to atherosclerotic growth.
Hypertension also impairs the function of cerebral blood vessels – it reduces endothelium-
dependent responses to agonists [52] and alters cerebrovascular autoregulation profiles [152]
(Figure 4.1). Evidence also suggests that hypertension alters functional hyperaemia in mice
and in humans [59].
Figure 4.1 Autoregulation profile for normotensive and hypertensive patients. Adapted from [152].
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4.5 Neurovascular Regulation in Alzheimer’s Disease
Alzheimer’s disease (AD) is the commonest form of dementia and is characterised by the de-
position of amyloid-β -peptide (Aβ ) in neuronal tissue (neuritic plaques) and blood vessels
(cerebral amyloid angiopathy (CAA)), and by the accumulation of altered neurofilaments (neu-
rofibrillary tangles). Aβ has long been identified as a major malefactor in AD, but, importantly,
it is vascular factors that have only recently been implicated in AD progression [59].
4.5.1 Vascular Factors Involved in AD
Cerebrovascular disease and AD share common risk factors (such as hypertension, diabetes,
and hypercholesterolaemia [43]), which suggest that their pathogenic mechanisms are similar.
Furthermore, AD patients have more severe atherosclerosis in arteries of the Circle of Willis
than age-matched controls without AD [134]. The occlusions caused by these atherosclerotic
plaques limit cerebral blood supply.
Cerebrovascular structure and function is significantly affected by AD, with cerebral mi-
crovessels reducing in number, endothelial cells flattening, and smooth muscle cells degen-
erating [53]. Both resting CBF, and the increase in CBF produced by activation (functional
hyperaemia) are impaired [59]. Importantly, this cerebrovascular dysfunction often precedes
the noticeable symptoms of cognitive impairment, suggesting that it could play a role in the
underlying mechanisms of the dementia [78].
4.5.2 How Aβ Affects the Cerebrovasculature
A closer look at the vascular biology involved is necessary for us to understand the involvement
of these “vascular factors” in AD. Aβ is produced when amyloid precursor protein (APP) – a
protein that is present in most cells – is cleaved by enzymes known as secretases [78]. In mouse
models of AD, mutated APP is overexpressed to increase Aβ levels. These “Alzheimer mice”
develop cognitive impairments at 6 months of age supposedly due to the arrival of the insol-
uble forms of Aβ (neuritic plaques) [163]. However, it is the cerebral circulation that is first
affected, at 2–3 months of age [119, 122]. In these mice, endothelium-dependent vasomodula-
tion is affected [79], and responses to vasoconstrictors are exaggerated [121]. Cerebrovascular
(myogenic) autoregulation is severely diminished [119], and functional hyperaemia is impaired
[122].
Aβ affects not only the contractile machinery of the vessels (through SMC and EC dam-
age), but also, by promoting oxidative stress [125], inhibits the production of vasodilators [13],
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such as neuronal nitric oxide synthase (nNOS) [154].
Multiple pathogenic events, in either the capillaries or larger vessels, can initiate the break-
down of the neurovascular unit (Figure 4.2). These events include insufficient angiogenesis
(growth of new vessels) and atherosclerosis, cerebral amyloid angiopathy (CAA), or faulty
clearance of Aβ across the blood-brain barrier (BBB). Even normal healthy aging causes
changes in the cerebrovasculature that can trigger a pathogenic cascade. These cascades can
initiate the breakdown of communication between elements of the neurovascular unit (neu-
rovascular uncoupling), leading to hypoperfusion, vessel inflammation, BBB compromise and
reduced control of the neuronal microenvironment. These changes result in, or exacerbate,
neuronal and glial dysfunction, eventually culminating in cell injury or death [174].
Figure 4.2 Changes to capillaries and arteries in AD and their associated vascular, neuronal and cognitive effects.
Adapted from [174].
Interactions of Aβ with atherogenesis and cholesterol metabolism can potentially explain
the increased atherosclerosis seen in patients with AD.
In AD, large arteries can develop atherosclerotic plaques that can produce thrombi; intrac-
erebral arteries experience CAA, develop amyloid lesions and a thinning SMC layer. At the
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capillary and tissue level, amyloid lesions develop, endothelial cells (and hence the BBB) de-
generate, the basement membrane thickens, and microglia and astrocytes are activated [174] –
Figure 4.3.
Figure 4.3 Comparison of healthy and AD-afflicted cerebral blood vessels. Adapted from [174].
4.5.3 Interactions Between Vascular and Amyloid Factors in AD
It is very difficult to separate the vascular and amyloid factors involved in AD, as they are
closely coupled. Aβ induces the early vascular dysregulation which leads to a deficient blood
supply (oligaemia). Oligaemia affects protein synthesis, which facilitates the further production
of Aβ . A sluggish blood supply also causes a reduced clearance of Aβ , resulting in aggrega-
tion. Accumulated Aβ then promotes the formation of atherosclerotic plaques which further
reduces the blood supply by occluding large cerebral arteries. Aβ , with its ability to affect
synaptic function, and oligaemia, with its effects on protein synthesis, contribute to dementia
early in AD. As the disease progresses, neurons (as well as as SMCs, ECs and astrocytes) can
no longer withstand the amyloid accumulation and lack of blood supply, and are subsequently
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destroyed [78]. The hypothetical time course of the disease may therefore be represented by
Figure 4.4. There is a latent, asymptomatic phase where the initial vascular dysregulation oc-
curs (from 1–2). Cognitive impairments then result when Aβ -induced neuronal dysfunction
and sluggish blood supply begin to affect cell functioning (from 2–3). As the disease pro-
gresses, cerebrovascular regulation deteriorates at a similar rate to cognitive function. In the
final stages, neurons and vessels degenerate and brain function is maximally compromised.
Figure 4.4 Proposed time course of Alzheimer’s disease. Adapted from [78].
4.5.4 Astrocyte Dysfunction in AD
So far we have focused on the neuronal and vascular pathology of AD. However, the astrocyte,
an integral part of the neurovascular unit, has also been implicated. Activated astrocytes are
found close to Aβ plaques in the brain tissue of AD sufferers [167]. This suggests a causal
relationship between Aβ and alterations in astrocyte function. Astrocytes, in the process of
performing their many housekeeping chores, may accumulate neuron-derived amyloid material
that has been released from degenerating neurons. If they accumulate enough toxic debris they
may too undergo cell death, resulting in the formation of another type of amyloid plaque [116].
Mouse models of AD also tend to have “hyperactive” astrocytes; that is, astrocytes with in-
creased intercellular calcium wave signalling [91]. Calcium oscillations are also altered in cells
expressing the familial AD presenilin 1 mutation [82]. Astrocytes are important for maintaining
the neuronal environment; if they are operating and communicating in a dysfunctional manner,
this could lead to neuronal dysfunction. It is not only Alzheimer’s disease where astrocyte dys-
function is known to be affected. Astrocyte changes have been observed and implicated in the
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pathology of amyotrophic lateral sclerosis (ALS) and Huntington’s, Parkinson’s and Alexander
disease [107].
4.6 Vascular Responses to Spreading Depression
Spreading depression (SD) is defined as “a slowly propagated wave of depolarization of neu-
rons and glial cells, followed by a subsequent sustained suppression of spontaneous neuronal
activity, accompanied by complex and variable changes in vascular calibre, blood flow, and en-
ergy metabolism [34].” Other phenomena associated with this process include cellular swelling,
the release of neurotransmitters, and dramatic fluxes of ions in and out of cells [34]. Of par-
ticular interest to us, as NVC researchers, is the release of the known NVC mediators, K+ and
glutamate, and the vascular changes associated with them. Figure 4.5 gives an overview of
some of the causes and effects of the SD-related K+ and glutamate releases.
Figure 4.5 Basic mechanisms of CSD (cortical spreading depression) development and its consequences using
migraine with aura as an example. Adapted from [34].
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Experimental vascular responses to SD are complex and variable, depending on the ex-
perimental conditions. The original paper describing CSD in the rabbit reported a transient
vasodilation, followed in some cases by a more sustained and less pronounced vasoconstric-
tion [97]. In both mouse and rat, there is an initial dilation of arterioles and an accompanying
increase in blood volume [15, 28]. However, in the mouse, this initial dilation is followed by
a profound constriction of vessels and then another dilation, whereas in the rat the initial di-
lation is sustained [15, 28, 118]. Therefore, under some conditions, the predominant vascular
response may be vasodilation, whereas under other conditions it may be vasoconstriction. The
variability of vascular responses to SD may depend on a number of factors including: resting
vascular tone, sensitivity of the vessels to extracellular K+, tissue oxygenation, and basal and
evoked levels of NO [34]. It is important to note that vascular responses in SD are not merely
passive reactions to fluctuating K+ and glutamate concentrations. One of the earliest studies
of SD by Leao and Morison [98] indicated that blood vessels may play an active role in the
propagation of SD. Vascular changes may even precede and condition SD [98].
Functional hyperaemia would be an extremely useful mechanism for preventing neuronal
damage in pathological conditions in which metabolism is raised. Unfortunately, it is often
in these conditions that this mechanism fails. This is so for spreading depression. In SD,
there is an increase in brain energy use (presumably due to the increases in the concentration
of glutamate, an excitatory neurotransmitter). As a result, the cerebral tissue consumes more
O2 and glucose, and the extracellular concentrations of these species decrease. The failure of
neurovascular coupling to provide adequate blood flow to match this increased consumption
may cause the neurological deficiencies associated with SD after subarachnoid haemorrhage
[13].
The mechanism by which SD affects (or disables) NVC responses is not well understood.
A possible pathway may lie with the impairment of the NO system [51, 141]. Remember that
NO can dilate vessels directly or suppress 20-HETE-effected constrictions (see Chapter 3).
In addition, NO both requires O2 for its production and causes the vasodilations that would
increase it. This could form a damaging feedback loop: SD-related increases in energy con-
sumption cause low O2 concentrations, which decrease NO formation, thereby reducing NO-
dependent vasodilations (and hence blood flow), which decreases O2 further [13]. It is also
possible that the failure of neurovascular coupling in SD can be attributed to the very unusual
vascular responses to extracellular K+ (vasodilations in low concentrations of K+, but vaso-
constrictions in high concentrations of K+).
Clearly, from a clinical point of view, understanding SD is essential, as SD has been shown
to play a role in many pathological conditions such as migraine, haemorrhagic and ischaemic
stroke, subarachnoid haemorrhage, traumatic brain injury, and epilepsy [34]. From a NVC
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research point of view, understanding SD is also important, as the phenomenon’s distinctive
features may provide insights into the mechanisms of signalling between neurons, astrocytes,
and vascular cells in normal brain function [34].
4.7 Diabetes and Vascular Disease
Diabetes (Diabetes Mellitus) is a metabolic disease characterized by hyperglycaemia (high
blood sugar). It affects millions of people worldwide and will affect many million more in
the years to come [166].
The connection between diabetes and vascular disease is not a trivial one: vascular dis-
eases are the leading causes of death and disability in people with diabetes and can manifest as
macrovascular consequences, such as atherosclerosis and hypertension, as well as microvascu-
lar consequences, such as retinopathy and nephropathy (responsible for blindness and end-stage
renal failure, respectively) [39, 156]. The exact pathogenesis of vascular disease in diabetes is
still unclear – there are many possible links between the metabolic abnormalities that character-
ize diabetes and the cellular mechanisms that affect the function and integrity of blood vessels
[39] (some of which are displayed in Figure 4.6).
Figure 4.6 Abnormalities that occur in diabetes (hyperglycemia, free fatty acids, and insulin resistance) provoke
endothelial cell dysfunction. Adapted from [39].
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It is important to note that ECs, positioned between the flowing blood and the vessel wall,
are well-placed to regulate vascular function and structure. When functioning normally, they
synthesize and release substances that ensure adequate blood flow while preventing thrombo-
sis. NO is just one of the many important molecules that the EC produces and its availability is
used as a sign of vascular health. NO causes vasodilation by acting directly, and indirectly via
cGMP, on adjacent SMCs. In addition, NO protects the blood vessel from atherosclerotic injury
by mediating signals that prevent platelet and leukocyte interactions with the vessel wall. En-
dothelial dysfunction, manifesting as impaired NO-mediated relaxation, occurs in experimental
models of diabetes. Further, experimental evidence supports the idea that hyperglycaemia de-
creases EC-produced NO [39]. The excellent review by Traub and Van Bibber [156] examines
the role of NO in the development of vascular disease in diabetes.
Studies have also found a weak association between diabetes and Alzheimer’s disease and
a strong association between diabetes and stroke-associated dementia [105]. The relationship
between diabetes and Alzheimer’s disease is difficult to determine; however, it is possible that
glycoxidation, glycation-related oxidative processes that occur in both AD and diabetes, forms
the biochemical link [139, 147].
4.8 Prospects For New Therapies
Cerebrovascular disorders and neurological/neurodegenerative disorders do not exist as mutu-
ally exclusive phenomena – often they are coupled. Vascular cell integrity can be affected in
many conditions associated with neurological deficits and cognitive decline (such as AD [174],
ischaemia/reperfusion [108] and subarachnoid haemorrhage [88]). Furthermore, decreased or
dysfunctional vascular responses can initiate, exacerbate or propagate the damage caused by
other pathological pathways (as in AD [78], SD [34], and hypertension [45]). Having an under-
standing of the cellular mechanisms that underlie the blood flow dysregulation in pathological
conditions allows us the opportunity to identify and develop therapies that could be of help.
Cerebrovascular disease and AD share common risk factors (such as hypertension, dia-
betes, and hypercholesterolaemia [43]). Reducing these risk factors through early treatment or
preventative measures (such as lifestyle changes) may reduce the development of AD. Also,
a useful adjuvant approach could be formed when treatments that rescue blood flow responses
act in tandem with the treatment of other disease processes.
According to the neurovascular hypothesis put forth by Zlokovic [174] (shown in Fig-
ure 4.2), physiologically altered ECs, SMCs, and glia are important targets for controlling the
cerebrovascular disorder in AD. Research into genes and other pathways that cause predis-
position for neurovascular degeneration might also provide new leads for AD therapies [174].
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Further, therapeutic agents that provide protection for stressed and ischaemic endothelial cells
and neurons could protect the NVU from the combined attack of Aβ and hypoxia that is seen
in AD [174].
Evidence also suggests that NO metabolism and vascular responses to NO are altered in
diabetes [156]. There is also a documented NO system impairment in SD [51, 141]. Therapies
that address pathogenic NO deficiencies may therefore benefit these patients.
Development of new therapies relies on the discovery and analysis of very complex and
coupled cellular processes. Mathematical models that can describe cellular-level processes in
detail will aid in the understanding of the stages of disease initiation, progression and degen-
eration. More than that, they can provide a mathematical framework for predicting the effects
that potential pharmacological mediators could have [143].
4.9 Summary
The pathogenic gap is narrowing between cerebrovascular disorders and other common dis-
eases. Stroke, Alzheimer’s disease, spreading depression and diabetes all have vascular com-
ponents in their pathology. These vascular changes are not necessarily a side or secondary
effect of the disease; vascular responses can play an integral part in the initiation, propagation
or degeneration of the disease itself.
Understanding the interplay between vascular and non-vascular components of a disease,
and indeed developing new therapies to target these components, relies on the discovery and
analysis of very complex and coupled cellular processes. Mathematical models that can de-
scribe cellular-level processes will aid in this understanding [143].

Chapter 5
Literature Review
5.1 Introduction
The problem of blood flow control is not a new one; it has been studied since the late 1800s.
Since then, the mechanisms involved have been extensively researched, and include: pressure-
dependent, shear-dependent, metabolic and propagated vessel responses, to name but a few.
However, although the individual mechanisms are reasonably well characterized, the process
in which the various mechanisms combine and counteract each other to produce flow and per-
fusion control as a whole is not. The problem is a complex one. The vascular system is
comprised of many interconnected vessels. The flow through each branch is dependent on the
flow resistance of that branch as well as the resistance of the many vessels connected to it. The
many regulatory mechanisms act in varying degrees on different sections of the vascular tree
and depend on variables, like pressure and metabolic rates, that are actually dependent on flow
themselves – they form a closed loop. Information is exchanged in a variety of different ways,
and many cells – smooth muscle, endothelial, erythrocyte, glial and neuronal – contribute to
this complicated information exchange. Blood flow regulation is therefore multiplex and theo-
retical models can help us to analyze and understand these physiological intricacies.
This chapter gives a brief review of the smooth muscle, endothelial and astrocyte cell mod-
els, as well as whole vessel models, that have been developed and published in the literature.
Each model is briefly summarized under its own heading and compared to other models.
Whilst reading this review, it is perhaps useful to remain mindful of two of the main ob-
jectives of this study: to 1) construct a working model of the neurovascular unit (SMC, EC and
astrocyte), and 2) analyze the contributions of two known neurovascular coupling mechanisms
– namely, a K+- and EET-based mechanism and a NO-based mechanism – to blood flow regula-
tion. Blood flow regulation as a whole – and even neurovascular coupling by itself – constitutes
a large, complex and contentious area, and cannot all be reviewed here. Many aspects of the
research have been necessarily omitted. For example, models of neuronal cell processes are
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not reviewed here, as this lies outside the scope of this research (that is, we consider chemical
processes relevant to neurovascular coupling occurring within the synapse but not within the
neuron itself, at least at this stage).
5.2 Smooth Muscle Cell and Contraction Models
Arteriolar diameter (or arteriolar “tone”) is adjusted by smooth muscle cells (SMCs). The
magnitude of the adjustment generated by the SMC is dependent on many factors, includ-
ing the SMC’s length or tension, metabolite concentrations, the presence of other signalling
molecules, and neural inputs. Of course, the consummate model of blood flow autoregulation
would include SMC responses to all of these stimuli. Currently, such an integrated model does
not exist; however, particular components of these cellular responses have been considered,
and to varying degrees, modelled.
5.2.1 Gonzalez-Fernandez and Ermentrout [61]
The model of Gonzalez-Fernandez and Ermentrout [61] attempts to simulate the cellular pro-
cesses underlying, firstly, stationary vasomotion (diameter oscillations), and secondly, the myo-
genic response, in a small artery. They use a system of 7 differential equations to accomplish
this. These equations incorporate ionic movements, the SMC membrane potential, muscle con-
traction, and the mechanics of a thick-walled cylinder. Gonzalez-Fernandez and Ermentrout
[61] show that the interaction of potassium and calcium fluxes (mediated by BK and VOCC
channels, respectively) brings about cyclical changes of the ion transports. This causes peri-
odic changes in the SMC cytosolic calcium, myosin light chain phosphorylation, and cross-
bridge formation (with corresponding muscle stress development). The vessel’s transmural
pressure provides a circumferential stress which, together with the elastic and muscle stresses,
determines the rate of change of the vessel’s diameter. Further, they hypothesize that the re-
lationship between calcium-channel openings on voltage is shifted by changes in transmural
pressure (indeed, this is how they simulate a myogenic effect in their model). This allows the
experimentally determined myogenic response (decreasing of vessel diameter with increasing
pressure) to be reproduced.
This model introduced a number of useful concepts, including the mechanical representa-
tion of the arterial wall as a three-element model (with active muscle elements in series and
parallel with non-linear “spring” elements). Limitations include the omission of SMC KIR
channels and endothelial cell effects on the smooth muscle cell dynamics, and the assumption
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that myogenic effects rely solely on pressure changes (ignoring the potential contributions of
wall stress).
5.2.2 Yang et al. [170] and Yang et al. [171]
In their earlier publication, Yang et al. [170] develop a mechanistic model of the vascular
smooth muscle cell (VSMC), which provides descriptions of:
1. ionic transmembrane currents
2. cytoplasmic Ca2+ regulation, and
3. Ca2+-catalyzed MLC phosphorylation, crossbridge and force development
This work is very similar to the work of Gonzalez-Fernandez and Ermentrout [61] just
described. Hodgkin-Huxley representations are used to describe voltage changes and the me-
chanical model is much the same, but is extended to include a viscoelastic element in series
with the active contraction element. However, the mathematical description of myosin phos-
phorylation differs. In Gonzalez-Fernandez and Ermentrout [61]’s model, it is simply assumed
that the dependence of phosphorylation on calcium is sigmoidal and approximates the rela-
tionship found at equilibrium, but in Yang et al. [170]’s model, calcium and force generation
are related by the crossbridge phosphorylation and latch-state model of Hai and Murphy [65]
(depicted in Figure 5.1). Their four-state model is more physiologically correct than the phe-
nomenological description proposed by Gonzalez-Fernandez and Ermentrout [61] (although
more complex models have since been developed in [64]). Further, Yang et al. [170] do include
the contributions of KIR channels to SMC dynamics.
Figure 5.1 Crossbridge phosphorylation and latch-state model of Hai and Murphy [65]. Adapted from [65].
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Their SMC model [170] is then incorporated into a vessel model of the myogenic response
[171].
5.2.3 Yang et al. [169]
In a later study, Yang et al. [169] utilize their VSMC model and incorporate the signal trans-
duction of vasodilatory NO/cGMP pathways, which includes model descriptions of:
1. sGC activation by NO,
2. sGC-catalyzed cGMP production,
3. cGMP- and NO- mediated intracellular Ca2+ regulation, and
4. cGMP-modulated MLC phosphorylation and VSMC contraction [169]
In this study, they identify many different mechanisms by which NO can act on cell ma-
chinery (through cGMP-dependent and -independent pathways) (Figure 5.2).
Figure 5.2 Diagram of endothelium-derived smooth muscle relaxation via NO/cGMP pathways as modelled by
Yang et al. [169]. Adapted from [169].
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A limitation in this model is that the arteriolar diameter (or subsequent blood flow) changes
are not calculated so that they can be compared to experimental data. Furthermore, the mech-
anisms by which NO is actually generated (by neuronal or endothelial NOS) are not modelled
in Yang (SMC NO concentration is simply an input). NO generation has, however, been con-
sidered theoretically by other groups [35, 38] and will be discussed further in a later chapter
(Chapter 8).
5.2.4 Koenigsberger et al. [86]
The model of Koenigsberger et al. [86] uses a system of 14 differential equations to describe
vasomotion in a small arteriole (56.3 µm). The fundamental difference between this model
and those already described is that this one includes the ionic transports in both SMCs and
ECs. Koenigsberger et al. [86] successfully reproduce the synchronous calcium oscillations
that cause vasomotion, as well as the myogenic response. Further, as they include ECs in the
model they are also able to show how the presence of ECs modulate the results obtained only
with SMCs.
The calcium dynamics of an SMC are described in [86] by five variables: the calcium
concentration in the cytosol ci, the calcium concentration in the sarcoplasmic reticulum si,
the cell membrane potential vi, the open channel probability of voltage and calcium-activated
(BK or KCa) potassium channels wi, and the IP3 concentration Ii. The dynamics in an EC
are modelled similarly using four variables: cytosolic calcium concentration c˜ j, endoplasmic
reticulum calcium concentration s˜ j, cell membrane potential v˜ j, and the IP3 concentration I˜ j.
Channel openings are modelled stochastically.
Cells are connected to their nearest neighbours via gap junctions, which allow electrical,
calcium and IP3 coupling. The model includes both heterocellular coupling (coupling between
different cell types, i.e., an SMC and EC pair) and homocellular coupling (coupling between
the same cell type, i.e., an SMC-SMC or EC-EC coupling).
The effects of SMC vasoconstrictors can be simulated using this model. Increases in vaso-
constrictor concentration effect an increase in the PLC rate (a term in the differential equation
for IP3 concentration, Ii).
For the development of vessel tone, like Yang et al. [170], Koenigsberger et al. [86] use
the crossbridge phosphorylation and latch-state model of Hai and Murphy [65]. The vessel
radius in this model is then computed by considering the balance of circumferential forces
in the wall and using Laplace’s Law: pr/h = σp + σa + σv, where σp, σa and σv are the
parallel elastic, active and viscous stress components of a viscoelastic model, respectively (see
Chapter 2 for an explanation of viscoelastic models). Here, p is the pressure exerted on the
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wall and h is the thickness of the arteriole. Viscous stress is represented by σv = η drdt , where η
is the wall viscosity coefficient. The differential equation for the vessel radius (r) can therefore
be represented by Equation 5.1:
dr
dt
=
1
η
( pr
h
−σp−σa
)
(5.1)
Active stress (σa) is assumed to be directly proportional to the fraction of attached crossbridges
([AMp]+ [AM]). They also assume that the vessel wall volume remains constant.
The equations were incorporated on a cylindrical grid of rectangular SMCs superimposed
on a cylindrical grid of ECs. ECs are arranged parallel and SMCs perpendicular to the vessel
axis. Each cell is connected via gap junctions with its nearest neighbours on the same layer
and with the cells on the other layer directly across from it. SMCs and ECs are different sizes.
In this model, each SMC has six nearest-neighbour SMCs and 5–6 nearest-neighbour ECs,
and each EC has six nearest-neighbour ECs and approximately 15 nearest-neighbour SMCs.
Koenigsberger et al. [86] first omit the population of ECs to analyze the effects of stress only
on SMCs. Once the ECs are added, it was shown that they have only a modulating effect.
The work of Koenigsberger et al. [86] therefore describes a model that extends on its pre-
decessors by including the important contributions of coupled ECs. It is essential to include
ECs as they facilitate not only wall shear stress mediated-mechanisms, but potentially many
other vasomodulatory mechanisms that are effected from the “blood” or lumen side of the neu-
rovascular unit.
5.2.5 Kudryashov and Chernyavskii [92]
In their study, Kudryashov and Chernyavskii [92] model a “biological active tube,” or arteriole.
They are primarily interested in modelling the two main mechanisms of local autoregulation,
the myogenic and wall shear stress mechanisms, while accounting for the non-linear viscoelas-
tic behaviour of the vessel wall and the diffusion and kinetics of the key agents: NO, Ca2+ and
phosphorylated myosin. The mechanism by which wall shear stress exerts an effect on vessel
muscle relaxation in their model is as follows: 1) an increase in wall shear stress on the surface
of the endothelial cells opens the calcium channels, which 2) leads to an increase in NO syn-
thesis from L-Arginine; 3) NO then diffuses across the intima (EC and elastic) layer to smooth
muscle cells in the media layer; 4) NO is taken up by the smooth muscle cells and initiates
the synthesis of cGMP; 5) cGMP stimulates the outflow of intracellular calcium ions (Ca2+);
6) the Ca2+ concentration decreases, reducing the concentration of contracting myosin-actin
complexes, which 7) causes SMC relaxation (Figure 5.3). They assume that there is a linear
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dependence of the muscular force on the phosphorylated myosin concentration and that the rate
of NO production in the ECs is proportional to shear stress.
Figure 5.3 Diagram of the autoregulation process modelled by Kudryashov and Chernyavskii [92]. Adapted
from [92].
Kudryashov and Chernyavskii [92] then use a Kelvin-Voigt type model to describe the
viscoelasticity of the arterial wall, with an active force in parallel with the spring and damper
(dashpot). This basic Kelvin-Voigt representation is adjusted by Kudryashov and Chernyavskii
[92] in a number of ways. Namely:
• the passive elastic force is assumed to be weakly nonlinear with a quadratic correction
• the active force is assumed to be linearly proportional to the average concentration of
phosphorylated myosin along the vessel
• the Young’s Modulus, E, is also a function of phosphorylated myosin (as the “stiffness”
of the wall changes as more crossbridges are formed)
This model is similar to that of Yang et al. [169] in that it incorporates NO mechanisms
which act upon SMCs to cause dilation. However, the mathematical descriptions of the NO
and cGMP processes involved here are largely phenomenological – this model does not include
equations for important ion channels or ionic transports or gap junction coupling between EC
and SMC layers. The viscoelastic model of the arteriolar wall is, however, more sophisticated
than that in Yang et al. [169].
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5.2.6 Summary of Smooth Muscle Cell and Contraction Models
These models typically include a description of the ionic transports and calcium dynamics that
occur within a SMC, as well as equations that relate those changes in cytosolic calcium to the
development of myosin-actin crossbridges and force development which effect changes in the
vessel’s dynamics.
For the purposes of our study, we require a SMC model that incorporates all known im-
portant ionic transports and chemical species involved in the major neurovascular coupling
mechanisms – SMC KIR channels, EC-SMC interactions, and NO-cGMP pathways – but we
also need a model that includes a physiological description of crossbridge formation and the
non-linear viscoelastic properties of the vessel wall. Although models in the literature include
pieces of this “ideal” model, no one incorporates a full description.
5.3 Astrocyte Models
Astrocytes, as well as other glia, were once believed to be only the “glue” that held neurons
together [107]. It is now known that astrocytes serve multiple functions and are responsible
for aiding in the process of neurovascular coupling. However, this relatively recent discovery
means that our understanding of the cellular processes involved in astrocyte-aided neurovas-
cular coupling is formative at best. This fact is both a disadvantage and an advantage for the
theoretical modeller interested in understanding more about neurovascular coupling. On the
one hand, it is difficult to model a process that is not well characterized by experimental stud-
ies. On the other hand, a theoretical modeller is well placed to help analyze, and in doing so,
elucidate, the mechanisms that are truly at play.
There are few astrocyte models in the literature. Three different models, with very different
goals and outcomes, are presented below.
5.3.1 Chen and Nicholson [36]
“Spatial buffering” by K+ channels in glia is the focus of this mathematical model by Chen and
Nicholson [36]. Although the scope of our research includes the mechanisms by which K+ is
released by astrocytes to SMCs during neurovascular coupling, this does not necessarily mean
we are interested in spatial buffering. Spatial buffering is an ambiguous term, and different
groups utilize different definitions. In the model of Chen and Nicholson [36], spatial buffering
refers to the phenomenon of “spatial potassium concentration gradients in extracellular space
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(ECS)” and their dissipation via “glial intracellular pathways” [36]. Their mechanism is as
follows:
1. due to increased neuronal activation, K+ ions are released into the interstitial spaces
between cells and local [K+]o (extracellular potassium) rises
2. this causes local depolarization of glial membranes that can be propagated along the cell
and to other neighbouring cells, via gap junctions
3. there now exists a spatial distribution of membrane potentials along the length of the glial
cell,
4. which elicits a local current that mediates either:
• an influx of K+ into the region of the cell where [K+]o is locally raised, or
• an efflux of K+ from other glial cells that have low local [K+]o
Chen and Nicholson [36] use a two-part model, consisting of an extracellular space com-
partment and an intracellular glial compartment, together with the coupled partial differential
equations describing the distribution of intra- and extra- cellular K+ and membrane potential
varying across space and time. Passive uptake by KCl was assumed to be the dominant method
by which the cell sequestered its K+ ions. Therefore, to estimate how the glial intracellular
potassium [K+]i varies with [K+]o, the dynamics of intracellular [Cl−]i and extracellular [Cl−]o
are modelled. The Na+/K+/2Cl− co-transporter, the active Na+/K+ pump, and the change
in ECS volume due to osmotic water movement were not considered. Chen and Nicholson
[36] analyzed the effect that distributions of KIR channels (in endfooted and non-endfooted
membranes) had on spatial buffer currents and [K+]o. They also analyzed the effects of glial
geometry. Finally, they discussed whether their mechanism was able to efficiently transport K+
over longer (multiple cell length) distances.
Although this model begins to analyze potassium processes that potentially form an im-
portant part of one known NVC pathway, it is not a NVC model. Important pieces of the
K+-based NVC mechanism are missing entirely, as they are not central to the understanding of
spatial buffering, the primary focus for this group.
5.3.2 Bennett et al. [20]
The cell model of Bennett et al. [20] is based on the work of Lemon et al. [99]. Bennett’s
model, used to describe blood volume changes in microvessels as a result of glutamate release at
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neuronal synapses, is depicted in Figure 5.4. Essentially, they are trying to model the following
processes:
1. Synaptic glutamate, through its actions on metabotropic receptors, triggers a calcium
transient in the astrocyte;
2. calcium changes generate the production of EETs that activate BK and KAT P (ATP-
activated K+ channels) in the smooth muscle cells of adjacent arterioles; and,
3. this leads to SMC hyperpolarization and relaxation, and increases in blood flow.
It is important to note here that Bennett et al. [20] assume that EETs act on SMC channels
and not on astrocyte channels (i.e., they work in a paracrine, rather than autocrine, manner).
They also do not include the interactions of K+ and EET mechanisms.
Figure 5.4 Major processes modelled by Bennett et al. [20] in an astrocyte and a smooth muscle cell. In the
astrocyte, receptor binding initiates a G-protein cascade and production of IP3 which elicits the release of Ca
2+
from the ER and EETs from the astrocyte. In the smooth muscle cells, EETs cause a hyperpolarization leading to
the closure of voltage operated calcium channels (VOCCs) and relaxation. Adapted from [20].
The equations are then integrated into a three-dimensional grid with several cells modelled
(a representative two-dimensional cross-section is shown in Figure 5.5). They therefore model
the spatial variation of chemical species throughout their grid.
This work is the first to attempt to model the neurovascular unit as a whole (in fact, they are
modelling several adjacent neurovascular units at once). However, in their case, the neurovas-
cular unit is comprised of an astrocyte and a SMC and does not include ECs. This omission
limits their model in two ways: 1) the modulatory effects of ECs cannot be included, and 2)
other, potentially interacting, pathways of arteriolar tone control that are elicited through ECs
(such as wall shear stress-related pathways) cannot be incorporated into this model at a later
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Figure 5.5 Geometric arrangement of astrocytes and smooth muscle cells in the model of Bennett et al. [20].
Astrocytes are represented by cubes of side length 25µm. Smooth muscle cells are cuboids with a square cross
section of side length 5µm; they wrap twice around an arteriole of 14 mm diameter. The endfeet of astrocytes are
about 10−20µm long and cover one to two smooth muscle cells. Adapted from [20].
stage. Further, although astrocyte processes are well described in this model, the processes
occurring in the SMCs are not. The EET targets (ion channel/s) that actually effect the SMC
membrane voltage change are not modelled in Bennett et al. [20]. Instead, they assume a simple
relationship for the SMC membrane potential: that the voltage change is directly proportional
to the EET concentration. The SMC Ca2+ and VOCCs are, however, modelled. The Hai and
Murphy [65] model is used to describe the dynamics of the myosin-actin interactions; although
here a simplified three state ([M], [Mp] and [AMp]) version was used. Bennett et al. [20] state
that the “contraction of the muscle cell is taken to be proportional to [AMp]” and also that the
“change in cell length is translated into a change in arteriole diameter and hence by integration
to a change in blood volume.” The details of this method, however, are not given; they are also
not apparent from the reference given ([157]).
In summary, this work, although commendable in many ways, lacks the physiological com-
plexity required. It is pertinent to reiterate here that cellular-level modelling is particularly use-
ful for understanding the effects of pharmacological mediators [143]; if insufficient molecular
targets are modelled (or are modelled in too simplistic, or too phenomenological, a fashion) it
will be impossible to investigate these mediators.
5.3.3 Østby et al. [124]
Shrinkage of the extracellular space (ECS) occurs when neuronal activity is increased. Østby
et al. [124] outline a mathematical model that attempts to explain the main mechanisms be-
hind ECS shrinkage (Figure 5.6). They note that this shrinkage accompanies the potassium
clearance undertaken by astrocytes, and as such, they model the relationships between potas-
sium clearance, water transport, and ECS shrinkage. They investigate, among other things,
water transport via aquaporins in astrocytes, cotransporters and their involvement in potassium
clearance, and the effects of particular knockouts on ECS shrinkage.
76
Figure 5.6 Outline of the basic model of Østby et al. [124]. In the baseline state, the neuron is “silent.” In
the excited state, the neuron contributes to changes in ECS and astrocyte volumes by generating potassium and
sodium fluxes during firing. The changes in font and astrocyte size indicate the changes from the baseline to the
excited state. Adapted from [124].
Although this work focuses mainly on the phenomenon of ECS shrinkage (which they suc-
cessfully simulate), the model, with the inclusion of important ionic transports, could be used to
investigate other phenomena, such as potassium spatial buffering and K+-based neurovascular
coupling.
5.3.4 Summary of Astrocyte Models
There are few astrocyte models in the current literature. Although some are interested in the
analysis of neurovascular coupling mechanisms, many are interested more in the (albeit related)
areas of potassium buffering and ECS shrinkage.
We require a model that describes glutamate receptor activation, the production of IP3
and release of Ca2+ from internal stores, and the subsequent astrocyte-based NVC pathways
that are elicited as a result (such as the K+ and EET related pathways). Again, as it was
with the SMC models currently in the literature, current astrocyte models do not contain all
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the necessary components of the sort of physiological and flexible model that we require in
order to investigate several NVC pathways operating in unison. Furthermore, only one model
[20] attempted to link the astrocyte model with an SMC/vessel model, and none attempt to
include the dynamics occurring within an EC. We aim to build a model that fully describes the
important cellular processes occurring in all cells of the neurovascular unit.
5.4 Summary
In this review, it has been shown that although aspects of the cellular responses involved in neu-
rovascular coupling (and indeed other metabolic autoregulatory pathways) have been modelled
already, they have not been integrated into one complete coupled model. A coupled model
contains all components of the neurovascular unit so that cells can communicate to one another
and so that many different autoregulatory signals (those originating from the neuron side or the
blood side) can be built in and can coexist and interact.
Essentially, there is a need for a model that:
• incorporates all cells of the NVU (astrocyte, SMC and EC) and the spaces between them
• contains all the important cell machinery that “powers” these cells (ion channels, pumps,
receptors)
• describes a vessel that incorporates anatomically correct viscoelastic properties
• contains enough of the important cell equipment and chemical species to serve as a gen-
eral framework for studying a variety of vasomodulatory mechanisms
• is physiologically correct, not just phenomenologically correct
• simulates small (single cell) changes as well as big (whole vessel) changes that can be
separately compared with relevant experimental data

Chapter 6
Model Development
6.1 Introduction
The major aim of this research project is to create a theoretical model of neurovascular coupling
(NVC) working within an entire neurovascular unit (NVU). Although there are many possible
pathways involved in NVC, this project will focus on two: 1) K+- and EET-mediated, and
2) NO-mediated pathways. This chapter outlines and explains the “foundation” NVU model,
whereas the following two chapters are devoted to the extensions of the model and the obtained
results for the two mechanisms.
It is important to note here that theoretical models do not follow a single accepted for-
mat. Some are phenomenological, some not; some use many sources of experimental data,
some don’t; some have simplifications and assumptions that others don’t have, and some incor-
porate physical laws or mathematical concepts in subtly different ways to their predecessors.
Therefore, to describe this model correctly and unambiguously – and indeed to get a “feel” for
exactly what sort of model we are dealing with – the following points outlined in [144] must
be addressed in this chapter:
• type of model (phenomenological or conceptual)
• scale(s) to which the model applies
• number of parameters and whether they are known a priori, fitted to data, or simply
assumed
• experimental data used (for the formation of model parameters or for comparing to model
results)
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6.2 The Neurovascular Unit Model – General Overview
6.2.1 Model Type
The model presented in this thesis is of the quantitative conceptual model type (see Chapter 2).
A “conceptual” model is based on the underlying physical mechanism that governs the be-
haviour. The “quantitative” component of this type arises from the fact that the description
of the mechanism is fully parameterized. The model parameters are mostly scavenged from
experimental data. Model results can be compared quantitatively to experimental observations
for suitable values of the unknown parameters. Discrepancies between model and observed
behaviour could mean that the mechanism is not valid or that it has been poorly represented by
its parameters. If there is agreement, the parameters can be optimized so that the model can
obtain the best fit to experimental data. The resulting parameter values can then be analyzed in
terms of what they represent in the proposed mechanism.
6.2.2 Scale of the Model
This model applies in the scale range of a cell to a single vessel level. We focus first on the
changes occurring in the cells of one neurovascular unit (namely, an astrocyte, a smooth muscle
cell and an endothelial cell) during the process of functional hyperaemia. However, because
it is important for us to understand if these cellular changes adequately account for the blood
flow changes seen in experimental measures, we must also calculate the change in diameter
of a model vessel. We can then translate these modelled changes in vessel diameter into an
estimate of the blood flow change that could be expected (relative change in blood flow is
approximately 4 times the relative change in diameter – see Equation 2.40 in Chapter 2). Note
that these calculations of blood flow change apply only for a vessel considered in isolation; the
calculation of the true physiological value of the blood flow change in a brain vessel would
require a model that was incorporated into a large vascular tree network.
6.2.3 Experimental Data and Model Parameters
Model parameters are taken, where possible, from many different sources from the literature.
Where there is insufficient (or non-existent) experimental data, we have had to make model
estimations. All parameters are either referenced to their data source or labelled as estimations
in the parameter tables (Appendix B).
The ideal experimental data set to use for parameterization of our model would:
81
• include the concentrations of all pertinent ionic and chemical species in all pertinent cells
at rest and during varying “intensities” of neuronal activation, and
• include the consequent changes in myosin phosphorylation, crossbridge formation, mus-
cular stress, arteriolar radius, pressure, blood flow, and wall shear stress, and
• would be conducted in a human
• in the cerebral vasculature and
• would be captured in vivo
• in real time.
Unfortunately, such a data set does not, and potentially never will, exist. We therefore col-
lect our parameters not from one cohesive data set, but instead in pieces from experiments in
which one ion channel or one cell or one ionic concentration is measured. Often the experi-
ments are working in the coronary vasculature instead of the cerebral vasculature. Sometimes
experiments are done on intact arterioles. Other times, they are performed on denuded arte-
rioles (those lacking ECs). Often the cell has been removed from a live source and is then
studied in vitro; some experiments are done on cultured cells. It is extremely rare to find data
from human cell studies.
Further, there is not often the opportunity to validate one source of experimental data with
another. The concentrations of the species in the solutions that the cells are grown in or are
studied in vary between studies, which may have an effect on the quality or magnitude of
the observed behaviour. Also, the expression of cellular entities (such as ion channels, for
example) change throughout the lifetime of the animal; some studies are performed on devel-
oping/juvenile animals and others on fully-grown animals.
As there is little experimental data to work with, we must assume that the experimental
conditions employed in the studies are as close as possible to those experienced by the cell in
vivo. Additionally, as most studies are performed on non-human cells, we also assume that the
properties of ion channels and other cellular machinery in the vasculature of other animals can
be used to approximate the properties in the human cerebrovasculature.
6.2.4 Model Assumptions
Assumptions will be stated as they are made in the model development. However, some general
assumptions to consider before we begin are:
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• that 1) K+- and EET- mediated and 2) NO-mediated pathways are the dominant mecha-
nisms employed in NVC
• ion channel properties to do not change appreciably between different cells and species
• concentrations of ionic species are uniform throughout the compartment in which they
reside (they are well mixed compartments – no spatial variation is considered)
• compartments have a constant volume – no osmotic shrinkage effects occur
• ionic species in the extracellular medium (except for K+, explained in the following
chapter) are approximately constant
• the Ca2+ concentration in the cytosol is buffered
• EET affects the voltage- and calcium- gated potassium (BK) channels on the astrocyte
endfoot and does not diffuse across to the SMC
• there is two point sources for NO: NO is produced in the EC by eNOS and in the neuron
by nNOS
• there exists fast binding kinetics of glutamate to mGluR receptors and G-protein activa-
tion in the astrocyte
• there is no depletion of PIP2 and no catalytic effect of Ca2+ on IP3 production in astrocyte
• there is an approximate 1 SMC : 1 EC : 1 astrocyte ratio
• cytosolic Ca2+ is contributed to by SR Ca2+-release in the SMC (this is termed “Ca2+-
induced Ca2+-release” (CICR))
• we assume that Ca2+-dependent phosphorylation is the only mechanism of myosin phos-
phorylation present in the smooth muscle cell
• only attached crossbridges contribute to active force generation in the arteriole
• crossbridge attachment increases the stiffness of the active layer of the arteriole
• the populations of crossbridges are all identical to one another and are identically formed
(heterogenous)
• we have an axially symmetric and viscoelastic artery
• blood is an incompressible and viscous fluid
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• the flow is quasi-stationary
• the transmural pressure (difference of the pressures acting on the vessel wall, approxi-
mately equal to blood pressure) is constant
6.2.5 Model Schematics
A summary of the model – and the data, concepts and assumptions that it is built from – is
given in Figure 6.1.
Figure 6.1 Non-mathematical overview of the neurovascular unit model.
The pathways that are modelled in this thesis are shown in Figure 6.2.
6.3 Description of the Basic Model
We develop here a model of the entire neurovascular unit, including the synaptic cleft, astro-
cyte, perivascular space and both active layers of the arteriole (smooth muscle cells (SMCs)
and endothelial cells (ECs)). There have been several models produced of the component parts
of the neurovascular unit (see Chapter 5) and we extend and adapt some of these. We use the
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Figure 6.2 Aspects of neurovascular coupling studied in this thesis. Note here the NO produced by nNOS in
the neurons and also by eNOS in the endothelial cells. Refer to Figure 3.14 for the full collection of known NVC
mechanisms.
models of Koenigsberger et al. [86] for our coupled EC and SMC layers of the arteriole, with
extensions to include the SMC KIR channels and EC eNOS activation needed as part of our
model. The neurovascular unit model of Bennett et al. [20] includes only the EET (and not
the K+) mechanisms, and both Koenigsberger et al. [86] and Bennett et al. [20] use simplistic
(first order or proportional) models of muscle contraction. We therefore use only the astrocyte
equations of Bennett et al. [20], extending them to include potassium signalling. Finally, we
further develop the muscle contraction equations of Kudryashov and Chernyavskii [92] to pro-
duce a more physiologically correct model that takes into account the multilayer structure of
the arterial wall and the nonlinear viscoelastic properties of the wall material. Furthermore, in
contrast to other autoregulation models [20, 61] who consider only the dynamics in the SMC
component of the wall; we include a coupled SMC and EC cell layer. An illustration of how
these existing models are included and extended is given in Figure 6.3.
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Figure 6.3 Building blocks of the neurovascular unit model.
6.3.1 Dimensional Consistency and Unit Conversions
This model uses equations from sources in the literature (Figure 6.3). The models in these
sources have different focuses and goals and derive their parameters from a variety of different
experimental data. For these reasons, the equations in these sources have a variety of units.
For example: some will describe ionic fluxes in terms of an electrical current (with units of
coulombs per second, Cs−1, or amps, A) and others will describe the size of the fluxes in
terms of the change in concentration that they cause when they enter or leave the cell (units of
µMs−1 or mMs−1). In order for these dimensionally inconsistent equations to be used together
in our model, model parameters must be first converted to common units using certain physical
laws or additional parameters taken from the literature. For example: to convert a parameter
with units of Cs−1 to that of µMs−1, we need to have an understanding of the relationship
between electricity and chemistry, or more specifically: the relationship between charge and
concentration. We therefore need to use concepts borrowed from Faraday’s electrochemical
laws to relate the amount of charged ions to the number of the chemical species (mols) and we
will also need to have an estimation of the volume of the cell taken from the literature (to get
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the molar concentration in µmol L−1 (equivalent to µM)). The working for this is as follows:[
electrical flux in
C
s
]
× 1
k1
mol
C
× 1
k2
1
L
× 10
6 µM
1 M
=
[
molar flux in
µM
s
]
∴
[
electrical flux in
C
s
]
×
(
106
k1k2
)
=
[
molar flux in
µM
s
]
(6.1)
where k1 is the valency/charge of the ion (i.e., Ca2+ has a valency of 2 and K+ has a valency of
1) multiplied by Faraday’s constant (96500 C mol−1) and k2 is the volume of the cell or space
described by the equation (in L). To convert from a value in Cs−1 to one in µM s−1, we must
multiply by the “conversion factor” of 106/(k1k2).
The conventional units for physiological measures of pressure or stress are mmHg or dyne
cm−2, so many model parameters also need to be converted from these into the SI units of Pa
for dimensional consistency. A simple relationship between these units exists:
1 mmHg = 1333 dyne cm−2 = 133.3 Pa (6.2)
An even simpler conversion is required when model equations are described by parameters
or variables that differ only in an order of magnitude. For example, one equation may describe
concentration changes in µMs−1 and another may be expressed in mMs−1. These equations
differ only by a factor of 1000 and can therefore be easily converted using the following rela-
tionships:
1 µM
s
× 1 mM
1000 µM
=
0.001 mM
s
1 mM
s
× 1000 µM
1mM
=
1000 µM
s
(6.3)
There are many equations in this model where this sort of conversion has been applied. These
simple conversions will not be mentioned specifically in this text, but parameters listed through-
out the main thesis body and especially in Appendix B will be listed in their converted units, as
they were used in model equations.
As a guide, here is a list of the common units that will be used throughout the model
development:
• Ionic fluxes and changes in concentration are usually expressed in µMs−1 or mMs−1
(mMs−1 is used for K+ concentrations and neuronal Ca2+; otherwise µMs−1 is used)
• Glutamate concentrations are in nM
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• Voltages/membrane potentials are in mV (this is the convention for cellular measure-
ments)
• Pressures and stresses are in Pa except in cases where the units will cancel within an
equation to produce a dimensionless quantity (in which case, units of mmHg used in the
original sources are used)
• Temperatures are in K
• Time and rate constants are in s and s−1, respectively
• Some conductance values are given in the parameter tables as electrical conductances
(pS) instead of molar conductances (µM mV−1 s−1). Similarly, cell capacitances are
given in pF (a farad, F, can be represented as a coulomb per volt, C V−1). The equations
that utilize these electrical units possess a conversion factor within them that produces
molar values. These equations and their conversion factors will be explained as they are
introduced in this thesis.
6.3.2 Astrocyte
Voltage-operated calcium channels (VOCCs) are expressed in cultured astrocytes, and Filosa
and Blanco [55] include these channels as an important entity in their hypothesized process
of neurovascular coupling. However, Carmignoto et al. [33] show that VOCCs may not nec-
essarily be responsible for the propagating calcium waves involved as part of neurovascular
coupling. We therefore exclude these channels in this model. We do, however, include a
general “leak” term. The equations and parameters for the leak current are those of Gonzalez-
Fernandez and Ermentrout [61].
The voltage- and calcium- operated potassium channel (BK) and the “inwardly-rectifying”
potassium- and voltage-gated potassium channel (KIR) are both expressed in astrocyte pro-
cesses surrounding synapses and arterioles [72, 129]. However, according to Zhou and Kimel-
berg [173], astrocytes can be divided into two classes: variably-rectifying astrocytes (VRA)
and outwardly-rectifying astrocytes (ORA), where only VRA seem suited for uptake of extra-
cellular potassium via KIR channels. We assume then that ORA are therefore responsible for
“pushing” potassium out via BK channels, and VRA for “pulling” it back in again via KIR
channels, and together they cooperate to move potassium in and out of extracellular spaces
(“potassium buffering”). As we are not investigating the process of potassium buffering at this
time, we will look only at the ORA, and as such will only include the BK channels in the
astrocyte.
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The foundation for this model of the astrocyte cell processes is that of Bennett et al. [20].
We further develop their equations with additions and adaptations to include a differential equa-
tion for the astrocyte membrane voltage, which includes ohmic relationships for BK and leak
fluxes. The BK channel flux is modelled from Gonzalez-Fernandez and Ermentrout [61], with
a voltage shift term that is dependent on the EET concentration.
The differential equations describing the dynamics in the astrocyte are as follows. Here ck
is the cytosolic Ca2+ concentration, vk is the membrane voltage, sk is the concentration of Ca2+
in the endoplasmic reticulum (ER), hk is the inactivation variable for IP3, ik is the concentration
of IP3 and eetk is the concentration of EETs.
Calcium moves between the cytosol and the ER, and the cytosol and the extracellular space
surrounding the astrocyte, by several mechanisms. We denote the calcium flux from the ER to
the cytosolic volume through IP3 receptor/channels (IP3R) by JIP3 , the leakage flux from the
ER to the cytosol as JERleak and the ATP-dependent pump flux from cytoplasm to ER as Jpump.
Thus we can write:
dck
dt
= Bcyt (JIP3− Jpump+ JERleak) (6.4)
The constant Bcyt is a steady state approximation for buffering in the cytosol [20] and is a
dimensionless quantity. JIP3 , Jpump and JERleak are molar fluxes in µMs
−1.
The astrocyte membrane voltage changes due to fluxes of ions leaving the astrocyte: the
potassium flux through BK channels (JBKk) and a general leak flux (Jleakk – not to be confused
with JERleak). Note that we have assumed that Ca
2+ does not enter or leave the astrocyte cell
itself; it only enters and leaves the internal cell stores (the ER). We can therefore state the
relationship:
dvk
dt
=
1
Cast
(−JBKk− Jleakk) (6.5)
where Cast is the astrocyte cell membrane capacitance (in pF). JBKk and Jleakk are “electrical
currents” (in fA). This gives the desired units of mVs−1 for the change in voltage with time.
sk, the concentration of calcium in the ER, was assumed to be constant in the original
model [20]. In order to be able to investigate this variable further, we incorporate the following
differential equation:
dsk
dt
=
−1
V RERcyt
(
dck
dt
)
(6.6)
where V RERcyt is the ratio of ER volume to cytosolic volume.
The flux JIP3 is taken from Li and Rinzel’s simplification [100] of the De Young and Keizer
[44] model of the IP3R. The IP3 receptor/channel can be represented by three identical subunits,
which each contain one IP3 binding site, one Ca
2+ activation site, and one Ca2+ inactivation
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site, hence the following formulation:
JIP3 = Jmax
[(
ik
ik +KI
)(
ck
ck +Kact
)
hk
]3
×
[
1− ck
sk
]
(6.7)
Jmax is the maximum rate in µMs−1, KI is the dissociation constant for IP3 binding to an IP3R
(in µM) and Kact is the dissociation constant for Ca2+ binding to an activation site on an IP3R
(also in µM). The cubic power arises from the fact that the receptor/channel conductance was
experimentally determined to be at its highest when all three subunits experience binding [44].
The Ca2+ inactivation variable hk is modelled as a dynamic variable:
dhk
dt
= kon [Kinh− (ck +Kinh)hk] (6.8)
Here kon is the rate of Ca2+ binding to the inhibitory site on the IP3R (µM
−1s−1) and Kinh is
the corresponding dissociation constant (µM). JERleak is determined by:
JERleak = PL
(
1− ck
sk
)
(6.9)
where PL is determined from the steady state calcium balance (µMs−1), and Jpump is:
Jpump =Vmax
c2k
c2k + k
2
pump
(6.10)
Vmax is the maximum pumping rate (µMs−1) and kpump is the dissociation constant (µM). For
IP3, we have:
dik
dt
= rhG− kdegik (6.11)
where rh is the maximum rate of IP3 production in the astrocyte due to glutamate attachment at
metabotropic receptors (µMs−1), kdeg is the rate constant for IP3 degradation in the astrocyte
(s−1), and G is the ratio of active G-protein to total G-protein, and satisfies:
G =
ρ+δ
KG+ρ+δ
(6.12)
ρ is the ratio of bound to total glutamate receptors on the synapse end of the astrocyte, and
KG is the G-protein dissociation constant (dimensionless). δ is the ratio of the activities of the
unbound and bound receptors. The inclusion of δ allows for there to be background activity
even in the absence of ligand binding (i.e., unbound receptors can still activate a small amount
of G-protein). This behaviour is more fully described in the work of Lemon et al. [99].
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Finally, Ca2+-dependent EET production is described with the simple relationship:
deetk
dt
=Veet
(
ck− ck,min
)− keeteetk (6.13)
ck,min is the minimum Ca2+ concentration required for EET production (µM). Veet and keet are
the rate constants for EET production and EET degradation, respectively; these both carry units
of s−1. Degradation is assumed to follow first order kinetics.
6.3.2.1 Dimensional Consistency in Astrocyte Equations
Many of the parameters listed in the tables in Bennett et al. [20] were dimensionally incon-
sistent with their own equations. We therefore have had to estimate values for any unusable
parameters in Bennett et al. [20] (i.e., Veet , keet , rh, and kdeg). We have estimated values that
give approximately the same concentration changes for IP3 and EET as those showed in the
results of Bennett et al. [20].
6.3.2.2 BK Channel Model
JBKk in Equation 6.5 can be described by the ohmic relationship:
JBKk = gBKkn(vk− vBKk) (6.14)
where gBKk is the conductance (in pS), vBKk is the Nernst reversal potential (in mV) and n is the
open BK channel probability (dimensionless). BK channel equations and parameters are taken
from the SMC model of Gonzalez-Fernandez and Ermentrout [61], with the exception of the
conductance which is a model estimation (the astrocyte BK channel conductance has not been
experimentally determined as yet).
Work by Lu et al. [104] shows that both EETs and EET-derived dihydroxyeicosatrienoic
acids (DHETs) act as potent activators of BK channels, where DHETs were shown to shift the
voltage at which the channel open probability was half-maximal. We therefore incorporate a
EET-dependent voltage shift (eetshi f t) into the relationship given by Gonzalez-Fernandez and
Ermentrout [61], to get n∞, the equilibrium distribution of openings for the BK channel:
n∞ = 0.5
(
1+ tanh
((
vk + eetshi f teetk
)− v3
v4
))
(6.15)
The time course of the fraction of BK channel open states, n, is described, after Morris and
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Lecar [115], by the first-order kinetics of opening:
dn
dt
= φn (n∞−n) (6.16)
where the rate constant associated with the opening of these channels, φn, is based on statistical
considerations [49]:
φn = ψn cosh
(
vk− v3
2v4
)
(6.17)
v3 =−v52 tanh
(
ck−Ca3
Ca4
)
+ v6 (6.18)
In this case, ψn is a characteristic rate (s−1) and v3 incorporates a calcium-dependent shift on
the distribution of BK channel open states with respect to membrane voltage. v3 is the voltage
associated with the opening of half the population and v4 is a measure of the spread of the
distribution. v5, determines the range of the shift of n∞, as calcium varies. Constants v3 to v6
carry units of mV. Ca3 and Ca4 describe the shift in this distribution with calcium; these have
units of µM.
Note: Unlike Bennett et al. [20], we assume that the astrocyte-derived EETs do not diffuse
through the perivascular space to the arteriole, but act primarily upon the BK channels at the as-
trocytic endfeet (that is, we assume that diffusion processes occur over much longer timescales
than the interactions between EETs and the nearby astrocyte BK channels). It is possible that
EETs or other AA-derived metabolites act on the SMCs themselves [13], but at this stage, for
simplicity, we only look at EET interactions within the astrocyte itself.
6.3.2.3 “Leak” Channel Model
The relationship for Jleakk is also taken from Gonzalez-Fernandez and Ermentrout [61].
Jleakk = gleakk
(
vk− vleakk
)
(6.19)
Here Jleakk carries the unit of fA, and gleakk (pS) and vleakk (mV) are assumed to be constant.
6.3.3 Smooth Muscle and Endothelial Cells
The foundation for this model of the smooth muscle and endothelial cell processes follows that
of Koenigsberger et al. [86] (full equation set in Appendix A). We add a KIR channel flux in the
SMCs, which is modelled similarly to that of the BK potassium channels described above. We
use the following relationship for the time course of the fraction of open KIR channel states, k:
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dk
dt
=
1
τ
(k∞− k) (6.20)
τ is a characteristic time (in s) associated with the opening of these channels and k∞ is the
equilibrium distribution of open states.
JKIRi is incorporated into the SMC voltage differential equation in the following form:
JKIRi = gKIRik (vi− vKIR) (6.21)
Again, here gKIRi is the membrane conductance (in pS) for the KIR current and vKIR is the
corresponding Nernst reversal potential (given in mV).
Patch clamp experiments by Kurachi [93] give a kinetic model for the opening of the KIR
channel. The time constant associated with the change in the fraction of the open channels (τ)
is the “balance” of the two opening and closing constants, α and β (as described in Appendix C
and below).
τ =
1
α+β
(6.22)
with:
α =
1020
1+ exp
(
vi+18
6.8
) (6.23)
β = 26.9exp(0.06(vi+18)) (6.24)
α and β are time constants and possess units of seconds. vi is the membrane potential minus
vKIR (the reversal potential) – both of these are measured in mV.
The equilibrium open channel probability (a dimensionless quantity) is given by the (sig-
moidal) relation:
k∞ =
α
α+β
(6.25)
vKIR (the Nernst reversal potential for the KIR channel) increases with [K+]o (the perivascular
potassium concentration in mM). Using the data from Oonuma et al. [123], and assuming a
linear relationship in their [K+]o range, we obtain:
vKIR = KKIR1
[
K+
]
o−KKIR2 (6.26)
Finally, Quayle et al. [130] gives the change in inward rectifier conductance with changes
in [K+]o:
gKIRi = 145
√
[K+]o (6.27)
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where [K+]o is in mM. We assume a conductance coefficient of 7250 pSmM
−0.5 (50 times
higher than the 145 pSmM−0.5 value given by Quayle et al. [130]) as the density of inward
rectifier potassium current (in single cells from pig coronary arteries) can vary by a factor of up
to 50 times if it is taken from a small arteriole as opposed to a larger artery [130].
6.3.3.1 Dimensional Consistency in the SMC/EC Equations
A scaling factor is needed to convert between the electrical conductance (gKIRi , in pS) given in
Equation 6.27 to a molar conductance (in µMs−1) for use with the SMC equations of Koenigs-
berger et al. [86]. We could use the conversion described in Equation 6.1 using Faraday’s
constant and the volume of the SMC. However, in this case, we don’t need to find the vol-
ume of the SMC, as we can apply another conversion using parameters from the SMC models
of Gonzalez-Fernandez and Ermentrout [61] and Koenigsberger et al. [86]. We use the “cell
capacitance coefficient” from [61] ( z1 = 1.9635×10−14 C/mV) and the “scaling factor relat-
ing net movement of ion fluxes to the membrane potential” from [86] (z2 = 1970mV/µM) to
obtain the appropriate scaling factor (1/(z1z2×1015), as shown below:
1 pS = 10−12×1 S
= 10−12× 1 C
1 Vs
= 10−12× 1 C
1 Vs
× 1 V
103 mV
=
10−15 C
1 mVs
× 1
z1
mV
C
× 1
z2
µM
mV
=
(
1
z1z2×1015
)
µM
mV
(6.28)
6.3.4 Calcium-Dependent Crossbridge Formation
The cellular calcium concentration and the subsequent development of myosin-actin cross-
bridges in SMCs is related by the crossbridge phosphorylation and latch-state model of Hai and
Murphy [65] (Figure 6.4). In their model, an elevation of calcium induces contraction through
the formation of crossbridges between myosin and actin. Myosin can be in four possible states:
free non-phosphorylated crossbridges [M], free phosphorylated crossbridges [Mp], attached
phosphorylated crossbridges [AMp], and attached dephosphorylated crossbridges (“latchbridges”)
[AM].
94
Figure 6.4 Crossbridge phosphorylation and latch-state model of Hai and Murphy [65]. Adapted from [65].
Four differential equations are used to model the fraction of myosin in each of the four
states (Appendix A). The conversion to and from each state is described using 7 rate constants
(Figure 6.4). K1i and K6i depend on the cytosolic calcium concentration of the SMC (or ci).
That is:
K1i = K6i = γc
n
i (6.29)
where γ represents the sensitivity of the contractile apparatus to calcium.
6.3.5 Muscle Stress Development and Vessel Calibre Changes
Equations describing the motion of the arterial wall are modified from the model of Kudryashov
and Chernyavskii [92], who use a Kelvin-Voigt type of viscoelastic model (described in Chap-
ter 2). The hoop (circumferential) stress acting upon the arteriolar wall, σθθ , can be described
as follows:
σθθ = Eε+µ
dε
dt
+ fa (6.30)
where E and µ are the Young’s (elastic) modulus and viscosity of the viscoelastic arteriolar
wall, respectively. fa is the active force supplied by contraction of smooth muscle in the wall
and ε represents the strain (a measure of how much a material has been elongated with ref-
erence to its original length). In the case of an arteriole, we are interested in how much the
circumference (L) can be stretched from the basal circumference (L0). So, in more useful terms
(i.e., in terms of the radius of the vessel, R):
ε =
∆L
L0
=
L−L0
L0
=
2piR−2piR0
2piR0
=
R−R0
R0
(6.31)
where R0 is the basal radius of the arteriole.
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The term dεdt in Equation 6.30 can also therefore be written in terms of R:
dε
dt
=
d(R−R0R0 )
dt
=
d
(
R
R0
)
dt
−
d
(
R0
R0
)
dt
=
1
R0
dR
dt
−



0
d1
dt
(6.32)
The second term cancels to zero as constants always differentiate to give zero.
Rewriting Equation 6.30 in terms of R:
σθθ =
E
1−ν2
R−R0
R0
+
µ
R0
dR
dt
+ fa (6.33)
(Note that in transforming from strain to circumferential stress the transformation constant is
given (for an isotropic material) as 11−ν2 , where ν is Poisson’s ratio. See Equations 2.4 and 2.20
in [90]).
The representation in Equation 6.33 is adjusted by Kudryashov and Chernyavskii [92] in a
number of ways. Namely:
• they simplify the µR0 to a viscosity coefficient, φ
• the passive elastic force is assumed to be weakly nonlinear with a quadratic correction,
so R−R0R0 becomes
[
R−R0
R0
+ c1
(
R−R0
R0
)2]
, where c1 is a constant
• the active force, fa, is assumed to be linearly proportional to the average concentration
of phosphorylated myosin along the vessel (F), giving fa = c2F , where c2 is a constant
• the Young’s Modulus, E, is also a function of F (i.e., E(F)) as the “stiffness” of the wall
changes as more crossbridges are formed
This gives their final representation of σθθ :
σθθ =
E(F)
1−ν2
[
R−R0
R0
+ c1
(
R−R0
R0
)2]
+φ
dR
dt
+ c2F (6.34)
Finally, Kudryashov and Chernyavskii [92] apply a force balance to the wall. They consider
a wall element of mass ∆m, density ρw , thickness h, radius R, and length ∆x. The two forces
acting on the wall are fr, a force proportional to the tangential stress tensor, σθθ , and fp, the
force exerted by blood pressure. These are given by Equations 6.35 and 6.36 respectively.
fr =−σθθ2pih0∆x (6.35)
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fp = ∆p2piR∆x (6.36)
where ∆p is the transmural pressure. R0 and h0 are the basal radius and thickness of the arteri-
ole, respectively.
Using Newton’s second law of motion for the wall:
∆m
d2R
dt2
= fr + fp (6.37)
where ∆m can be defined as:
∆m = ρw2piR0∆xh0 (6.38)
Kudryashov and Chernyavskii [92] make the assumption that RR0 =
h0
h or R ·h = R0 ·h0. In
words, this relationship means that as the radius increases from its basal state (stretches), the
thickness decreases (is pulled tighter and thinner) by the same ratio. Finally, by cancelling the
common term ∆x, and defining a radius perturbation, η , as:
R = R0(1+η) (6.39)
they obtain the following differential equation for η :
ρwh0R0
d2η
dt2
+φh0
dη
dt
+
h0E(F)
R0(1−ν2)
[
η+ c1η2
]
= ∆p(1+η)− h0
R0
c2F (6.40)
Firstly, it must be noted that in [92] there was a mathematical “cancelling” error (or per-
haps a simple typographical error) in the equation where the term ∆p(1+η) is listed as ∆p.
Secondly, the second order term in Equation 6.40 is actually very small and only has an effect
when looking at very small timescales. As our interest is confined to times much greater than
those dominated by the second derivative, we ignore this term and reduce the DE to a first order
equation instead (Equation 6.41). Finally, it is important to understand that the perturbation η
is actually the same quantity as the strain ε . We assume the authors define the “new” variable
η so as to be specific about the particular strain they are referring to. We use η throughout this
thesis to achieve some consistency with [92].
The simplified and rearranged ODE for η is:
dη
dt
=
1
φh0
(
∆p(1+η)− h0
R0
c2F− h0E(F)R0(1−ν2)
[
η+ c1η2
])
(6.41)
We also make the following further adjustments to Equation 6.41:
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1. It is the fraction of myosin in the two attached states (AM and AMp described in the
previous section) that determines the active stress, and hence the contraction that can
be effected in the arteriolar wall. Kudryashov and Chernyavskii [92] define the active
force on smooth muscle due to muscular tonus as c2F (where c2 is a constant and F
is the concentration of contracting actin-myosin filaments). To fit better with the pro-
posed crossbridge model above, we instead define F as FA, the total fraction of attached
crossbridges, i.e:
FA = [AMp]+ [AM] (6.42)
Maximal active stress in [86] was given as 1.8× 105 Pa. Gore and Davis [62] stated a
value of maximal active stress (for second order arterioles from hamster cheek pouches)
of 3.9×105 Pa. We chose a value of 2.25×105 Pa for c2 (the maximal active stress) in
our model.
2. In σθθ (Equation 6.34), E(F) (Pa) represents Young’s modulus, a measure of the “stiff-
ness” of the cell wall material. We take Young’s modulus to be an exponential function
of F , as we assume that the cell wall material becomes increasingly (and exponentially)
stiff when more crossbridges are in the attached state (see similar assumption in [61]).
E(F) = E0
(
1+ ε exp
(
F
Fmax
))
(6.43)
Here E0 (Pa) and ε (dimensionless) are estimated constants and Fmax is the maximum
fraction of attached crossbridges (0.8 from [65] – See Appendix A) and ε is an estimated
stiffness coefficient.
3. The value of the viscosity coefficient is ambiguously described in the work of Kudryashov
and Chernyavskii [92]. It does not appear to have been taken from experiment; instead it
is calculated based on the desired characteristic timescale for vessel calibre change. We
want to formulate a model that is as anatomically correct as possible; as such, we obtain
a viscosity value from the literature and scale it for our purposes:
The viscosity of the pulmonary artery wall of a sheep is given in [22] as (2.1± 1.4)×
10−1mmHg s mm−1. Based on these units, we assume that this “viscosity” is actually
a viscosity coefficient as in [92] (i.e., λsheep =
µ
Rsheep
). Applying the conversion factor
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1 mmHg = 133.3 Pa, we obtain:
λsheep =
µ
Rsheep
=
(2.1±1.4)×10−1 mmHg s
1 mm
× 1000 mm
1 m
× 133.3 Pa
1 mmHg
=
(2.8±1.9)×104 Pa s
m
So for our model we can use:
λ = 2.8×104× Rsheep
R0
Pa s
m
If we assume the pulmonary artery radius of the sheep (Rsheep) is approximately 10 mm
and the basal arteriolar radius for our model (R0) is 10 µm, we get λ = 2.8×107 Pa s m−1
(which is 20 times smaller than the (appropriately rescaled for radius) parameter given
by Kudryashov and Chernyavskii [92]).
F
6.3.6 Model Scope Boundaries and Limitations
As stated, the blood flow problem is a complex one and this project attempts to understand a
small piece of this larger problem: the interactions that occur within and between the cells in
one neurovascular unit. Therefore, at this stage, we exclude the following:
• other mechanisms of metabolic autoregulation such as those involving CO2, H+, HCO3
or ATP
• NVC mechanisms driven by direct neural innervation of vessels
• spatial variations of chemical species (i.e., there is no diffusion terms or partial differen-
tial equations)
• stochastic opening of ion channels
• homocellular coupling between adjacent SMCs and ECs in the same vessel or a neigh-
bouring vessel in a vascular tree
• conducted signal responses along a vessel or between branches of the vascular tree
• networks of NVUs
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Further identified limitations include:
1. This foundation model contains 22 differential equations and approximately 100 param-
eters. In models containing large numbers of parameters (all of which have error toler-
ances) there exists the possibility of large total errors (especially due to the non-linear
interactions between parameters). Reducing both the number of “free” parameters and
their respective error tolerances reduces the possibility of non-physiological model solu-
tions.
2. The mechanisms by which potassium is released and/or taken up by astrocytes is still
very much in dispute [56, 87, 113, 126]. We will only attempt to explore one or two of
the possible hypothesized mechanisms (in Chapter 7).
3. Ca2+-induced Ca2+ release (CICR) is the process by which the release of Ca2+ from
intracellular stores triggers a positive feedback mechanism, whereby more store channels
are opened, accelerating the rate of Ca2+ release. Capacitative calcium entry (CCE) is
a similar mechanism where the release of Ca2+ from stores can also stimulate influx of
Ca2+ across the plasma membrane [128]. The exact mechanism of action of both CICR
and CCE is unclear and a variety of different explanations have been suggested in the
literature. We model CICR in the astrocyte and SMC as they have been modelled in [20]
and [86], respectively, but do not model CCE. This may later limit our understanding
of the NO-based NVC pathway as CCE appears to be inhibited by cGMP (which is
produced as a part of the NO signalling cascade) [128].
4. In our model, we assume that Ca2+-activated MLC phosphorylation is the major pathway
for contraction, but alternative, more complex, pathways are known to exist [149].
6.4 Summary
In this chapter, we develop a model of the component cells of the neurovascular unit including
the astrocyte and both active layers of the arteriole (smooth muscle cells (SMCs) and endothe-
lial cells (ECs)). To accomplish this, we both adapt and extend on previous models found in
the literature. We mainly use Koenigsberger et al. [86] for our coupled EC and SMC cell pair,
the astrocyte equations of Bennett et al. [20], the myosin-actin crossbridge model of Hai and
Murphy [65], and the viscoelastic models and muscle stress development equations developed
by Kudryashov and Chernyavskii [92]. We extend these models to incorporate missing, physio-
logically important equations, such as those representing the SMC KIR channels and astrocyte
BK channels. This model, with the important cells and cell components included, forms a
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physiologically sound foundation on which any number of hypothesized or known regulatory
pathways can be incorporated and analyzed. This sort of model, with this level of physiological
complexity, is truly necessary to help elucidate the complex mechanisms at play in neurovas-
cular coupling, a phenomenon not well characterized by experimental or theoretical work. In
the following chapters, we will explore the contributions that two major pathways – K+/ EET-
and NO- mediated – make to metabolic autoregulatory control.
Chapter 7
Models of Neurovascular Coupling via K+ and EET
Signalling
7.1 Introduction
There have been many astrocyte-derived vasoactive signals identified, including NO, ATP and
arachidonic acid (AA) metabolites (such as epoxyeicosatrienoic acids (EETs)) [59]. Numerous
studies have also documented that increases in extracellular K+ concentration ([K+]o) can lead
to vasodilation (and in higher concentrations, vasoconstriction) [31, 48, 60, 94, 111]. Further
studies by Filosa et al. [56] and others [37, 81, 84, 117] have proposed that the release of K+
ions from astrocyte endfeet and the subsequent activation of KIR channels on vascular smooth
muscle cells (SMCs) comprises a rapid mechanism of arteriolar dilation. There has long been
an argument for chemical versus electrical signalling in neurovascular coupling, and it has still
not been determined if it is these biochemical signals that modulate arteriolar diameter and
hence blood flow, or if it is the “electric” signal in the form of a flux (current) of positive
K+ ions. Filosa and Blanco [55] suggest that both of these mechanisms coexist and interact,
with the chemical signals being better suited to maintaining changes in vessel tone in response
to sustained neuronal activation and K+ fluxes being more appropriate for eliciting the rapid
response following the onset of neuronal activation. In keeping with these hypotheses we
include aspects of both of these signals in the form of K+ fluxes and EET release.
It is important at this point to make a distinction between the mechanism known as ‘K+
siphoning’ and the mechanism that we are proposing. The ‘K+ siphoning’ hypothesis states
that K+ released from active neurons depolarizes astrocytes, leading to K+ efflux from astro-
cyte endfeet [126]. This mechanism of neurovascular coupling has been tested by depolarizing
astrocytes and measuring neighbouring blood vessel diameter simultaneously [113]. Depolar-
ization fails to dilate blood vessels, proving that K+ siphoning does not contribute to vasodi-
lation. In our mechanism, K+ is pumped into the astrocyte via the Na+-K+ pump (causing an
overall depolarization), but is released by endfoot BK channels due to the action of EETs on
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them, not due to the depolarizing membrane. Therefore, we have two independent mechanisms
controlling the influx and efflux of K+ in our model astrocytes.
7.2 Model
7.2.1 Overview of the Model
The presented model includes all major mechanisms that occur in the neurovascular coupling
process as proposed by Filosa and Blanco [55], starting with the release of glutamate at the
synapse due to neural activity and ending with the dilation of an arteriolar segment. Figure 7.1
shows the major cells and processes involved. They are modelled as follows: (1) neural ac-
tivity causes the release of K+ and glutamate into the synaptic space; (2) K+ is taken into the
astrocyte cytosol via the Na-K pump, while glutamate binds to metabotropic receptors on the
top “arm” of the astrocyte leading to the release of IP3 into the cytosol of the astrocyte; (3) IP3
stimulates the release of calcium from intracellular stores via PLC, causing a rise in cytosolic
calcium. AA-derived EETs are also produced due to this rise in calcium; (4) both EETs and
increases in cytosolic calcium gate the “BK” K+ channels that are present in the endfeet of the
astrocyte causing a release of K+ into the perivascular space between the smooth muscle cells
surrounding the arteriole and the endfoot; (5) the rise in K+ in the perivascular space further
gates the “KIR” K+ channels in the smooth muscle cells (SMCs), causing them to open, ex-
truding further K+ into this perivascular space, hyperpolarizing the SMC membrane in doing
so; (6) this hyperpolarization closes voltage-operated calcium channels in the SMCs, prevent-
ing the influx of Ca2+; (7) the decreased SMC cytosolic calcium then mediates the dilation of
the arteriole through the consequent detachment of myosin-actin crossbridges and relaxation of
smooth muscle.
During the neurovascular coupling process described above, K+ accumulates within the
perivascular space, and is removed by a process known as “K+ buffering” [36]. To properly
develop a model of K+ buffering, an interacting network of NVUs would need to be established.
We therefore do not attempt to model K+ buffering at this time, but instead look only at the
uptake of K+ from the synaptic cleft and the extrusion of K+ into the perivascular space.
We also do not take into account the small (2%) extracellular space shrinkage that occurs as
a result of extracellular ionic concentration changes [87]; all intracellular and extracellular
compartments are assumed to possess constant volume.
Diffusion processes are known to occur as a part of neurovascular coupling; in particular,
calcium increases are known to propagate down from the synaptic arm of the astrocyte to the
endfeet as a “calcium wave.” We do not however a spatial distribution of chemical species
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throughout any of the cells; rather, we adopt a lumped parameter approach and model each cell
as a well mixed compartment.
Figure 7.1 Neurovascular coupling via K+ and EET Signalling: an overview.
7.2.2 Extensions to the Foundation Model
The release of K+ into the synaptic and perivascular spaces is crucial for the K+/EET NVC
mechanism. Therefore, we extend the NVU model described in the previous chapter (Chap-
ter 6) by adding equations describing the concentrations of K+ in these spaces (Figure 7.2).
7.2.2.1 Potassium in the Synaptic Cleft
We adopt a very simple model for the concentration of K+ in the synaptic space Ks. K+
is released into this space by the neurons only during neuronal activation, and is constantly
104
Figure 7.2 Extensions to the “foundation” NVU model that are described in this chapter. Authors of the model
components are shown in brackets where applicable.
removed from the space via the Na-K pump positioned on the top “arm” of the astrocyte. The
smooth “pulse” of K+ release during neuronal activation is represented by JKs , and the Na-K
pump flux is denoted by JNaKs . The concentration of K
+ in the synaptic cleft is therefore the
difference of these two fluxes, as described in Equation 7.1.
dKs
dt
= JKs− JNaKs (7.1)
JKs and JNaKs carry units of mMs
−1. JKs is estimated and the formulation for JNaKs is taken
from Østby et al. [124]:
JNaKs = JNaKmax
(
Ks
Ks+KKoa
)(
Naia1.5
Naia1.5+KNaia1.5
)
(7.2)
JNaKmax is the maximum pump flux (in mMs
−1) and KKoa and KNaia are the threshold val-
ues for the extracellular (synaptic) K+ concentration (Ks) and intercellular Na+ concentration
(Naia), respectively. These concentrations are given in mM and Naia is assumed to be constant
for simplicity.
The influx of K+ into the astrocyte from the Na-K pump changes the astrocyte membrane
voltage. We therefore need to add this flux term into the astrocyte membrane voltage ODE that
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was developed in the last chapter (Equation 6.5). However, before we can do this we need to
convert the JNaKs molar flux (expressed as the change in concentration of K
+ in the synaptic
cleft per unit time in mMs−1) to an electrical flux JNaKk (expressed as the number of charged
particles entering the astrocyte per unit time in fCs−1 or fA). This sort of conversion has been
explained in Equation 6.1, but is also shown below for completeness.
JNaKs in
mM
s
= JNaKs in
mmol
Ls
JNaKs in
mmol
Ls
× vcle f t L = JNaKs in
mmol
s
JNaKs in
mmol
s
×F C
mol
= JNaKs in
mC
s
JNaKs in
mC
s
× 10
12 fC
1 mC
= JNaKs in
fC
s
∴ JNaKs in
mM
s
× (vcle f t×F×1012) = JNaKk in fCs
where vcle f t is the volume of the synaptic cleft in L (calculated from the cube of the synaptic
cleft width from [140]) and F is Faraday’s constant.
JNaKk is now ready to be incorporated into the astrocyte voltage ODE, as follows:
dvk
dt
=
1
Cast
(−JBKk− Jleakk + JNaKk) (7.3)
7.2.2.2 Potassium in the Perivascular Space
We adopt a simple model for the concentration of K+ in the perivascular space Kp at this stage,
assuming that the accumulating K+ is removed by a K+-dependent decay term. K+ enters
the perivascular space via astrocyte BK channels, SMC KIR and SMC BK channels, with
corresponding fluxes (in mMs−1) denoted by J˜BKk , J˜KIRi and J˜BKi , respectively. The balance of
these fluxes, along with the decay term, gives the following differential equation:
dKp
dt
=
1
V Rpa
(
J˜BKk
)
+
1
V Rps
(
J˜KIRi + J˜BKi
)
−Rdecay (Kp−Kpmin) (7.4)
Here Rdecay is the estimated K+ clearance rate from the extracellular space (in s−1) and Kpmin
is the equilibrium K+ concentration in the perivascular space (in mM). V Rpa and V Rps are the
estimated volume ratios of perivascular space to astrocyte and to SMC, respectively. There
are very few histological experiments done on astrocytes; it is therefore particularly difficult to
estimate the relative volumes of the perivascular space, whole astrocyte and astrocyte endfoot.
Figure 7.3 shows the relative size of the perivascular space and the astrocyte endfeet sur-
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rounding a small arteriole in the white matter of a newborn rabbit.
Figure 7.3 An arteriole in the white matter of a newborn rabbit is surrounded by a small perivascular space
(PVS), astrocytes (A) and astrocyte end-feet (as indicated by the thin green rectangles). Adapted from schematic
in [150].
In Figure 7.3, it is clear that the size of the perivascular space can be relatively large, like
the one denoted by “PVS”, or relatively small, like those indicated by the small blue shapes
underneath the other astrocyte endfeet. If we assume the volume of the large “PVS” is a cube
of width 10 µm in size, and the volume of one of the smaller perivascular spaces is a cuboid of
5 µm by 1 µm by 1 µm, we obtain a range of PVS sizes of approximately 5–1000 fL. Dividing
the numbers in this range by the astrocyte volume (vast) of 38,000 fL from [124] gives a range
of V Rpa of approximately 0.0001–0.02.
Recall that astrocytes are star-shaped and have many branching processes. This means
that the volume of the astrocyte endfoot compared to the whole astrocyte volume is not easily
obtained from Figure 7.3. The outlines of the astrocytes shown are not necessarily indicative
of the volume of a whole astrocyte (it is not clear if the outlines show the astrocyte soma or
simply a wider branch of the astrocyte). It is also difficult to ascertain a three-dimensional
estimate from a two-dimensional schematic. Perhaps a better appreciation of the relative scales
of astrocyte and endfoot can be gained instead from Figure 7.4. This figure shows that the
volume of the endfoot (and hence the perivascular space that it contacts) is a very small fraction
of the whole astrocyte volume.
To summarize: it is difficult to ascertain an accurate V Rpa from the experimental data avail-
able (Figures 7.3 and 7.4). At best, we can take a sensible value that can provide a significant
model response and then investigate the importance of changes in this parameter in a sensitiv-
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Figure 7.4 Indication of the relative sizes of astrocyte endfeet compared to the entire astrocyte. Both a fibrous
and protoplasmic astrocyte are shown. It is important to understand here that astrocytes constitute a heterogenous
cell population, the morphology of which can lie anywhere in a continuum between the two types shown here.
This figure is a simplified tracing of those in [138].
ity analysis (in Results section of this chapter) – we therefore use a value of 0.0009 for our
simulations.
Important comments about dimensional consistency in Equation 7.4:
• JBKk (described in Equation 6.14) possesses units of fA. This value needs to be converted
to J˜BKk (with units of mMs
−1) before it can be used in the ODE for perivascular potassium
(Equation 7.4). This was done using the following conversion:
JBKk in fA = JBKk in
fC
s
JBKk in
fC
s
× 1 C
1015 fC
= JBKk in
C
s
JBKk in
C
s
× 1
F
mol
C
× 1
vast
1
L
= JBKk in
M
s
JBKk in
M
s
× 10
3 mM
1 M
= J˜BKk in
mM
s
∴ JBKk in fA×
(
1
F× vast×1012
)
= J˜BKk in mMs
−1
where vast is the volume of the astrocyte in L (from [124]) and F is Faraday’s constant.
• J˜KIRi and J˜BKi also need to possess units of mMs−1 for use in Equation 7.4. JKIRi and
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JBKi carry units of µMs−1, and so the following conversions apply:
JKIRi in
µM
s
× 1 mM
103 µM
= J˜KIRi in
mM
s
JBKi in
µM
s
× 1 mM
103 µM
= J˜BKi in
mM
s
7.2.3 Solution Methodology
Neuronal activation was simulated by a release of glutamate and K+ into the synaptic cleft. This
was achieved by assuming a smooth pulse (amplitude 0.07) for ρ (the fraction of bound gluta-
mate receptors) and for the synaptic cleft K+ influx (JKs = 0.7 mMs
−1) for 60 seconds. All 24
differential equations representing the entire neurovascular unit (ODEs in Chapters 6 and 7 and
Appendix A) were then solved using the solver RKSUITE, a robust mathematical solver writ-
ten by Brankin et al. [26]. RKSUITE uses the embedded RK pair BS(4,5) method derived by
Bogacki and Shampine [24]. It has a fifth order accuracy and uses an adaptive step size method
where the new step size (h0) is calculated using the algorithm: h0 = h1
∣∣∣ ε0ε1 ∣∣∣1/p where p is the
order (5), and h1 and ε1 are the previous step size and error, respectively. ε0 is the desired accu-
racy (or relative error tolerance) that we set to be 1×10−6. Using RKSUITE, the production
of 800 seconds of model data for all 24 equations took 10.989 seconds of CPU time.
We also varied perivascular K+ concentration within the physiological range of values,
and solved only the EC and SMC equations at each of these values. According to experiment,
a modest increase of K+ should induce vasodilation [84, 94, 111], but, paradoxically, a fur-
ther increase in perivascular K+ should then cause vasoconstriction [77, 84]. A similar effect
(vasodilation followed by vasoconstriction) is observed in Girouard et al. [58] when astrocyte
cytosolic calcium is varied. We therefore manually altered the astrocyte cytosolic calcium in
our model equations so that we could compare to these experiments.
Simple sensitivity analyses were also performed on a subset of the parameters by 1) adjust-
ing the parameter, 2) solving the set of equations again with the new parameter, and 3) plotting
the “new” results alongside the results found using the “old” value of the parameter. Solutions
for 3–4 different variations of each parameter were usually calculated. The following param-
eters were chosen either because they were estimated or because they differed across different
literature sources:
• gBKk (conductance of the astrocyte BK channel – Equation 6.14)
• Rdecay (the rate of K+ clearance from the perivascular space – Equation 7.4)
• V Rpa (the volume ratio between perivascular space and astrocyte – Equation 7.4)
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• γ and n (the power and coefficient of the phosphorylation rate constant equation for K1i
and K6i – Equation 6.29 )
• eetshi f t (the shift in the distribution of open BK channel states along the voltage axis due
to EET – Equation 6.15)
• Gstretch (the conductance of the stretch-activated Ca2+ channel (channel responsible for
the myogenic response in the model of Koenigsberger et al. [86] – Equation A.33)
We will also further investigate the mechanism by which K+ is taken up and released by
astrocytes in this model. Amongst experimentalists, the mechanism is still in dispute. The
‘K+ siphoning’ hypothesis assumes that K+ effluxes from neurons causes astrocyte depolar-
ization, which leads to a K+ efflux from astrocyte endfeet. Our model incorporates a different
hypothesis: that K+ is pumped into the astrocyte from the synaptic cleft via the Na-K pump
(causing astrocyte depolarization), but is released by endfoot BK channels due to the action of
EETs on them, not due to the depolarizing membrane. Essentially, we have two independent
mechanisms controlling the fluxes of K+ in and out of our model astrocytes. However, it is still
possible that depolarization will influence the BK channels to a certain degree. To explore the
relative effects that the depolarization and EET have on NVC, we compare model results with
EET present and EET absent (thus allowing us to observe the depolarization effect alone).
For simplicity, we consider one NVU only (that is, one synaptic space, one astrocyte
and one arteriolar segment which will be represented as a set of identical smooth muscle
cell-endothelial cell pairs heterogeneously coupled via IP3 and electrical coupling (see Equa-
tions A.35 – A.38).
7.3 Results and Discussion
7.3.1 Overall Model Behaviour
Figure 7.5 shows the response of modelled astrocyte variables to a 60-second “neuronal activa-
tion” (starting at Time=0). The increase in calcium in the cytosol, and the subsequent increase
in EETs, gate the BK channels in the astrocyte causing a large increase in the open channel
state probability (not shown), which then allows the release of a large K+ flux into the perivas-
cular space (pvk). The astrocyte cell membrane undergoes a transient hyperpolarization during
this process (see “voltage” plot). The changes in perivascular K+ gate KIR channels on the
vascular SMCs concluding in the dilation of the arteriole (shown here in the “diameter” plot).
It is difficult to see here whether or not EET lags calcium (as it is known to do). We can do a
simple analysis to determine this (see Appendix D). If we assume that the increase in calcium
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after activation occurs in a linear fashion, we find that as long as 1keet <
1
Veet
+1 (which it is for
our model) then EET will always lag calcium.
Figure 7.5 Summary of the neurovascular response to a 60-second neuronal activation (shown here are the
glutamate-induced increases in astrocytic IP3, calcium and EET concentrations (µM), and their effect on the
astrocyte membrane potential or “voltage” (mV), as well as subsequent increases in perivascular K+, pvK (mM),
and arteriolar diameter (µm).
The change in diameter is modest: an approximate 3% change in diameter (which corre-
sponds to an approximate 12% change in blood flow). The timescale of the arteriolar diameter
111
change is much slower than the timescales of the other variables shown in Figure 7.5; the arte-
riole doesn’t respond to changes in pvk (perivascular K+) until 15s after the onset of neuronal
activation. The reasons for this slow response will be analyzed in the next section.
These results successfully support the hypothesis of K+- and EET-mediated signalling from
astrocyte to arteriole (proposed by Filosa and Blanco [55]). We show (Figure 7.5) that synaptic
glutamate- and K+- induced astrocytic changes can gate BK channels in the astrocyte such that
K+ is released into the perivascular space, causing a dilation.
Although we are able to achieve a diameter change similar in magnitude to the flow changes
seen in the experimental work of Shi et al. [145] (approximately 15% flow change correspond-
ing to an approximate 4% diameter change), we are unable to emulate the speed of the response.
Maximum flow changes are reached in less than 5 seconds from the onset of stimulation in the
experiments of Shi et al. [145], but only occur after 30 seconds in our model solution. Shi et al.
[145] also show that blood flow changes occur in the presence of EET antagonists, proving
that EET mechanisms are certainly not the only mechanisms working to achieve successful
functional hyperaemia. A recent (and excellent) review on the regulation of blood flow via
neurons and astrocytes by Attwell et al. [13] describes these other mechanisms, including those
involving O2 and NO. The arteriolar response to neuronal activation is therefore the sum of
many such signals, some of which are faster than others. For example, it is known that NO
is capable of diffusing rapidly over fairly long distances and is produced at many locations in
the NVU (by neuronal NOS and endothelial NOS) meaning that its concentration at any given
point is determined by the sum of all NO sources [29]. NO may be better placed to elicit the
initial, rapid blood flow response, whereas the EET/K+ signals may control dilations over more
sustained activations. The dynamics of the O2 and NO pathways are therefore of great interest
in the next stage of developing a model capable of the rapid metabolic autoregulation seen in
experiment.
7.3.2 Potassium Effects
Figure 7.6 compares the changes in SMC membrane potential (“voltage’)’ at different perivas-
cular K+ concentrations for our model and the experimental data of Edwards et al. [48]. This
experimental data looks at proximal and distal segments of the middle cerebral artery (MCA).
The same general trend can be seen in both the model and experimental data; that is, in-
creasing the perivascular K+ concentration causes a hyperpolarization, and then a depolar-
ization in SMC membrane potential. However, there is a clear difference in the membrane
potential of the SMC at the resting value of K+ (3mM) in the model data and even between
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Figure 7.6 Change in SMC membrane potential due to changing perivascular K+ concentration.
different sets of experimental data (seen as an offset between each curve). This is unsurprising
as it is known that there is a variable distribution of resting membrane potentials [80, 146] and
ion channel expression [130] throughout the vasculature, just as there is very different struc-
tural and signalling specialisations underlying how blood flow is locally regulated at different
levels of the vascular tree [25]. However, if our model SMC did possess a membrane poten-
tial of approximately −40 mV at the perivascular K+ concentration of 3mM (i.e., a membrane
potential similar to the experimental values at that concentration – Figure 7.6), there would be
a much larger hyperpolarization (−40 mV to −70 mV) with neuronally-activated perivascular
K+ rises (from 3 to 6 mM). This larger hyperpolarization would induce larger changes in SMC
cytosolic Ca2+ resulting in much larger dilations.
In general, SMC hyperpolarization causes vasodilation and depolarization causes vaso-
constriction. Therefore, following the result shown in Figure 7.6, model simulations produce
vasodilation at lower K+ concentrations and vasoconstriction at higher K+ concentrations (Fig-
ure 7.7).
The paradoxical, but experimentally observed, effect where increased K+ causes first an
increase and then a decrease in diameter is successfully simulated (Figure 7.7). The mech-
anisms behind this phenomenon have never been fully elucidated, although it has previously
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Figure 7.7 Change in diameter due to changing perivascular K+ concentration.
been attributed to the interactions of SMC Na-K pumps and KIR channel currents [111, 131].
The trend seen in Figure 7.6 (and the subsequent trend in Figure 7.7) can be best explained
by observing the behavior of vKIR (the KIR Nernst reversal potential) and k (the fraction of
open KIR channels) as K+ in the perivascular space increases – shown in Figure 7.8.
Our investigations into the cause of this trend (Figures 7.8A and B) point to the interactions
between the fraction of open KIR channels (k) and the changing value of the K+-dependent
resting potential of the KIR channel (vKIR). These peculiar interactions cause the KIR channels
to exhibit an “all-or-nothing” effect. The KIR channels will always attempt to bring the SMC
membrane potential back (or “rectify”) to vKIR by passing K+ in or out of the cell1. The
size of the K+ current passed is the product of the membrane potential “driving force” (the
difference between the SMC membrane potential and the reversal potential) and the fraction of
open KIR channels (Equation 6.21). Figure 7.8A shows that the driving force is very large at
lower concentrations of K+, and the SMC membrane potential should attempt to hyperpolarize
so as to return to the reversal potential. However, because there is only a very small fraction
of channels open at more depolarized membrane potentials (Figure 7.8B), only very small
1The naming of the KIR channels (or “inwardly rectifying” potassium channels) can lead to confusion. “In-
wardly” makes it seem as if they can only pass potassium ions into the cell. However, they can actually pass ions
both in and out of the cell; they are just able to pass ions into the cell more readily (i.e., with less resistance).
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Figure 7.8 Comparison of vKIR, k and voltage relationships and perivascular K+ concentration.
fluxes of K+ can pass through the KIR channels. The small fluxes of K+ leaving through the
KIR channels do eventually cause the SMC membrane potential to hyperpolarize to the critical
“gating” membrane potential (≈ −75 mV) at which KIR channels open rapidly. The rapid
increase in channel openings allows large fluxes of K+ to exit via the KIR channels; rapidly
hyperpolarizing the SMC membrane. The SMC membrane potential then depolarizes at higher
K+ concentrations in an attempt to rectify to the changing vKIR (Figure 7.8A).
Another paradoxical effect (this time: vasodilation followed by vasoconstriction with in-
creasing endfoot calcium concentrations) seen in the work of Girouard et al. [58] is successfully
emulated in our model simulations also (Figure 7.9); these results were generated by manually
altering the astrocyte cytosolic Ca2+ in the model equations. It is important to note, however,
that the calcium concentration at which the “switch” (from dilation to constriction) occurs is
higher in our results (≈ 1000 nM) than in the work of Girouard et al. [58] (≈ 500 nM).
The cellular mechanisms behind this experimental phenomenon can perhaps be explained
now that we have an appreciation of the SMC KIR channel dynamics (Figure 7.8). Endfoot cal-
cium begins the vasomodulatory signal by determining the BK release of K+ from astrocytes;
SMC KIR channels then “read” this signal and determine whether to constrict or dilate, and
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Figure 7.9 Endfoot calcium determines both arteriolar constriction and dilation.
by how much. Therefore, these model investigations, like the experimental results of Girouard
et al. [58], support the concept that endfoot BK and smooth muscle KIR channels act in series,
together forming a signalling module.
Figure 7.10 shows the simulated changes in perivascular K+ (A) and diameter (B) when
different estimates for the astrocyte (whole cell) BK channel conductance were used for a 60-
second neuronal activation. The larger the conductance, the larger the flux of K+ from astrocyte
to perivascular space. The higher the concentration of K+ in the perivascular space, the larger
the dilation and the longer the vasodilation is sustained.
Figure 7.11 shows the simulated changes in perivascular K+ (A) and diameter (B) when
different estimates for the ‘K+ clearance rates’ were used for a 60-second neuronal activation.
The longer K+ is allowed to remain in the perivascular space, the larger the dilation, and the
longer the vasodilation is sustained.
Figure 7.11B also shows that the K+ clearance rate determines what sort of vessel response
is achieved (dilation or constriction), as well as the size of that response (large or small). Fur-
thermore, the K+ clearance rate affects the equilibrium value of the perivascular K+ concen-
tration and the value of the resting (“basal”) arteriolar tone. Why? Because as long as there is
K+ in the perivascular space, SMC KIR channels will be affected (even if there is no neuronal
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Figure 7.10 Model perivascular K+ concentration (A) and diameter (B) changes for various estimates of the
astrocyte whole cell BK channel conductance.
activation at that time), K+ will be released from SMCs, changing both the perivascular K+
concentration and the level of tone (through membrane potential and Ca2+-mediated steps).
The results presented in this section highlight the potential importance of controlling not
only the release of K+ into the perivascular space but also the clearance of K+ from it – if
K+ is not cleared at the appropriate rate, arterioles may exhibit the incorrect behaviour (con-
strict instead of dilate or not dilate to a large enough degree or dilate longer than is necessary
for efficient blood flow autoregulation). This current model does not include the important
physiological mechanisms involved in K+ clearance (i.e., ‘K+ buffering’ via VRAs); these
mechanisms need to be added to the model in a future revision.
As discussed earlier in this chapter, the ratio of perivascular space to astrocyte volume is
difficult to calculate from experimental data. Figure 7.12 shows the effect that changing this
parameter has on NVC. The larger the perivascular space – essentially, the larger the “reservoir”
for ion accumulation – the lower the concentration of K+ for a given ion “release.” A smaller
change in perivascular K+ effects a smaller change in diameter and blood flow.
We hypothesize that the slow timescale of the arteriolar response is due to slow K+ release
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Figure 7.11 Model perivascular K+ concentration (A) and diameter (B) changes for various ‘K+ clearance
rates.’
by the SMC KIR channels due to the “gated” behaviour of the KIR channels (i.e., that the KIR
channels only open and release sufficient K+ after a critical K+ concentration is reached – see
Figure 7.8). An analysis of the important K+ fluxes is shown in Figure 7.13 along with the
pvK, SMC membrane potential and diameter changes. Included are jbkk (the K+ efflux to the
perivascular space from the BK channels in the astrocyte endfoot), jkiri (the K+ efflux to the
perivascular space via SMC KIR channels) and jbki (the K+ efflux to the perivascular space
from the BK channels in the SMC) as all these contribute to the perivascular K+ concentration.
Here, the K+ flux from the astrocyte (jbkk) is very rapid (≈ 2 s), but the flux from the KIR
channels (jkiri) is comparatively slow to reach its maximal value (≈ 10 s). SMC KIR channels
form the only signalling link between the astrocyte’s “initiating” NVC signal (K+ release into
the perivascular space) and the final “concluding” signal in the SMC (membrane potential and
calcium changes and subsequent dilation). We therefore hypothesize that all other SMC cellular
processes (membrane potential, calcium, myosin phosphorylation and crossbridge attachment,
and vessel relaxation/dilation) are “waiting” for the KIR flux that “calls them to action.” Note
also that jbki (the K+ efflux from the BK channels in the SMC) is negligible compared to jkiri
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Figure 7.12 Changing the ratio of perivascular volume to astrocyte volume affects the perivascular K+ concen-
tration (A) and subsequently the diameter of the neighbouring arteriole (B).
(the K+ efflux via SMC KIR channels) and could be excluded to simplify the model.
The perivascular K+ concentration (pvk) would have to increase to above the KIR’s “gat-
ing” level much faster to stimulate a faster arteriolar response. If K+ was instantaneously
released from astrocyte BK channels into the perivascular space the NVC response would be
that of Figure 7.14 (these results were simulated assuming an instantaneous rise (and fall) or
perivascular K+ from 3–6 mM for the 60 s “activation” period). Here, KIR channels open
immediately, rather than “waiting” until the K+ concentration in the perivascular space has
reached the critical value. The latency (time to onset of the arteriolar response) in Figure 7.14
is approximately 5 s, much smaller than the 30 s in the “non-forced case” (Figure 7.5). The
rise time (time to maximal dilation) is 60 s, exactly the time when the perivascular K+ is forced
back to its resting concentration. In the non-forced case, the rise time is ≈ 70 s; this is possibly
due to “lingering” perivascular K+ (that which has not yet cleared from the perivascular space)
continuing to exert its effects on SMC processes even after the activation period has ceased.
Obviously, K+ release into the perivascular space cannot be instantaneous (as simulated
in Figure 7.14). However, it is unclear what the timescale of the perivascular K+ concentra-
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Figure 7.13 Important contributors to the perivascular K+ concentration (pvk in mM) and hence the arteriolar
diameter change (in µm): jbkk (the K+ efflux from the BK channels in the astrocyte endfoot), jkiri (the K+ efflux
via SMC KIR channels) and jbki (the K+ efflux from the BK channels in the SMC) (these all in mMs−1). SMC
membrane potential vi (mV) is shown here for completeness.
tion change should be. D’Ambrosio et al. [41] and Holthoff and Witte [76] experimentally
investigate [K+]o increases after neuronal stimulation but find very different response times.
D’Ambrosio et al. [41] find a rise time of approximately 40 s (close to the response time of our
model) whereas the time acquired by Holthoff and Witte [76] is much quicker at approximately
6 s.
120
Figure 7.14 SMC response when perivascular K+ is “forced” to 6 mM for 60 s. Shown here are kiri (open
channel probability for the SMC KIR channel), vi (SMC membrane potential) in mV, wi (open channel probability
for the SMC BK channel), ci (cytosolic Ca2+ concentration) in µM, AM+AMp (the fraction of attached myosin-
actin crossbridges), and arteriolar diameter in µm.
In another study, Hillman et al. [74] investigate the response of pial arterioles to a 4 s
forepaw stimulation. Arterioles in this study begin to respond within 1 s.
In our model, even if K+ was instantaneously released into the perivascular space, the arte-
riolar response is still slower than that seen in experiment [74]). Referring back to Figure 7.14,
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we can see that when K+ is “instantaneously” released there is corresponding fast responses
for KIR (kiri), membrane potential (vi), BK (wi) and calcium (ci) in the SMC. However, the
changes in crossbridge attachment (AM+AMp) are much slower and the arteriolar response
follows. This discovery prompted us to analyze the crossbridge model further (as follows).
The myosin phosphorylation and crossbridge model is that of Hai and Murphy [65]. Pre-
vious models [20, 86, 170] have used Hai and Murphy [65], but all with different choices
of parameters. In particular, there seems to be a large variation in the coefficient (γ) and
power (n) used in the myosin phosphorylation rate constants (K1i and K6i); remember that
K1i =K6 = γcni . Bennett et al. [20] use γ = 80 µM
−4s−1 and n= 4 and Koenigsberger et al. [86]
uses γ = 17 µM−3s−1 and n = 3. Yang et al. [170] uses a Hill model (with Hill coefficient= 2)
to describe K1i and K6 (therefore: K1i = K6 ∈ [0,1]). Tables 7.1 and 7.2 summarize the effects
that changing these parameters has on the model response during a simulated 60 s neuronal
activation.
γ n Di %∆D
17 1 13.4 0.3
17 2 14.7 1.4
17 3 18.1 2.2
17 4 20 5.0
Table 7.1 Summary of model responses during a simulated 60 s neuronal activation with varying phosphory-
lation constant powers (n). Tabulated here are the coefficient (γ in µM−3s−1) and power (n) used in the myosin
phosphorylation rate constants (K1i and K6i), the baseline arteriolar tone (Di, in µm) and the maximum change in
arteriolar diameter (%∆D, in %)
γ n Di %∆D
1 3 20.3 2.0
10 3 18.9 1.9
100 3 14.8 3.0
Table 7.2 Summary of model responses to changes in phosphorylation constant coefficient during a simulated
60 s neuronal activation. Tabulated here are the coefficient (γ in µM−3s−1) and power (n) used in the myosin
phosphorylation rate constants (K1i and K6i), the baseline arteriolar tone (Di, in µm) and the maximum change in
arteriolar diameter (%∆D, in %)
Altering the power (n) and coefficient (γ) of the phosphorylation rate constants K1i and
K6 affects the resting tone and the size of the dilation due to neuronal activation (Tables 7.1
and 7.2), albeit by a small degree. However, the speed of the arteriolar response (at least for
the parameter variations simulated here) does not increase to the speed that we require for this
122
model to be physiologically accurate (i.e., for all parameter variations, the time to half maximal
dilation exceeded 30 s). It is important to remember that K1i and K6 are not only a function
of n and γ but are also Ca2+-dependent; therefore, Ca2+ can also determine the size and the
speed of the response. We can also observe in Figure 7.14 that the change in SMC calcium
concentration (ci) is relatively small (as it has been in all simulations thus far) – only 0.01 µM.
Figure 7.15 shows the crossbridge formation and arteriolar changes that would occur when the
Ca2+ is altered manually from a resting concentration of 0.16 µM to 0.10 µM for 60 s.
Figure 7.15 Model response when SMC cytosolic calcium is “forced” from 0.160 µM to 0.100 µM for a 60 s
simulation. Phosphorylation rate constants are that used in Koenigsberger et al. [86] (γ = 17 µM−3s−1 and n= 3).
Figure 7.15 demonstrates that much larger changes in diameter can occur with a larger
decrease in SMC cytosolic Ca2+ (≈ 14% compared to the ≈ 3% in Figure 7.5). A larger
change in Ca2+ may be induced if SMC hyperpolarization was more profound (as it might be if
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the resting potential of the SMC at the resting perivascular K+ concentration (3 mM) was closer
to that determined experimentally – see Figure 7.6). The rise time (time to maximal dilation) is
still 60 s (the end of the activation period), however, the time to half maximal dilation is ≈ 10–
15 s (as opposed to ≈ 30 s in Figure 7.5). Therefore, larger calcium changes can effect a faster
response, although 10–15 s is still considerably slower than the physiological speed. More
investigation into the myosin phosphorylation and crossbridge attachment model is needed to
determine its suitability, and indeed its physiological accuracy, for use in the NVC model.
The mechanisms for phosphorylation and crossbridge attachment described in the original Hai
and Murphy [65] model are far from exhaustive; there is evidence to suggest that there are
alternative mechanisms of myosin phosphorylation [149], some of which have been modelled
more recently [64].
Spreading depression (SD – see Chapter 4) is defined as “a slowly propagated wave of
depolarization of neurons and glial cells, followed by a subsequent sustained suppression of
spontaneous neuronal activity, accompanied by complex and variable changes in vascular cal-
ibre, blood flow, and energy metabolism [34].” Interestingly, one other major hallmark of the
phenomenon is an extremely large K+ efflux which increases the extracellular K+ concentra-
tion from a resting level of 3–4 mM to > 40mM [14]. Having created a vessel model capable
of reacting to changing [K+]o, we wanted to examine how the SMC and vessel model would re-
spond to the pathophysiological extracellular K+ concentrations implicated in SD. Figure 7.16
demonstrates the NVC model responses that occur at the pathophysiological perivascular K+
concentrations of 10 mM and 40 mM (simulated by again “forcing” the perivascular K+ to
these values for the 60 s activation period).
Experimental vascular responses to SD are complex and variable and depend on the ex-
perimental conditions. The original paper describing CSD in the rabbit reported a transient
vasodilation, followed in some cases by a more sustained and less pronounced vasoconstric-
tion [97]. In both mouse and rat, there is an initial dilation of arterioles, and an accompanying
increase in blood volume [15, 28]. However, in the mouse, this initial dilation is followed by
a profound constriction of vessels and then another dilation, whereas in the rat, the initial di-
lation is sustained [15, 28, 118]. Therefore, under some conditions, the predominant vascular
response may be vasodilation, whereas under other conditions, it may be vasoconstriction. The
variability of the vascular responses to SD may depend on a number of factors including: the
resting vascular tone, sensitivity of the vessels to extracellular K+, tissue oxygenation, and
basal and evoked levels of NO [34].
Previously, we have shown that our model achieves vasodilations in the lower range of
physiological [K+]o (Figure 7.7 and also Figure 7.14). Here, in Figure 7.16, we show that in
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Figure 7.16 SMC response when perivascular K+ is “forced” to concentrations of 10 mM (left) and 40 mM
(right), respectively, for 60 s. Shown here are kiri (open channel probability for the SMC KIR channel), wi (open
channel probability for the SMC BK channel), ci (cytosolic Ca2+ concentration) in µM, and arteriolar diameter in
µm.
the upper ranges of physiological [K+]o (10 mM), the model arteriole exhibits small constric-
tions, and in pathophysiological [K+]o (40 mM), the model arteriole exhibits profound (and
very rapid) constrictions. This is an interesting result, and not unlike the experimental SD ob-
servations in the mouse [28], where initial dilation is followed by constriction. It is important
to note here that if we had not set the change of [K+]o to be a Heaviside function from 3 mM
to the higher concentration (10 or 40 mM) at t = 0 and instead allowed the concentration to
gradually increase through the lower [K+]o levels first, we would have seen the arteriole first
progressing through the initial dilation seen in Figure 7.14. Please note that the value of the
K+-dependent KIR Nernst potential used for the simulations in Figure 7.16 is taken again from
[123], using their log relationship for values in the upper [K+]o levels.
It is clear that vascular responses occur as a part of SD, but it would be unwise to as-
sume that the vasculature responds only passively. One of the earliest studies of SD by Leao
and Morison [98] indicated that blood vessels may play an active role in the propagation of
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SD. Vascular changes may even precede and condition SD [98]. Vascular responses to SD
are therefore important to understand, both from a clinical point of view (because vascular re-
sponses contribute to SD and the pathological conditions, like migraine, that arise from it), but
also from an NVC research point of view (because the behaviour of neurons, astrocytes and
blood vessels during SD could provide insight into the workings of the NVU in normal brain
function).
Our current model does not include a physiologically correct model of K+ clearance. We
have shown earlier in this section that the arteriolar behaviour is very sensitive to both the
rate of clearance of K+ in the perivascular space (Figure 7.11) and indeed the volume of the
perivascular space (Figure 7.12). It is therefore possible that insufficient control of these two
variables could play a contributing role in SD. An improved understanding of SD and its
accompanying vascular responses could be achieved through the power of a theoretical model
that included physiologically accurate K+ buffering and clearance mechanisms.
7.3.3 EET Effects
The parameter eetshi f t determines to what degree the BK channels are gated by EET (i.e., it
determines the size of a voltage-dependent shift in the BK channel open probability distribution
when EET is produced in the astrocyte cytosol – see Equation 6.15). Figure 7.17 shows the
effect that changing this parameter has on both the BK channel open probability (BKPo) and
the corresponding arteriolar diameter when a 60 second neuronal activation is simulated.
As would be expected, increasing the parameter eetshi f t (applying a larger voltage shift to
the BK open channel probability) effects a larger change in the fraction of open BK channels
in the astrocyte (Figure 7.17A), releasing larger fluxes of K+ into the perivascular space (not
shown). The rate of K+ deposition (by astrocyte BK channels) into the perivascular space,
determines the “polarity” of the vessel response that is achieved (dilation or constriction), as
well as the size of that response (large or small) (Figure 7.17B). Further, when there is more
astrocyte BK channels open at rest, the equilibrium value of the perivascular K+ concentration
is higher, which affects the value of the resting (“basal”) arteriolar tone. This behaviour is
similar to that shown in Figure 7.11, in which changes in the perivascular K+ clearance rate
also affects the magnitude and polarity of the arteriolar response.
The value for eetshi f t that we use in our model (2 mV/mM) shifts the BK open channel prob-
ability distribution so that BKPo increases by approximately 125% during neuronal activation
(Figure 7.17). This increase corresponds well to the BKPo increase seen for EET application
in Lu et al. [104]. Increasing eetshi f t further can cause BKPo changes greater than this (BKPo
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Figure 7.17 Sensitivity analysis for parameter eetshi f t . Shown here are the changes in the fraction of open
astrocytic BK channels (BKPo) and arteriolar diameter during a 60 s neuronal activation.
changes seen in Lu et al. [104] due to the application of the EET-derived metabolite DHET
reaches much higher values). Further experimental work is needed to better characterize 1) the
amount of AA, EET and DHET that is produced during neuronal activation, and 2) the effects
that these molecules have on astrocyte endfoot channels, and hence NVC.
To explore further the relative effects that (synaptic K+-induced) astrocyte depolarization
and (synaptic glutamate-induced) EET production have on the K+/EET pathway, we compare
model results 1) when EET alone is allowed to exert its effects on astrocyte BK channels (the
depolarization signal is silenced), and 2) when the astrocyte depolarization is allowed to exert
its effect on astrocyte BK channels (with the EET signal silenced) – Figure 7.18.
Recall that the ‘K+ siphoning’ hypothesis states that K+ released from active neurons
depolarizes astrocytes, leading to K+ efflux from astrocyte endfeet [126]. This mechanism
of neurovascular coupling has been tested by depolarizing astrocytes while measuring blood
vessel diameter [113]; depolarization fails to dilate blood vessels, proving that K+ siphoning
does not contribute to vasodilation. In our model mechanism, K+ is pumped into the astrocyte
via the Na-K pump (causing a depolarization), and is released by endfoot BK channels due to,
we assumed, the action of EETs on them, not due to the depolarizing membrane. However,
in Figure 7.18 it is apparent that both the depolarization of the astrocyte membrane and the
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Figure 7.18 Is the depolarization of the astrocyte the major mediating signal responsible for vasodilation in the
arteriole? Or is it the EET signal? Shown here are the changes to the astrocyte BK channel open probability
(Astrocyte BKPo) and arteriolar diameter (µm) during a 60 s neuronal activation when depolarization and EET
signals are silenced in turn.
produced EETs act on endfoot BK channels to cause K+ efflux into the perivascular space,
with the “depolarization only” effect taking an overwhelming dominance.
7.3.4 Stretch-Activated Channel Effects
The stretch-activated Ca2+ channel (SAC: channel responsible for the myogenic response in
the model of Koenigsberger et al. [86]) is potentially important for determining tone-dependent
vascular responses (more on this in Chapter 8). Therefore, we briefly analyze the effects that
changing the conductance of this channel (Gstretch: a “model estimation” in [86]) would have
on the model response (Figure 7.19).
The size of the SAC channel conductance affects the magnitude and polarity of the arte-
riolar response, as well as the resting tone of the arteriole. Increasing Gstretch ensures that the
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Figure 7.19 Changes in the SMC model response to a neuronal activation of 60 s when the conductance of the
stretch activated calcium channel (Gstretch) is altered. Shown here are cytosolic calcium concentration (in µM),
AM+AMp (the fraction of attached myosin-actin crossbridges), and arteriolar diameter (in µm).
balance of ionic fluxes in the SMC is more heavily influenced by the activity of the SAC chan-
nel. In general, the larger the value of Gstretch, the larger the Ca2+ efflux from SMCs (Jstretchi),
the less Ca2+ in the SMC to cause myosin phosphorylation and crossbridge formation, and
hence: the larger the relaxation/dilation.
7.4 Verification of the Model Code
The code used to produce the results given in this chapter was verified by Kristina Raba, a
summer scholarship student, whose project involved the non-dimensionalisation of the model
equations outlined in Chapters 6 and 7.
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Throughout the course of her 3 month project, she:
1. non-dimensionalized the model equations
2. checked the validity of the code used for this thesis by comparing the thesis results to her
non-dimensionalized results (which were also obtained using the RKSUITE ODE solver)
3. simplified the model by removing any terms that were more than two orders of magnitude
smaller than the largest term in the equation they belonged to
Her verification showed no significant difference between the non-dimensionalized solu-
tion and the solution found using the thesis source code (see Appendix E for details of the code
developed for this thesis).
7.5 Summary
Our mathematical model simulates neurovascular coupling using EET and K+ as the major
signalling pathways. Important steps in this process are the production of EETs in the astrocyte
and the release of K+ into the perivascular space via BK and KIR channels. Constructing a
model of sufficient physiological complexity has allowed us to not only support experimentally
observed observations, but actually investigate the causes of them, such as the effect where
increased perivascular K+ causes first an arteriolar dilation and then a constriction. We suggest
that the interaction of the changing smooth muscle cell membrane potential and the changing
K+-dependent resting potential of the KIR channel is responsible for this effect.
We were able to achieve vasodilations (and vasoconstrictions) similar in magnitude to those
seen in experiment [58, 145]. However, the latency and rise time of the arteriolar response is
slower than that observed [74, 145]. We believe that the introduction of other known major
neurovascular coupling pathways (especially those of NO and 20-HETE) may be capable of
producing a response closer to the physiological speed required. We will explore the NO-
mediated neurovascular mechanism in the next chapter (Chapter 8).
We also looked more closely at the specific effects that EET and K+ have on the complex
NVC mechanism modelled. In the literature, differing views exist about the exact mechanism
and effects of K+ movement in and out of the extracellular space surrounding neurons and
glia [56, 73, 113, 126]. We developed this model with the intention that (synaptic glutamate-
induced) EET production and not (synaptic K+-induced) astrocyte depolarization would be
responsible for the activation of astrocyte BK channels and the subsequent release of K+ into
the perivascular space. Closer examinations of the model have shown that both the depolariza-
tion of the astrocyte membrane and the produced EETs act on endfoot BK channels to cause
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the K+ efflux, with the depolarizing effect taking dominance. This analysis will further add
to the ongoing debate and discussion that surrounds the seemingly separate but inexorably in-
tertwined phenomena known as K+ siphoning, K+ buffering and K+-mediated neurovascular
coupling.
Our investigation into the vascular responses that occur during Spreading Depression (a
pathological process characterized by large rises in perivascular K+), led to results that support
experimental observations in the mouse [28]: that dilations can give way to constrictions. We
also postulate that control of the deposition and removal of K+ into the perivascular space is
vital for the K+-mediated NVC mechanism as the behaviour of the arteriole is profoundly af-
fected if the rate of clearance of K+ from the perivascular space is altered. Even the volume
of the perivascular space can affect the arteriolar behaviour – vasodilation can be abolished if
the volume ratio between the astrocyte and perivascular space changes. This demonstrates that
a well-controlled mechanism that works to maintain K+ homeostasis in the extracellular envi-
ronment of the brain could be very important for not only successful neurovascular coupling,
but also successful recovery from Spreading Depression.
Chapter 8
Models of Neurovascular Coupling via Nitric Oxide
Signalling
8.1 Introduction
Neuronal activation and the subsequent release of glutamate (Glu) into the synapse activates
neuronal NMDA receptors, resulting in an influx of Ca2+ into the neuron and the activation of
neuronal nitric oxide synthase (nNOS). nNOS releases nitric oxide (NO), a vasodilator. Experi-
mental inhibition of nNOS in the cortex reduces functional hyperaemia [106], suggesting a role
for NO in neurovascular coupling (NVC). This response is, however, restored by the addition
of NO donors, which provide a constant concentration of NO. This indicates that NO is an
important contributor to neurovascular coupling, but the dynamic rise in NO caused by neu-
ronal activation itself does not directly mediate the message between neuron and blood vessel.
Perhaps then, at least in the cortex, NO is needed to modulate other vasomodulatory pathways,
such as those involving K+ or EET. In any case, the exact role of NO in NVC is unclear. This
chapter is devoted to extending the mathematical framework we have created in the past two
chapters to include NO-driven signals of NVC.
8.2 Model
8.2.1 Overview of the Model
The NO-driven mechanism we propose is as follows: a) glutamate binding activates NMDA
receptors in the neuron causing Ca2+ entry; b) Ca2+ forms a complex with calmodulin (CaM)
which c) activates neuronal nitric oxide synthase (nNOS). There is also NO production in the
endothelial cells (ECs) lining the neighbouring arteriole due to activation of endothelial nitric
oxide synthase (eNOS) by the wall shear stress (WSS) exerted by flowing blood. The NO
produced by nNOS and eNOS then d) diffuses to the vascular smooth muscle cell (SMC) and
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activates soluble guanylate cyclase (sGC), which e) catalyses the formation of cyclic guanosine
monophosphate (cGMP), which in turn causes f) vessel dilation by:
1. opening BK (voltage- and calcium- activated K+) channels, which decreases SMC mem-
brane potential and effects a decreased influx of Ca2+ through voltage operated calcium
channels (VOCCs) into the cell, and
2. increasing the rate of myosin light chain dephosphorylation (MLCP) (effectively desen-
sitizing the contractile system to the effects of Ca2+)
An overview of the cells, chemical species, and cell componentry involved in this model is
shown in Figure 8.1.
Figure 8.1 NO production and action in the neurovascular unit. NO is produced by nNOS in active neurons and
by eNOS in ECs. NO from these two sources then diffuses into the SMC and activates sGC from its basal state,
B, to its active state, 6c. The active sGC then converts GTP to cGMP which acts via protein kinase G (PKG).
Our model focuses on two vasodilatory pathways: 1) the effect of cGMP (via PKG) and NO on the BK channel
open state probability, and 2) the effect of cGMP (via PKG) on the rate of MLC dephosphorylation. These are
numbered on the diagram as described. Adapted from [169].
Note that there are other proposed means (in addition to those shown in Figure 8.1) by
which cGMP acts on various other cell components (such as the VOCCs) to bring about re-
laxation; we focus on the two pathways described because they are those investigated by Yang
et al. [169]. Any effect that NO has on EET concentration is ignored.
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Figure 8.2 Extensions to the NVU model to include NO equations. Authors of the model components are shown
in brackets where applicable.
Figure 8.2 provides an overview of the components that constitute the NO model extension
described in this chapter.
8.2.2 Glutamate Release and NMDA Receptor Binding
The presented model of glutamate binding to NMDA receptors is based on that of Santucci
and Raghavachari [137]. They state that the majority of NMDA receptors in the mammalian
brain are either of an NR2A or NR2B subtype with an average of 0.63 (NR2A) and 11 (NR2B)
receptors per synapse, respectively. The fraction of open NR2A NMDA receptors (PNR2A−O) is
dependent on the synaptic glutamate concentration, as follows:
PNR2A−O =
[Glu]
βA+[Glu]
(8.1)
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Similarly, the fraction of open NR2B NMDA receptors (PNR2B−O) is:
PNR2B−O =
[Glu]
βB+[Glu]
(8.2)
where βA and βB are 0.41 nM and 1.02 nM, respectively.
8.2.3 Calcium Influx and Calmodulin Binding
The inward calcium current per open NMDA receptor is given by Santucci and Raghavachari
[137]:
ICa =
4V GM(PCa/PM)(Caex/M)
1+ exp(−0.08(V +20))
exp(2V F/RT )
1− exp(2V F/RT ) (8.3)
where GM is the conductance of the NMDA channel (pS); PCa/PM is the relative conductance of
the NMDA channel to Ca2+ compared to monovalent ions (dimensionless); Caex is the external
calcium concentration (mM); M is the concentration of monovalent ions (mM), T is tempera-
ture (K); R is the gas constant (Jmol−1K−1) and F is Faraday’s constant (Cmol−1). V is the
neuronal membrane potential (voltage) and is assumed to be approximately constant. In reality,
the neuron hyperpolarizes and repolarizes many times during the action potentials that occur in
periods of activation. This model does not include equations describing this “spiking” activity
and so we take an approximate average voltage that occurs during this period. Note that this
assumption means that, in this model, calcium currents in the neuron depend purely on the
concentration of glutamate in the synapse. This is a very simplified mathematical description
of the complex dynamics that actually occur in the neuron but is suitable for our purpose (as
we are focusing on glutamate-effected calcium changes in the neuron).
Note about dimensional consistency in Equation 8.3: The expression 2V F/RT requires
V to have units of V (volts) in order to be dimensionally consistent. However, this equation has
been fitted to data measured in mV, and so the term exp(−0.08(V +20)) actually requires units
of mV. To obtain ICa in our desired units of fA, the V term in the numerator of the equation
also needs to be in mV. Therefore, for dimensional consistency, Equation 8.3 should really be
written as the following equation:
ICa =
4V GM(PCa/PM)(Caex/M)
1+ exp(−0.08(V +20))
exp(2V F/1000RT )
1− exp(2V F/1000RT ) (8.4)
where V is in mV.
The total inward calcium current for all open NMDA receptors (ICaT ) is the calcium current
for one open receptor (ICa) multiplied by the total number of open receptors. As there are two
types of receptor, NR2A and NR2B, that are each present in different densities (0.63 (NR2A)
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and 11 (NR2B) receptors per synapse, respectively), we obtain (in fA):
ICaT = ICa (0.63PNR2A−O+11PNR2B−O) (8.5)
The change in neuronal cytosolic Ca2+ (in mMs−1) was also given by Santucci and Raghavachari
[137] as the ordinary differential equation:
d[Ca2+]n
dt
=
(ICaT /(2Fvspine×103))−κex([Ca2+]n−Carest)
1+Λ
(8.6)
vspine is the volume of the neuronal dendritic spine (in L), Carest is the resting calcium con-
centration (mM), Λ is the buffer capacity (dimensionless), and κex is the decay rate constant
of the internal calcium concentration (s−1). The (2Fvspine×103) term is required here to con-
vert between the electrical flux (in fA) given in Equation 8.5 and the molar flux (in mMs−1)
required by Equation 8.6 – see Equation 6.1 in Chapter 6 for a more complete explanation of
this conversion.
nNOS activation depends on the concentration of calcium-calmodulin complexes (Ca2+-
CaM) present in the neuron. To relate the neuronal calcium changes described in Equation 8.6
to changes in the calcium-calmodulin complex concentration ([Ca2+- CaM] or [CaM] for
short), we can use the Ca2+-CaM kinetics of Crouch and Klee [40]. Each calmodulin can
bind a maximum of four Ca2+. The number of Ca2+ bound per calmodulin, N, is given by
Crouch and Klee [40] as:
N =
[Ca2+]n
φ
dφ
d[Ca2+]n
(8.7)
where φ describes the sum of all the states of bound Ca2+ (i.e., 1, 2, 3 or 4 Ca2+ bound) with
respect to free Ca2+. φ is given as the following function:
φ = 1+Q1[Ca2+]n+Q1Q2[Ca2+]2n+Q1Q2Q3[Ca
2+]3n+Q1Q2Q3Q4[Ca
2+]4n (8.8)
Q1–Q4 (mM−1) are constants describing the degree in which Ca2+ associates with each of the
four binding sites on the CaM molecule. Note that the binding of Ca2+ to CaM is a positively
cooperative process; i.e., Ca2+ binding to one site on CaM increases the affinity for Ca2+ on
another binding site.
8.2.4 Nitric Oxide in the Neuron
Hayashi et al. [71] have shown experimentally how nNOS activation depends on the concen-
tration of [CaM] when nNOS is overexpressed in the bacteria E. Coli, and they list Michaelis-
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Menten kinetic constants (i.e., VmaxNOS and KactNOS) that relate nNOS activity and [CaM] for
unphosphorylated and phosphorylated nNOS. However, the units used in [71] for VmaxNOS are
nmol/min/mg of bacteria, when we require units of µMs−1 in our equations. The nNOS en-
zyme is also overexpressed in E. Coli making the VmaxNOS value unrepresentative of the rate of
NO production that would occur in a neuron. For these reasons, we must estimate a value for
VmaxNOS (in µMs
−1) that will give physiological values for [NO]. We do however use the value
of KactNOS for unphosphorylated nNOS (in mM) that is given in [71].
We also assume that no nNOS activity occurs before a threshold concentration of [CaM]
([CaM]thresh, in mM) is reached (otherwise vasodilatory NO would be produced continuously
and arteriolar homeostasis would be difficult to maintain). As such, we develop the following
kinetic scheme for nNOS production in the neuron, NOnNOS (in µMs−1):
NOnNOS =VmaxNOS
([CaM]− [CaM]thresh)
KactNOS +([CaM]− [CaM]thresh)
(8.9)
where [CaM] is defined by:
[CaM] =
[Ca2+]n
N
(8.10)
N is given in Equation 8.7.
We formulate the differential equation for neuronal NO by taking the amount of NO pro-
duced from nNOS (Equation 8.9), and subtracting that which is lost by diffusion and that which
is scavenged by O2 (the formulations and parameters for the latter two terms are taken from
Chen and Popel [35]). We therefore describe NO concentration changes (in µMs−1) by:
d[NO]n
dt
= NOnNOS− [NO]n− [NO]iτni − kO2[NO]
2
n[O2]n (8.11)
The first term in Equation 8.11 represents the synthesis of NO by nNOS (from Equation 8.9),
the second represents that which diffuses to the smooth muscle cell (as indicated by the sub-
script i) and the third represents that which is scavenged by O2 in the neuronal tissue. A note
about the form of the second (diffusion) term: Describing the diffusion process accurately
would necessitate differential equations that describe variations in space and time (i.e., partial
differential equations, PDEs). These equations would complicate the solution of the equation
set considerably. So that we can keep a simpler ODE formulation, we represent diffusion using
a simple relationship: the difference between NO concentrations at two point sources (the neu-
ron [NO]n and the SMC [NO]i) determines the “driving force” for diffusion (and thus the size
of the diffusive flux) and τni determines the characteristic time for diffusion. In other words,
τni represents the approximate time taken for NO to diffuse the distance h1 between the neuron
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(subscript n) and the smooth muscle cell (subscript i). Mathematically:
τni =
h21
DNO
(8.12)
where DNO is the diffusion coefficient for NO used in the NO diffusion model of Chen and
Popel [35], and h1 is estimated as 6 µm.
8.2.5 Nitric Oxide in the Endothelial Cell
NO is also produced in the endothelial cells in response to shear stress exerted on the wall by
flowing blood.
The changes in NO in the endothelial cell (in µMs−1) can be described by:
d[NO] j
dt
=
deNOSact
dt
− [NO] j− [NO]i
τ ji
− ko2[NO]2j [O2] j (8.13)
This formulation is similar to that in Equation 8.11; the first term represents the production of
NO by eNOS, the second is the NO which is lost by diffusion to the SMC and the third is that
which is lost by reaction with oxygen.
Equation 8.14 represents the activation and deactivation of eNOS to produce NO and is
taken from the model of Comerford et al. [38]. The endothelial NOS is activated by cytosolic
free calcium c j (µM) at a maximum rate Kdis (µMs−1) and deactivated at constant rate µ2
(s−1). This equation also includes a source term, gmaxF(τω), for activation of eNOS directly
by WSS.
deNOSact
dt
=
Kdisc j
KeNOS+ c j
−µ2[NO] j +gmaxF(τω) (8.14)
where
F(τω) =
1
1+α exp(−W (τω)) (8.15)
and
W (τω) =W0
(τω +
√
16δ 2WSS+ τ2ω −4δWSS)2
τω +
√
16δ 2WSS+ τ2ω
(8.16)
Equations 8.15 and 8.16 are those in Wiesner et al. [164] where τω is the wall shear stress (Pa)
and δWSS is the membrane shear modulus (also in Pa). Also:
τ ji =
h22
DNO
(8.17)
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where h2 is the approximate distance between the SMC (subscript i) and the EC (subscript j).
We assume this distance is the same as h1 for simplicity (6 µm).
8.2.6 Nitric Oxide in the Smooth Muscle Cell
The rate of change of the NO concentration in the smooth muscle cell (in µMs−1) is given by:
d[NO]i
dt
=
[NO]n− [NO]i
τni
+
[NO] j− [NO]i
τ ji
− kdno[NO]i (8.18)
Here, the first and second terms are the diffusive fluxes from the neuron and EC, respectively.
The third term, kdno[NO]i, is the scavenging term resulting from NO binding to proteins – the
formulation and parameter value for this term is taken from [35].
8.2.7 Overview of NO/cGMP Interactions in the Smooth Muscle Cell
Some of the actions performed by NO/cGMP in the SMC were shown in Figure 8.1. The
following sections describe how these processes are described mathematically in this model.
As indicated in Figure 8.2, the mathematical descriptions for NO/cGMP interactions are taken
directly from Yang et al. [169], with adaptations to ensure they are compatible with the SMC
model that we are using.
8.2.7.1 sGC Activation
sGC is the only known receptor for NO. Activation of sGC produces cGMP and PKG (species
that act on SMC components to bring about vasodilation). sGC is therefore an important com-
ponent of NO-mediated vasodilation. The kinetics involved in sGC activation are shown in
Figure 8.3.
Essentially, in the smooth muscle cell, NO binds to sGC in the following reactions formu-
lated by Yang et al. [169], where:
• B is the basal state of sGC
• 6c is the intermediate form
• 5c is the fully activated form
• E is the fraction of each form
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Figure 8.3 The kinetics of sGC activation. NO activates sGC by transforming it from its basal state, B, to the
active state, 5c, via the intermediate form 6c. cGMP can also have a negative feedback effect on its own production
by inactivating sGC to its B-form again. This detail from Figure 8.1 is adapted from [169].
• k1, k2, k3, k4, and k−1 are rate constants
First B is activated by NO to form 6c:
Eb+NO
k1−−⇀↽−
k−1
E6c
There is an NO-independent decay of 6c to 5c described by:
E6c
k2−→ E5c
There is also a NO-dependent scheme:
E6c+NO
k3−→ E5c+NO
The dissociation of NO from sGC, and hence the recovery to basal sGC conditions, is
described by:
E5c
k4−→ Eb+NO
where
k4 =C4[cGMP]m (8.19)
C4 is a constant and m reflects the strength of feedback from cGMP. For simplicity, we assume
m = 0 (i.e., there is no feedback from cGMP).
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These interactions give the following set of differential equations:
dEb
dt
=−k1Eb[NO]i+ k−1E6c+ k4E5c (8.20)
dE6c
dt
= k1Eb[NO]i− k−1E6c− k2E6c− k3E6c[NO]i (8.21)
dE5c
dt
= k3E6c[NO]i+ k2E6c− k4E5c (8.22)
8.2.7.2 cGMP Production
The rate of cGMP production from GTP (guanosine-5’-triphosphate) is dependent on E5c. The
rate of cGMP degradation is dependent on cyclic nucleotide phosphodiesterases, PDEs, which
hydrolyze cGMP to GMP. The reactions are modelled by Yang et al. [169] as:
GTP+E5c −−⇀↽− GTP ·E5c −−→ cGMP+E5c
cGMP+PDE−−⇀↽− cGMP ·PDE−−→ GMP+PDE
under the assumption that GTP is abundant and that cGMP production foremost depends on
sGC concentration. Under the assumption that [PDE] is constant, the following equation arises:
d[cGMP]
dt
=Vmax,sGCE5c−
Vmax,pde[cGMP]
Km,pde+[cGMP]
(8.23)
where Vmax,sGC is the maximum cGMP production rate when E5c = 1 and
Vmax,pde = kpde[cGMP] (8.24)
In our simulations, we use the parameters Vmax,sGC, kpde, and C4 from Yang et al. [169]
(who fitted these equations to experimental data).
8.2.7.3 cGMP and NO Effects on BK Channels (Mechanism 1)
The BK channel open probability distribution can be shifted due to the effects of NO and cGMP
(via PKG) [151] – see Figure 8.4. These shifts act to open BK channels, increasing the efflux of
K+ from the SMC, hyperpolarizing the membrane. Voltage-operated Ca2+ channels (VOCCs)
close in response to this shift in the membrane potential (or “voltage”), restricting the access
of Ca2+ into the SMC, leading to a decrease in MLC phosphorylation, crossbridge attachment,
and force development, causing muscle relaxation and vasodilation.
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Figure 8.4 Mechanism 1: NO and cGMP act to increase the BK channel open probability. This leads to K+
efflux, hyperpolarization, decreased Ca2+ influx, decreases in the rate of MLC phosphorylation, and vasodilation.
Detail from Figure 8.1.
The regulatory effect of cGMP on the BK channel open probability is described by the Hill
function:
RcGMP(Km,cGMP,nH,cGMP) =
[cGMP]nH,cGMP
[cGMP]nH,cGMP +KnH,cGMPm,cGMP
(8.25)
There is also a direct effect of NO on the open probability. It is modelled in a similar way:
RNO(Km,NO,nH,NO) =
[NO]nH,NO
[NO]nH,NO +KnH,NOm,NO
(8.26)
The effect of NO/cGMP on the BK channel open probability, Po, is described in Equa-
tion 8.27, which is of the same formulation as that which we use in the SMC model of the
previous chapters (see Equation A.25), but with parameters adjusted to fit the experimental
data from Stockand and Sansom [151]. The closeness of fit is shown in Figure 8.5.
Po(ci,vi) = Kactivationi =
(ci+ cwi)
2
(ci+ cwi)
2+βi exp
[−(vi− vCa3)/RK f it] (8.27)
where
vCa3 =VcGMPRcGMP(Km,cGMP,nH,cGMP)−VNORNO(Km,NO,nH,NO)−Vb (8.28)
vi is the SMC membrane potential (mV) and ci is the SMC cytosolic calcium concentration
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(µM). We adjusted the parameters VcGMP, Vb and RK f it (all in mV) to provide the best model fit
to the experimental data (Stockand and Sansom [151]). We do not use the formulations for the
BK channel Po described in Yang et al. [169], because they use a different SMC model to us
– using the formulation by Yang et al. [169] would result in discrepancies between the models
that we are attempting to combine together.
Figure 8.5 BK channel open probability (Po) as a function of SMC membrane potential (vi) – fitted to the
experimental data of Stockand and Sansom [151].
8.2.7.4 cGMP Effect on MLC Phosphorylation Sensitivity (Mechanism 2)
cGMP can increase the rate of myosin light chain (MLC) dephosphorylation. This is also
known as “Ca2+ desensitization” because the process of MLC phosphorylation becomes less
“sensitive” to the level of Ca2+. The MLC is then less likely to be attached at the current Ca2+
level and will hence generate a smaller contractile force, resulting in smooth muscle relaxation
and vasodilation [169]. This mechanism is shown graphically in Figure 8.6.
Essentially, Mechanism 2 involves increasing the rate at which MLC is dephosphorylated.
In Figure 8.6, you can see that cGMP (via PKG) acts on both dephosphorylation operations
(M←−−Mp and AM←−− AMp). Yang et al. [169] use the crossbridge model of Hai and Murphy
[65], as do we. This allows us to use the same equations for Mechanism 2 that are provided by
Yang et al. [169]. The two rate constants for dephosphorylation, K2 and K5, are dependent on
cGMP concentration in the following way:
K2 = K5 = kbmlcp+ k
c
mlcpRcGMP(Km,mlcp,nH,mlcp) (8.29)
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Figure 8.6 Mechanism 2: cGMP (via PKG) can cause vasodilation by increasing the MLC dephosphorylation
rate (desensitizing the SMC contractile system to the effects of Ca2+). Detail from Figure 8.1.
where kbmlcp is the basal MLC dephosphorylation rate constant and k
c
mlcp is the first order rate
constant for cGMP-regulated MLC dephosphorylation (both in s−1). RcGMP(Km,mlcp,nH,mlcp),
the regulatory effect of cGMP on myosin dephosphorylation, is again expressed as a Hill func-
tion:
RcGMP(Km,mlcp,nH,mlcp) =
[cGMP]nH,mlcp
[cGMP]nH,mlcp +K
nH,mlcp
m,mlcp
(8.30)
Figure 8.7 graphically shows the mathematical relationship described in Equations 8.29
and 8.30.
With this shift in sensitivity, MLC is more likely to be dephosphorylated at a given Ca2+
concentration. This drives a further shift in the conformation of myosin-actin crossbridges to
a more detached / less attached state; a smaller contractile force is generated and the vessel
relaxes.
8.2.8 Solution Methodology
All the equations described in this chapter are combined with all the other equations for the
NVU previously developed in Chapters 6 and 7. All equations are again solved using RKSUITE
(details of which have already been given in Chapter 7) assuming a 60 s neuronal activation
(simulated as a rapid sigmoidal increase in synaptic glutamate from 0 µM to 0.75 µM as per
[75]). Once again, we consider an arteriole with a 10 µm radius and a wall thickness of 4 µm.
144
Figure 8.7 Effect of cGMP concentration [cGMP] on the dephosphorylation rate constants K2 and K5.
The pressure is set at 30 mmHg, the O2 concentration is set at 200 µM (as per Chen and Popel
[35]) and the level of wall shear stress is assumed to be 1.82 Pa [132].
In this chapter, we are focusing mostly on NO- (and cGMP-) mediated NVC and therefore
want to analyze it first in isolation. To this end, we initially ignore the K+/EET signals that
we previously developed in Chapter 7. Mathematically, we “silence” the K+/EET mechanism
by omitting their “triggers” (bound astrocyte metabotropic glutamate receptors (mGluR) and
synaptic K+ release). We will then reintroduce the K+/EET signals (by reincorporating their
triggers) so that we can analyze the NVC response when both pathways (NO-mediated and
K+/EET-mediated vasodilation) operate in tandem. The production of 800 seconds of model
data for all equations in the combined model took 15.448 seconds of CPU time.
8.3 Results and Discussion
The first section demonstrates the model response when only the NO-mediated mechanism acts
upon the NVU system. These results are then compared to the response obtained when only the
K+/EET-mediated signals act upon the NVU. The final results simulate a NVU system with
both NO-mediated and K+/EET-mediated NVC.
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8.3.1 NO-Mediated Neurovascular Coupling
8.3.1.1 Overall Model Behaviour
Following synaptic glutamate release (starting at t=0) there is a very rapid (< 1s) rise in NO
concentration in all the cells modelled (not shown). Of the three cell types modelled, the neu-
ron had the highest maximum NO concentration (0.20 µM) followed by the SMC (0.18 µM)
and the EC (0.16 µM). The NO changes in the SMC are due to diffusion from the neighbour-
ing neuron and EC. The NO concentrations achieved in our model differ considerably from
that of the NO diffusion model of Chen and Popel [35]. Their simulations show a maximum
NO value of 6 nM (which equates to 0.006 µM; about 30 times lower than in our simula-
tion). However, Mashour and Boock [109], in their study of WSS-induced NO levels in human
cerebral endothelial cells (in an artificial capillary system) report EC NO concentrations of
0.57± 0.0067 µM (at the WSS value of 1.35 Pa); these values align more closely with our
model results. Note that we used a very simple model for diffusion so that we did not have
to incorporate partial differential equations (PDEs) into our equation set. Adding PDEs (like
those used in the study of Chen and Popel [35]) will allow the NO diffusion process to be more
accurately modelled.
A summary of the effects of the NO model on the NVU is given in Figure 8.8. Note
that the NO/cGMP dynamics model we use is that of Yang et al. [169], a group that has also
formulated a myogenic and vessel model [170, 171]. Curiously, they don’t analyze diameter
or blood flow changes caused by NO/cGMP, despite having the means to do so through their
vessel model. The following results therefore constitute the first attempt at simulating these
NO/cGMP equations in a full vessel model. Here, an SMC NO concentration change from 0.1
to 0.18 µM causes an increase in diameter of 1% (Figure 8.8), equating to an approximate 4%
change in blood flow through that vessel (when considering a vessel in isolation).
In the SMC, an increase in NO concentration leads to a cGMP concentration increase from
9 µM to 12 µM (a 33% increase), when both neuronal and endothelial NO sources are in-
cluded (see Figure 8.8). NO acts directly (and indirectly, via cGMP) on BK channels, rapidly
increasing their open channel probability (BKPo) by a small amount (0.0060 – 0.0085). The
SMC Ca2+ concentration (ci) does decrease slightly (by only 4× 10−5µM) and at a much
slower timescale than the BKPo change. The changes in SMC BK open channel probability
(BKPo), SMC Ca2+ concentration (ci), and SMC membrane potential (vi) are very small, sug-
gesting that Model Mechanism 1 (NO- and cGMP- mediated BK channel opening) does not
contribute greatly to NO-mediated NVC. The (small) arteriolar change (1%) is likely due to
Model Mechanism 2 (cGMP-mediated Ca2+ desensitization of the contractile system).
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Figure 8.8 Arteriolar response to NO-mediated NVC mechanisms. Shown here are SMC NO concentration
changes (in µM), SMC cGMP concentration (in µM), SMC membrane potential (vi, in mV), SMC Ca2+ con-
centration (ci, also in µM), SMC BK channel open probability (BKPo), AM + AMP, the fraction of attached
crossbridges (the states generating a contractile force), and finally, the arteriolar diameter (in µm). A NO change
from 0.1 to 0.18 µM causes an increase in diameter of approximately 1%. Note that these results do not include
simulations of the K+/EET pathways involving the astrocyte.
The failure of Model Mechanism 1 to produce the expected changes in arteriolar tone
highlights an important issue that physiological modellers need to be aware of. If you describe
and/or analyze a mechanism in isolation (as was done in [169]) and don’t incorporate it into a
model of the “bigger picture” (a vessel or tree model), you may run the risk of making hypothe-
ses or conclusions based on only a small “zoomed-in” section of a much larger system. In this
case, it seemed Mechanism 1 was a promising pathway for successful NO/cGMP-mediated
NVC – after all, cGMP did significantly alter the BK channel probability in experiment –
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however, when incorporated into our NVU model it did not have any significant effect on ar-
teriolar tone. If we examine Figure 8.5 again more closely, it is apparent why Mechanism 1
(NO/cGMP-mediated BK channel opening) does not contribute to NO-mediated NVC. cGMP
can produce profound increases in the fraction of open BK channels (BKPo), but not at the
membrane potential our model SMC is operating at (≈ −74 mV). As we explored in the pre-
vious chapter (in Figure 7.6), if our model SMC did possess a membrane potential of approxi-
mately −40 mV at “rest” (i.e., a membrane potential similar to the experimental values shown
in Figure 7.6), we may see a more significant change in BKPo, and hence arteriolar diameter.
There are also many other potential cellular targets for NO, cGMP and their molecular deriva-
tives; these are reviewed in [169] and include the voltage-dependent Ca2+ channels (VOCCs)
themselves, as well as the Ca2+-ATPase pump (that pumps Ca2+ into the sarcoplasmic retic-
ulum, the SMC Ca2+ stores). Future extensions to this model will include these potentially
important targets.
When the eNOS contribution to NO production is omitted, as shown in the right hand plot
of Figure 8.9, the arteriole is more constricted at baseline (13.7 µm) than when the eNOS
contribution is included (14.54 µm), as shown in the left hand plot of Figure 8.9. Without the
EC NO contribution, the change in arteriolar diameter during neuronal activity is about 6%
(compared to 1% with EC NO contributions). The reason for his effect is unclear, but it is
possible that when the constant supply of vasodilatory NO (from ECs) is no longer present, the
arteriole will develop a more constricted resting tone. Then, during neuronal activation, when
a “burst” of NO is produced, there is a larger dilation because the arteriole has more “room
to move” (more room to dilate) if the arteriole is already in a more constricted state. This
“tone-dependent” dilation will be discussed more in the next section.
8.3.1.2 Wall Shear Stress and O2 Effects
WSS/O2 and arteriolar tone/blood flow changes are connected in a complex loop. First: WSS
and O2 concentration determine the levels of NO in the EC/SMC and hence the tone of the
arteriole and the blood flow through it. Then: the changed blood flow determines a new flow
profile (with a new WSS value) and increased perfusion (with a new O2 concentration). The
new WSS and O2 concentration closes the loop. We do not attempt to model this feedback at
this stage – this is better left to be incorporated into a larger tree model where flow, pressure,
WSS and perfusion will be more accurately calculated as part of a cooperating whole. We
instead do a simple sensitivity analysis so we can start to understand how the NO model is
affected by different background values for WSS (Figure 8.11) and tissue O2 concentration
(Figure 8.10). As in Chapter 7, simple sensitivity analyses are performed by 1) adjusting the
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Figure 8.9 SMC response to NO-mediated NVC mechanisms with the contribution from eNOS in endothelial
cells included (left hand plot) and omitted (right hand plot). Shown here are SMC NO concentration changes (in
µM), SMC cGMP concentration (in µM), voltage (vi, in mV), intracellular Ca2+ (also in µM), BK channel open
probability (BKPo), AM + AMP, the fraction of attached crossbridges (the states generating a contractile force),
and finally, the arteriolar diameter (in µm).
parameter, 2) solving the set of equations again with the new parameter, and 3) plotting the
“new” results alongside the results found using the “old” value(s) of the parameter.
A higher baseline O2 concentration gives a lower baseline NO concentration (Figure 8.10)
because O2 scavenges NO. Higher O2 concentrations at rest ensures lower levels of resting
tone (more relaxed vessels).
Figure 8.11 shows SMC NO concentration and arteriole dilation under different levels of
wall shear stress (WSS). Higher levels of WSS result in a more relaxed steady state arteriolar
diameter (resting tone). The changes in vessel diameter due to the effects of NO produced
during neuronal activation are between 0.5% – 0.8%. Here, as for O2 , the WSS changes that
would result from the diameter change do not feedback into the model; i.e., new diameter-
dependent WSS values are not calculated after the diameter changes occur. If we did introduce
feedback into the model, we would expect that an increase in shear stress leads to the relaxation
of the vessel wall (an increase in the diameter) and thus a decrease in the shear stress; therefore,
the entire WSS-arteriole interaction is characterized by the presence of negative feedback.
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Figure 8.10 NO concentration in the smooth muscle cell under different baseline concentrations of O2. NO
is scavenged by O2 and a higher O2 concentration means that NO is scavenged at a faster rate. The changes in
vessel diameter due to the effects of NO produced during neuronal activation are between 0.3% and 0.8%. The
time taken to achieve maximal dilation is independent of O2 concentration. Note that the O2 increases effected by
diameter changes are not “fed back” into the model at this stage.
The values of WSS and O2 concentration, through their exerted effects on vasomodulatory
NO, are important determinants of the basal arteriolar tone. The matter of resting tone is not
trivial; it is not simply an “initial condition.” In fact, resting tone can determine the magnitude
and even the polarity (constriction or dilation) of the diameter changes effected by neurovas-
cular coupling signals [23]. In the study of Blanco et al. [23], increases in extracellular K+
concentration, stimulation of astrocyte Glutamate receptors (mGluR), or application of 11,12-
EET all evoked vessel responses that were affected by the resting arteriolar tone. Their data
suggests that dilations occur when the resting tone is less than 70% of its initial diameter, i.e.,
the arteriole is more constricted to begin with. Conversely, constrictions tend to occur when
the resting tone is above 70% of the initial arteriolar diameter, i.e., when the arteriole is more
relaxed at “rest.” Furthermore, larger changes occur when the initial diameter/baseline tone is
further from the 70% “setpoint” (for example, larger dilations will occur when the arteriole is
relatively more constricted initially). Other studies [101, 106] suggest that NO may have more
of a mediating effect than a direct modulating effect. It is possible then that NO serves to es-
tablish resting tone, either directly through the pathway modelled here or indirectly through its
influence on other agonist pathways.
150
Figure 8.11 Smooth muscle cell NO concentration and arteriolar diameter changes at different baseline levels of
wall shear stress (WSS). WSS induces eNOS-dependent NO production in the EC. Higher levels of WSS results
in an arteriole that is more relaxed (has a lesser degree of tone). The time taken to achieve maximal dilation
is independent of the level of WSS. Note that WSS changes with flow and therefore is influenced by diameter
changes; this dependence is not modelled here.
Clearly, there is experimental evidence that tone-dependent vessel behaviour exists [23],
and in our model results, we do see larger dilations at more constricted states (Figure 8.9),
which could mean that our model also exhibits tone-dependent model behaviour. However,
this hypothesis begs the question: how is a tone-dependent relationship actually effected in
the model? That is: in this model, how could tone (the value of the diameter) directly lead
to cellular changes (of Ca2+, myosin phosphorylation and crossbridge attachment) that would
then effect a change in diameter, thus creating a new value of tone?
Answer: the only mathematical formulation in this model that provides a direct link be-
tween the level of tone (the diameter of the arteriole) and cellular changes that would effect
a new level of diameter is the equation for the flux through the stretch-activated Ca2+ (SAC)
channel (Equation A.33, Appendix A). In this equation, the radius/diameter of the arteriole
determines the activation (or open channel probability) of the SAC channel. Therefore, the
diameter of the arteriole can directly affect the value of the Ca2+ influx into the SMC, which
changes the cytosolic Ca2+ concentration. Ca2+-dependent myosin phosphorylation then af-
fects the values of crossbridge attachment, stress development and diameter.
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8.3.2 Two Mechanisms of Neurovascular Coupling: NO and K+/EET
This section focuses on the individual and additive effects that the NO-mediated and K+/EET-
mediated NVC processes have on the NVU (Figure 8.12).
Figure 8.12 Neurovascular coupling: K+/EET- and NO- mediated processes. Note that this figure is a copy of
that shown in Chapter 6 (Figure 6.2).
Figure 8.13 compares the original NVC K+/EET model results (from the previous chapter)
with the NO model results from this chapter. SMC KIR channel open probability (KIRPo) as
well as SMC BK channel open probability (BKPo) have been shown for completeness.
In the NO-only case (Figure 8.13 – left plot), very small pvK changes are due to the small
changes in KIRPo and BKPo induced by small voltage changes. The basal (resting) diameter
of the arteriole is 14.54 µm and the change due to neuronal activation is 1% when simulated
using the NO-only model.
When the K+/EET pathway alone is modelled (Figure 8.13 – right plot), voltage (vi) and
calcium (ci) changes in the SMC are much larger than that in the NO-only case (Figure 8.13 –
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left plot). This is indicative of the fact that the K+/EET model provides vasodilation through
Ca2+-dependent relaxation, as opposed to the NO model which predominantly relies on cal-
cium desensitization of the contractile apparatus (where relaxation can occur even without
changes in SMC Ca2+). The basal arteriolar diameter is larger in the K+/EET-only model
(18.1 µm), meaning that the conditions of the model are such that the arteriole develops less
tone at rest – this is potentially due to different definitions of K2 and K5 (dephosphorylation
rate constants) in the two models (in the K+/EET model, K2 and K5 are constants, and in the
NO model, K2 and K5 are functions of cGMP (Equation 8.29)). The diameter change due to
neuronal activation is 3% for the K+/EET model. From experiment [127, 145], we would ex-
pect that the NO mechanism would effect a similar dilation to that of K+/EET mechanisms.
However, in our results, NO signals only effect a dilation half that of the K+/EET signal. It
is possible that, as discussed in [13], the inhibitory action that NO exerts on the constricting
20-HETE signal (not modelled here) may in fact underlie a considerable fraction of NO’s “di-
lating” effect.
The latency (time till the onset of the arteriolar response) is smaller for the NO-only model
(≈ 5 s) than in the K+/EET-only model (≈ 10 s). Rise times for the arteriolar diameter changes
(times to maximal dilation) are similar for the two models (maximum changes occur at 60 s –
the end of the activation period). Generally, it would be expected that NO signals would act
faster than K+/EET signals, as NO diffuses rapidly through the extracellular space and acts
directly on processes in the SMC, whereas the K+/EET pathway relies on several ionic trans-
ports of K+ occurring one after another. So although the latency of the response is smaller for
the NO results than it is for the K+/EET results, the rise time is still comparable, and simi-
larly slow. Hillman et al. [74] studies vessel dilation in the rat brain following tactile forepaw
stimulation. Their data shows a maximal dilation 5 s after the onset of a 4 s stimuli, consider-
ably quicker than our results. There may be several explanations for the discrepancy in these
time scales. Firstly, as previously discussed in Chapter 7, the model (or model parameters)
we use to simulate the myosin phosphorylation kinetics may not describe the physiological
process of myosin phosphorylation accurately; for example, there is evidence to suggest that
there are alternative modes of myosin phosphorylation that we have not attempted to model
[149]. Secondly, our model is far from complete; it is possible that other NVC signals could
be responsible for the very rapid NVC response, whereas those modelled are responsible for
a later, attenuating response. We are yet to develop model equations to describe other known
NVC processes, such as those involving 20-HETE. Further, we cannot even begin to develop
a clear picture until there has been more experimental investigation that can characterize un-
known NVC mechanisms (those that still act to effect NVC after all known cellular targets are
blocked).
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Figure 8.13 Comparing model results when only NO-mediated (left side plot) or only K+/EET-mediated (right
side plot) processes are considered. Shown are perivascular potassium concentration (pvK, in mM), SMC voltage
(vi, in mV), SMC Ca2+ concentration (ci, in µM), SMC BK and KIR channel open probabilities, AM + AMP (the
fraction of MLC in the attached state) and vessel diameter (in µm). Please note that the “stair-like” appearance
of the data in the left hand pvK plot (and also in Figure 8.14) is a consequence of the plotting tool used (where
each modelled data point plotted is joined by a straight line rather than a smooth fitted curve) and the large step
size used by the RKSUITE solver (a large step size is sufficient for calculating numerical values for pvK in this
simulation because the changes in pVK are so small).
In Figure 8.14, NO model results with (right side) and without (left side) the contribution of
the K+/EET model are compared. Note that we are not modelling the inhibitive interactions that
potentially exist between these two, just the additive effect of modelling the two neurovascular
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coupling pathways at once.
Figure 8.14 The figure on the left shows the model results when only NO pathways are modelled. The figure
on the right shows the results when both NO and K+/EET mechanisms are simulated together. Shown are SMC
NO concentration (in µM), SMC cGMP concentration (in µM), SMC voltage (in mV), SMC Ca2+ concentration
(ci, in µM), perivascular potassium concentration (pvk, in mM), SMC BK and KIR channel open probabilities,
AM + AMP (the fraction of MLC in the attached state) and vessel diameter (in µm). Including K+/EET in the
simulation gives a larger dilation (4% compared to 1%) but the time scale remains the same.
When both pathways are simulated together (Figure 8.14), the magnitude of the change is
larger (4%) than when only NO signals are considered (1% change). Rise times and latencies
are similar in both simulations. Time to return to baseline after neuronal activation is longer
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in the combined NO and K+/EET model (≈ 270s) than the NO-only model (≈ 180 s); this
is potentially due to “lingering” K+ in the perivascular space – that which has not yet been
cleared away via clearance mechanisms – exerting its effects on SMC processes.
SMC NO (and hence cGMP) dynamics are unchanged when K+/EET are added, as ex-
pected (K+/EET are astrocyte-based signals and therefore do not affect the largely neuronal-
based NO pathways). The most striking difference between the two compared simulations in
Figure 8.14 is the changes in the SMC BKPo. Small increases in BKPo occur in the NO-only
model (as previously discussed) due to the effects of NO/cGMP on BK channels. Therefore,
small increases initially occur in the combined model (plot on the right hand side) due to the
NO effects, but then decreases are seen due to the influence exerted by the (more delayed) KIR-
induced changes in vi and ci (both of which gate the voltage- and calcium-gated BK channels).
Peng et al. [127] study changes in cerebral blood flow in rats (induced by forepaw stimula-
tion) by blocking the NO and K+/EET pathways. Blocking either of these vasodilatory routes
reduces the increase in cerebral blood flow (CBF) by about 60%. Paradoxically, when both
pathways are blocked, the decrease is still 60%. They suggest that there exists some interaction
between the two mechanisms; such interactions are yet to be accounted for in our model. We
also do not model the potential feedback effects that our arteriolar diameter changes may have
(on O2 or WSS or pressure). These potentially important interactions will be added when this
NVC model is incorporated with a branching vascular tree model.
8.4 Summary
In this model, NO exerts its vasodilatory effects via neuronal and endothelial sources. With
both sources included, the model achieves a 1% dilation due to neuronal activation (simulated
by synaptic glutamate release). When the endothelial contribution to NO production is omitted,
the arteriole is more constricted at baseline (13.7 µm compared to 14.54 µm when both sources
are included). Without the EC NO contribution, the arteriolar change in diameter during neu-
ronal activity is 6%. This larger dilation in the more constricted vessel may be due to the fact
that the vessel is “pre-constricted” due to the absence of EC NO and therefore has more “room
to move”, i.e., dilate. The continuous supply of NO from WSS-activated endothelial sources
could be responsible for the development of the resting tone, whereas neuronal NO may provide
the actual dilating signal after neuronal activation occurs. Perhaps then, NO has a dual purpose
in our NVC model: 1) it directly mediates NVC through release by neuronal sources, and 2) it
indirectly modulates (or attenuates) the size of the NVC response by determining the baseline
tone. Our findings provide support for two hypotheses put forward by the two experimental
groups: Lindauer et al. [101], who postulate that NO acts more as a modulator rather than a
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direct mediator of NVC, and Blanco et al. [23], who show that the magnitude and polarity of
NVC responses to certain agonists are tone-dependent.
Arteriolar dilations are smaller (1%) due to NO signals than for K+/EET signals (3%).
When both of these are modelled together, there is a 4% dilation. Although latencies decrease
for NO mechanisms as compared to K+/EET, rise times are similar. Both produce arteriolar
dilations slower than that seen in experiment. We postulate that either: 1) the mechanisms
modelled are not those responsible for rapid NVC but form part of slower “attenuating” NVC
control, or 2) the Ca2+-dependent myosin phosphorylation model that we use is not capable
of simulating a fast response (either because SMC Ca2+ changes are too small or because
important myosin phosphorylation and crossbridge attachment pathways are missing).
Our current NVC model could be improved by the incorporation of: 1) partial differential
equations to more accurately describe NO diffusion, 2) a more complete model of myosin phos-
phorylation and crossbridge attachment, and 3) equations describing other known NVC signals,
like that of 20-HETE, including descriptions of the various known interactions between them
(such as the inhibition of EET and 20-HETE pathways by NO). Furthermore, we acknowledge
that this model has very limited scope in the form of a single neurovascular unit; we must incor-
porate NVC cellular models into a physiological model of the cerebrovasculature. The process
of blood flow autoregulation in the brain does not occur through the solitary efforts of a single
cell or a single NVU. Regulation occurs as an integrated multi-scale, multi-level, multi-unit
process. Investigations into a particular cellular process must involve an investigation into the
larger environment in which that cell resides.
Chapter 9
Conclusions and Future Work
9.1 Summary and Key Findings
In this project, we first developed a foundation model of the component cells of the neurovas-
cular unit (NVU), including the astrocyte and both active layers of the arteriole (smooth muscle
cells (SMCs) and endothelial cells (ECs)). To accomplish this, we adapted and extended pre-
vious models found in the literature. Our foundation model, with the important cells and cell
components included, forms a physiologically sound base on which any number of hypothe-
sized or known regulatory pathways can be incorporated and analyzed.
We then created an extension of the foundation model that simulates neurovascular cou-
pling (NVC) using EET and K+ as the major signalling pathways. We were able to achieve
arteriolar dilations similar in magnitude (3%) to those observed experimentally. Using this
model, we also investigate the effect where increased perivascular K+ causes first an arteriolar
dilation and then a constriction. We suggest that the interaction of the changing smooth mus-
cle cell membrane potential and the changing K+-dependent resting potential of the SMC KIR
channels are responsible for this effect.
There exist differing views about the exact mechanism and effects of K+ movement in and
out of the space surrounding neurons and glia. In our model of K+ signalling, both the depolar-
ization of the astrocyte membrane and the produced EETs act on astrocyte endfoot BK channels
to cause K+ efflux into the perivascular space, with the depolarizing effect taking dominance.
Furthermore, our simulations demonstrate that the arteriolar behaviour is profoundly affected
if the rate of perivascular K+ clearance, or the volume ratio between the perivascular space and
astrocyte, changes. These analyses will further add to the ongoing debate and discussion that
surrounds the distinct, but connected, phenomena known as K+ siphoning, K+ buffering and
K+-mediated NVC. They may also aid in our understanding of Cortical Spreading Depression
(CSD), in which K+ homeostasis is known to be affected.
In a further extension to the model, NO exerts its vasodilatory effects via sporadic neuronal
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and continuous endothelial sources. With both sources included, the model achieves a 1%
dilation due to neuronal activation. When the endothelial contribution to NO production is
omitted, the arteriole is more constricted at baseline. Without the EC NO contribution, the
arteriolar change in diameter during neuronal activity is greater (6%). We hypothesize that NO
has a dual purpose in NVC: 1) it directly mediates NVC through release by neuronal sources,
and 2) it indirectly modulates the size of the NVC response by determining the baseline tone
via EC sources. Our findings provide support for two existing hypotheses: 1) that NO acts
more as a modulator than a mediator of NVC, and 2) that the magnitude of NVC responses is
tone-dependent.
Both mechanisms of NVC (K+/EET-mediated and NO-mediated) produce arteriolar dila-
tions slower than that seen in experiment. We postulate that either: 1) the modelled mecha-
nisms form part of a slower attenuating NVC control mechanism and that we are yet to model
the mechanisms responsible for rapid NVC, or 2) the Ca2+-dependent myosin phosphorylation
model that we use is simply not capable of simulating a fast response (potentially because SMC
Ca2+ changes are too small, the SMC resting membrane potential is too negative, or because
important myosin phosphorylation and cross-bridge attachment pathways are missing).
Finally, our NVC models have allowed us to replicate and explain some of the phenom-
ena seen in both NVC-oriented and clinically-oriented experimental research. This project
highlights the fact that mathematical modelling can be used as a tool to understand biological
processes in a way that physical experiment cannot always do, and most importantly, can help
to elucidate the cellular processes that induce or accompany our most debilitating diseases.
9.2 Future Work
This model – of NVC working within a single NVU – is incomplete. NVC encompasses a large
number of known, unknown and hypothesized pathways, only two of which were investigated
in this thesis. In future studies, other NVC mechanisms, such as those involving 20-HETE and
pericytes, will be modelled and included. These future models, and the current model, will
also benefit from an in-depth validation and a numerical analysis of the dominant mechanisms
and parameters (accomplished via the non-dimensionalization of all equations and a sensitivity
analysis on the full parameter set).
A common theme found throughout this thesis is that of dimensional consistency in the
model equations. One of the largest challenges for any physiological modeller is to develop
a model that possesses consistent units and sensible parameters at the same time as building
on the work of others who have developed their models (or experimental data) in a variety
of different units (or experimental conditions). Building physiological models is a complex
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task – developing, documenting, validating, and ensuring consistency in model equations is
difficult. In fact, it is rare to find a published model that is completely free of dimensional
inconsistencies and misquoted parameters. This need for consistency in the development of
physiological models has already been understood by the scientific community and has lead to
the development of a group of collaborative “Physiome projects.” These projects – including
the Human Brain, Cardiome, Lung Physiome and Kidney database – involve the collection of
models that have reached certain standards in verification, validation, and documentation [18].
Learning from, and contributing to, these projects and databases may be the best way to ensure
model progress and consistency occurs in future extensions to this model.
Our focus in this study was the development of a model for a single NVU. However, the
complex mechanisms of blood flow regulation and NVC do not occur in isolation in a single
unit. They operate as just a tiny part of a larger, integrated, multicellular, and multiplex whole.
It is crucial that mathematical investigations into a particular cellular regulation pathway in-
volve the larger environment in which that cell resides. Therefore, a major focus of future
work will be the integration of this cellular NVC model into the vascular tree model that has
been created by the University of Canterbury’s Brain Group [42]. This will create a physiolog-
ical model of blood flow to and within the entire cerebrovasculature – a whole “computational
brain.” Only in creating such a model will we gain an adequate understanding of the true phys-
iological importance of the cellular pathways that we have attempted to model here. However,
it is important to understand that the addition of complex cellular models to an already com-
plex representation of the vascular tree will greatly increase the computational expense of the
problem. To put the scale of this project into perspective: if our single NVU model requires 15
seconds of CPU time, the solution of an entire brain (which possesses more than 100 billion
NVUs) would require a single CPU to be working for 47 millennia. In practice, such a model
can only be solved using massively parallel high performance computers such as those belong-
ing to BlueFern, the University of Canterbury’s supercomputing facility. Further simplification
of the NVU model will also be necessary to reduce computational time – numerical analyses
will determine which terms and equations can be safely removed without significantly affecting
model behaviour.
Finally, it is not enough to only understand the cellular pathways as they occur normally
in a whole brain. It is also essential to understand what effects pathological processes have.
We hope that in the future the disease processes involving vascular, neuronal and astrocytic
cells, and drugs designed to target these processes, can too be simulated and investigated on
our “computational brain.”
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9.3 Review of Project Objectives
The overall objectives of this project were to build a mathematical model of NVC and inves-
tigate the model’s response to known physiological (and pathological) changes. In order to
achieve these overall objectives, the following key goals were identified:
1. Conduct a review of the current neurovascular (smooth muscle, endothelial and astrocyte
cell) models in the literature
2. Construct a working model of the NVU using previous cell models and additional phys-
iological information
3. Analyze the contributions of two known NVC mechanisms to blood flow regulation as a
whole; namely, 1) a K+- and EET- based mechanism, and 2) a NO-based mechanism
4. Ensure that the model and its results are communicated in a format that is accessible
to all members of the biological science community (experimentalists, clinicians and
mathematicians)
The first goal was achieved by the review of the literature presented in Chapter 5. Goals 2
and 3 were achieved through the model development and analysis performed in Chapters 6, 7
and 8. The final goal, Goal 4, was attempted by providing background chapters (Chapters 2, 3
and 4) that explain many of the mathematical and biological terminology and concepts in simple
terms.
I believe the most successful aspect of this work was the part of the model that hinted at how
the behaviour of the KIR channel is responsible for the dilation/constriction behaviour seen in
real vessels. I expect that further research into this phenomenon and its relationship to cortical
spreading depression could yield extremely interesting, and clinically-relevant, findings. The
NO-related model equations are the least developed aspect of this work.
Of course, when I began this work four years ago, I was tremendously ambitious and hoped
to produce a “perfect” model which would be able to replicate all experimental observations
made to date, and would also be capable of answering all of the questions I had about blood
flow in the brain. I have answered some of my questions, but I have also created many more. It
is tempting to be disappointed that my model results do not more closely fit experimental data.
However, as discussed in Chapter 2, “the point of mathematical models is not to fit the data but
to sharpen the questions.” It is also true that the paradox of the mathematical modeller is this: if
we knew how it worked, the model would be perfectly correct (and also very easy to develop),
but then, if we already knew how everything worked, the model would be redundant.
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The questions I have now are based on a much better understanding of the subject area –
they are much “sharper” than they were four years ago. It seems then that one of my objectives
should have been “to ask better questions.” Better questions are those that steer myself and
others away from the dark alleys and instead move us towards the ones that offer elucidation.
The asking of better questions is the making of a better scientist. I will therefore continue to
work on the science of question-asking. This will be my ongoing objective.

Appendix A
Model Equations
All equations not described in the main text are outlined in this Appendix Chapter.
A.1 Smooth Muscle and Endothelial Cell Model
The smooth muscle cell (SMC) and endothelial cell (EC) model is taken from Koenigsberger
et al. [85]. The equations in their model are reproduced in this section for reference. All
additions and extensions to this model are described in the main text (Chapters 6, 7, and 8).
A single SMC i is described by five variables:
• the calcium concentration in the cytosol ci,
• the calcium concentration in the SR si,
• the cell membrane potential vi,
• the open state probability wi of BK channels, and
• the IP3 concentration Ii.
A single EC j is modelled using four variables:
• the cytosolic calcium concentration c j,
• the calcium concentration in the ER s j,
• the cell membrane potential v j, and
• the IP3 concentration I j.
Cells can be coupled to their neighbour via gap junction connections in three ways: by
electrical, calcium, and IP3 coupling.
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A.1.1 Smooth Muscle Cell Differential Equations
The SMC model is as follows:
The change in the cytosolic calcium concentration is the summation of the fluxes moving
calcium in and out of the cytosolic space. Each “J” term here represents a different calcium
flux in and out of the cytosol (to and from the extracellular space, sarcoplasmic reticulum, or
neighbouring cells).
dci
dt
= JIP3i− JSRuptakei + JCICRi− Jextrusioni + Jleaki− JVOCCi + JNa/Cai +0.1Jstretchi (A.1)
The change in concentration of calcium (dcidt ) and the fluxes (“J” terms) are all expressed in
µMs−1.
The change in the concentration of calcium in the sarcoplasmic reticulum (SR) depends on
the fluxes in and out of these calcium “stores” (i.e. fluxes to and from the cytosol).
dsi
dt
=−JSRuptakei− JCICRi− Jleaki (A.2)
Again, the change in concentration of calcium in the stores (dsidt ) and the fluxes are all expressed
in µMs−1.
Borrowing from electrical theory, we have the relationship dvdt =
I
C (with C=capacitance,
v=voltage, and I=current). Therefore, the following differential equation describes the change
in membrane potential, where fluxes of ions across the cell membrane (essentially “currents”)
are related to the change in membrane potential by a scaling factor γi (which is related to the
inverse of membrane capacitance and carries units of mVµM−1).
dvi
dt
= γi
(
JNa/Ki− JCli−2JVOCCi− JNa/Cai− JKi− Jstretchi
)
+V SMC−ECcouplingi (A.3)
Fluxes coming into the cell are positive (effluxes are negative), and coefficients of these fluxes
represent the valency of the ion (2 for Ca2+ and 1 for all other fluxes). vi has units of mV.
The equilibrium distribution of open channel states for the voltage- and calcium-activated
potassium channels (BK channels) are described by Koenigsberger et al. [85] as Kactivationi . The
time course of the fraction of K+ channel open states is described after Morris and Lecar [115]
by the first-order kinetics of opening, as shown below:
dwi
dt
= λi(Kactivationi−wi) (A.4)
where λi is the rate constant for opening (in s−1).
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Finally, the change in IP3 concentration is the sum of IP3 fluxes:
dIi
dt
=−Jdegradi + JSMC−ECI−couplingi (A.5)
A.1.2 Endothelial Cell Differential Equations
The EC model is given by equations very similar in formulation to the SMC model described
above:
dc j
dt
= JIP3 j − JERuptake j + JCICR j − Jextrusion j + Jleak j + Jcation j + J0 j + Jstretch j (A.6)
ds j
dt
= JERuptake j − JCICR j − Jleak j (A.7)
dv j
dt
=− 1
Cm j
(
IK j + IR j
)
+V EC−SMCcoupling j (A.8)
dI j
dt
=−Jdegrad j + JEC−SMCI−coupling j (A.9)
Note that in Equation A.8, the electrical capacitance of the EC membrane (Cm j, in pF)
is used in this equation (as opposed to the scaling factor γi used in the SMC voltage DE –
Equation A.3.) The fluxes/currents IK j and IR j are therefore described as electrical fluxes (in
fA or pS·mV) instead of molar fluxes in µMs−1. A basic description of the relationship be-
tween electrical and molar fluxes is given in the subsection Dimensional Consistency and
Unit Conversions in Chapter 6.
A.1.3 Expressions in the Differential Equations
The various terms that appear in Equations A.1 to A.9 are described by the following expres-
sions given below. (Note the i subscript for the SMC and the j subscript for the EC).
The calcium fluxes
JIP3i = Fi
I2i
K2ri+ I
2
i
(A.10)
and
JIP3 j = Fj
I2j
K2r j + I
2
j
(A.11)
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model the release of calcium from IP3 sensitive stores in the SMC and EC.
JSRuptakei = Bi
c2i
c2i + c
2
bi
(A.12)
and
JERuptake j = B j
c2j
c2j + c
2
b j
(A.13)
model the uptake of calcium into the SMC sarcoplasmic and EC endoplasmic reticulum, re-
spectively.
JCICRi =Ci
s2i
s2ci+ s
2
i
c4i
c4ci+ c
4
i
(A.14)
and
JCICR j =C j
s2j
s2c j + s
2
j
c4j
c4c j + c
4
j
(A.15)
describe the calcium-induced calcium release (CICR).
Jextrusioni = Dici
(
1+
vi− vd
Rdi
)
(A.16)
and
Jextrusion j = D jc j (A.17)
represent the calcium extrusion by Ca2+-ATPase pumps.
Leak currents from the SR/ER are given as
Jleaki = Lisi (A.18)
and
Jleak j = L js j (A.19)
JVOCCi = GCai
vi− vCa1i
1+ exp [−(vi− vCa2i)/RCai]
(A.20)
is the calcium influx through VOCCs.
JNa/Cai = GNa/Cai
ci
ci+ cNa/Cai
(
vi− vNa/Cai
)
(A.21)
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is the flux of calcium exchanging with sodium in the Na+/Ca+ exchange
JNa/Ki = FNa/Ki (A.22)
is the constant flux due to activation of the Na+/K+-ATPase pump
JCli = GCli (vi− vCli) (A.23)
models the flux through chlorine channels.
JKi = GKiwi (vi− vKi) (A.24)
is the flux through voltage- and calcium-gated potassium (BK) channels in the SMC.
Kactivationi describes the equilibrium distribution of open channel states for the BK channel
in the SMC.
Kactivationi =
(ci+ cwi)
2
(ci+ cwi)
2+βi exp [−(vi− vCa3i)/RKi]
(A.25)
Jcation j is the flux through two non-selective cation channels in the EC.
Jcation j = Gcat j
(
ECa j− v j
) 1
2
(
1+ tanh
(
log(c j)−m3cat j
m4cat j
))
(A.26)
J0 j is the constant calcium influx into the cell.
IK j = Gtot j
(
v j− vK j
)(
IBKCa j + ISKCa j
)
(A.27)
is the potassium efflux through the BKCa channel (a large-conductance channel activated by
calcium and voltage changes in the EC), and the SKCa channel (a small-conductance channel
only activated by calcium), with:
IBKCa j = 0.2
(
1+ tanh
( (
log(c j)− c
)(
v j−b j
)−a1 j
m3b j
(
v j +a2 j
(
log(c j)− c
)−b j)2+m4b j
))
(A.28)
and
ISKCa j = 0.3
(
1+ tanh
(
log(c j)−m3s j
m4s j
))
(A.29)
Important note about dimensional consistency in Equations A.26, A.28 and A.29: tak-
ing the log of a dimensioned quantity – as is done in these equations (e.g., log(c j)) – makes it
difficult to make sense of the physical units used. However, these particular equations were not
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developed from descriptions of the underlying physical mechanisms occurring in ion channel
opening (see Appendix C). They are instead phenomenological: the sigmoidal (hyperbolic tan-
gent or tanh) relationships in Equations A.26, A.28 and A.29 are simply fitted to experimental
data. Koenigsberger et al. [85] publishes these “fitting parameters” (m3cat j , m4cat j , c, b j, a1 j,
m3b j, a2 j, m4b j, m3s j and m4s j) in terms of dimensioned quantities. This is misleading, espe-
cially when other model equations are dimensioned correctly. These parameters are therefore
listed in this thesis (in Table B.2, Appendix B) with dimensionless units to avoid confusion.
The residual current combining Cl− and Na+ currents in the EC is written:
IR j = GR j
(
v j− vrest j
)
(A.30)
and the IP3 fluxes for the SMC
Jdegradi = kiIi (A.31)
and the EC
Jdegrad j = k jI j (A.32)
model IP3 degradation.
A.1.4 Stretch-Activated Calcium Channels
The myogenic (pressure-dependent) response is effected in this model via SACs (stretch-activated
channels). These mechano-sensitive channels (present in SMCs and ECs) increase intracellular
calcium levels by effecting a direct influx of extracellular calcium, which depolarizes the SMCs
and leads to a further calcium influx through VOCCs. Jstretchi and Jstretch j give the SAC-activated
calcium fluxes in the SMC and EC, respectively.
Jstretchi =
Gstretch
1+exp[−α(σ−σ0)] (vi−ESAC)
= Gstretch
1+exp
[
−α
(
∆pr
h −σ0
)] (vi−ESAC) (A.33)
Jstretch j =
Gstretch
1+exp[−α(σ−σ0)]
(
v j−ESAC
)
=
GstretchEC
1+exp
[
−α
(
∆pr
h −σ0
)] (v j−ESAC) (A.34)
The constants ESAC and Gstretch (or GstretchEC) are the reversal potential and the whole cell
conductance for SACs. 1+ exp
[
−α
(
∆pr
h −σ0
)]
represents the open probability of SACs
where σ is the cell membrane tensile stress. This stress can also be rewritten (using Laplace’s
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Law) as ∆prh . Note that the coefficient 0.1 of Jstretchi in Equation A.1 allows for the fact that
Ca2+ is divalent (has a valency of 2) and constitutes approximately 20% of the total SAC
current.
Koenigsberger et al. [85] model a large arteriole (100 µm in diameter), whereas we are
interested in modelling a smaller terminal (pre-capillary) arteriole (20 µm in diameter). There-
fore, in our model, we “up-regulate” (increase) the conductance of the SAC (Gstretch) to reflect
the increased responsiveness to pressure that smaller arterioles experience (at least in the coro-
nary vasculature [83]).
A.1.5 Coupling between Endothelial Cell and Smooth Muscle Cell
Heterocellular electrical coupling between SMCs and ECs (in each direction) is modelled by
the terms:
V SMC−ECcouplingi =−G(vi− v j) (A.35)
V EC−SMCcoupling j =−G(v j− vi) (A.36)
Heterocellular IP3 coupling between SMCs and ECs (in each direction) is modelled by the
terms:
JSMC−ECI−couplingi =−PIP3(Ii− I j) (A.37)
JEC−SMCI−coupling j =−PIP3(I j− Ii) (A.38)
A.1.6 Corrections to Koenigsberger et al. [85] Model
In [85], Jstretch j is missing from Equation A.8 – we include this term in our model equation.
Jstretch j is included in Equation A.6 in [85] but with inconsistent units. We convert Jstretch j
from the inconsistent units of µMs−1 to the consistent units of fA (fCs−1) by multiplying by
the scaling factor
(
F×vEC×109
)
, where F is Faraday’s constant (in Cmol−1) and vEC is the
volume of the EC (in L). A description of this sort of conversion is given in the subsection
Dimensional Consistency and Unit Conversions in Chapter 6, but is also given below in
Equation A.39.
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[
molar flux in
µM
s
]
×F C
mol
×vEC L× 10
9 fM
1 µM
=
[
electrical flux in
fC
s
]
[
molar flux in
µM
s
]
× (F×vEC) CM ×
109 fM
1 µM
=
[
electrical flux in
fC
s
]
∴
[
molar flux in
µM
s
]
× (F×vEC×109) = [electrical flux in fCs
]
(A.39)
Some of the parameters given in [85] have also been copied incorrectly from their original
source; namely, c and m3cat . These parameters are given as −0.4 µM and −0.18 µM when
they should have been −6.4 µM and −6.18 µM, respectively. We have used the correct values
in our model.
A.2 Myosin Phosphorylation and Crossbridge Formation Model
In this NVC model, the cytosolic calcium concentration and the subsequent development of
myosin-actin crossbridges in SMCs is related by the crossbridge phosphorylation and latch-
state model of Hai and Murphy [65]. In their model:
• An elevation of calcium induces contraction through the formation of crossbridges be-
tween myosin and actin
• Myosin can be in four possible states: free non-phosphorylated crossbridges (M), free
phosphorylated crossbridges (Mp), attached phosphorylated crossbridges (AMp), and
attached dephosphorylated crossbridges (latchbridges) (AM)
• These four states are related by seven rate constants, which were found by Hai and Mur-
phy [65] by fitting their model to experimentally determined time courses of myosin
phosphorylation and stress development
The scheme modelled by Hai and Murphy [65] is shown in Figure A.1.
The fraction of myosin in each of the four states is given by the following equations:
d [M]
dt
=−K1i [M]+K2 [Mp]+K7 [Ap] (A.40)
d [Mp]
dt
= K4 [AMp]+K1i [M]− (K2+K3) [Mp] (A.41)
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Figure A.1 Crossbridge phosphorylation and latch-state model of Hai and Murphy [65]. Note that this figure
also appears in Chapter 5. Adapted from [65].
d [AMp]
dt
= K3 [Mp]+K6i [AM]− (K4+K5) [AMp] (A.42)
d [AM]
dt
= K5 [AMp]− (K7+K6i) [AM] (A.43)
K1i and K6i are the rate constants that represent phosphorylation (of M to Mp and AM to AMp)
by the active myosin light chain kinase (MLCK), Ca2+- calmodulin complex. K2 and K5 are
the rate constants for dephosphorylation (of Mp to M and AMp to AM) by myosin light-chain
phosphatase (MLCP). K3 and K4 are the rate constants representing the attachment/detachment
of fast-cycling phosphorylated crossbridges. Finally, K7 is the rate constant for latchbridge
detachment. K2 to K7 are constant and are given in Appendix B.
Their model uses two types of crossbridge interactions: 1) cycling phosphorylated cross-
bridges and 2) non-cycling dephosphorylated crossbridges (“latchbridges”). The major as-
sumptions of their model are that:
• Ca2+ - dependent myosin phosphorylation is the only mechanism for the development of
stress in the smooth muscle cell
• Each myosin head acts independently
• Latch bridges are formed by dephosphorylation of an attached crossbridge
• All reactions exhibit first-order kinetics
• Total myosin phosphorylation equals (Mp + AMp) and stress equals (AM + AMp)
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• An attachment-to-detachment ratio (K3/K4) was chosen as 4:1 for the phosphorylated
cycling crossbridges (a ratio of 3:1 is considered reasonable for skeletal muscle, but
no estimate was available for smooth muscle). The result of this constraint is that the
maximum fraction of crossbridges (AMp + AM) is 0.8 (Figure A.2)
The steady-state dependence of stress (AM + AMp, the fraction of total crossbridges) on
myosin phosphorylation in their model approximates that shown in Figure A.2.
Figure A.2 The steady-state relationship between stress and phosphorylation in the model of Hai and Murphy
[65], where the maximum value for (AM + AMp) is 0.8. Adapted from [65].
Appendix B
Model Parameters
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B.1 Smooth Muscle Cell Model Parameters
Parameter Value Source
Fi 0.23 µM s−1 [85]
Kri 1 µM [85]
GCai 0.00129 µM mV−1s−1 [85]
vCa1i 100.0 mV [85]
vCa2i −24.0 mV [85]
RCai 8.5 mV [85]
GNa/Cai 0.00316 µM mV−1s−1 [85]
cNa/Cai 0.5 µM [85]
vNa/Cai −30.0 mV [85]
Bi 2.025 µM s−1 [85]
cbi 1.0 µM [85]
Ci 55 µM s−1 [85]
sci 2.0 µM [85]
cci 0.9 µM [85]
Di 0.24 s−1 [85]
vd −100.0 mV [85]
Rdi 250.0 mV [85]
Li 0.025 s−1 [85]
γi 1970 mVµM−1 [85]
FNa/Ki 0.2 µM s−1 [85]
GCli 0.00134 µM mV−1s−1 [85]
vCli −25.0 mV [85]
GKi 0.0046 µM mV−1s−1 [85]
vKi −94 mV [85]
λi 45.0 s−1 [85]
cwi 0.0 µM [85]
βi 0.13 µM2 [85]
vCa3i −27.0 µM [85]
RKi 12.0 mV [85]
ki 0.1 s−1 [85]
KKIR1 4.5 mV mM
−1 [123]
KKIR2 107.5 mV [123]
Table B.1 Parameter values for smooth muscle cell model
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B.2 Endothelial Cell Model Parameters
Parameter Value Source
Fj 0.23 µM s−1 [85]
Kr j 1.0 µM [85]
B j 0.5 µM s−1 [85]
cb j 1.0 µM [85]
C j 5.0 µM s−1 [85]
sc j 2.0 µM [85]
cc j 0.9 µM [85]
D j 0.24 s−1 [85]
L j 0.025 s−1 [85]
k j 0.1 s−1 [85]
Gcat j 0.00066 µM mV−1s−1 [85]
ECa j 50.00 mV [85]
m3cat j −6.18 [85] – Corrected
m4cat j 0.37 [85]
J0 j 0.029 µM s−1 [85]
Cm j 25.8 pF [85]
Gtot j 6927 pS [85]
vK j −80.0 mV [85]
a1 j 53.3 [85]
a2 j 53.3 [85]
b j −80.8 [85]
c −6.4 [85] – Corrected
m3b j 0.00132 [85]
m4b j 0.30 [85]
m3s j −0.28 [85]
m4s j 0.389 [85]
GR j 955 pS [85]
vrest j −31.10 mV [85]
vEC 1.173×10−12 L [142]
Table B.2 Parameters for EC equations
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B.3 Other SMC and EC Model Parameters
Parameter Value Source
Gstretch 0.0061 µM mV−1s−1 [86]
∆p 30 mmHg(3990 Pa) [96]
α 0.0074 mmHg−1 [86]
ESAC −18 mV [86]
σ0 500 mmHg [86]
G 50 s−1 Estimation
PIP3 0.05 s
−1 [86]
Table B.3 Parameters for stretch-activated calcium channels and heterocellular coupling equations
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B.4 Myosin Phosphorylation and Crossbridge Formation Model
Parameters
Parameter Value Source
γ 17 µM−3s−1 [86]
K2 0.5 s−1 [86]
K3 0.4 s−1 [86]
K4 0.1 s−1 [86]
K5 0.5 s−1 [86]
K7 0.1 s−1 [86]
Table B.4 Parameters for model of myosin-actin crossbridge formation
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B.5 Smooth Muscle Mechanics Model Parameters
Parameter Value Source
R0 10×10−6 m [96]
h0 4×10−6 m [96]
∆p 3990 Pa(30 mmHg) [96]
ρw 1100 kg m−3 [92]
ν 0.5 [92]
c1 0.015 [92]
φ 2.8×107 Pa s m−1 [22]
c2 2.25×105 Pa Estimation – based on [62]
E0 3×105 Pa Estimation – based on [92]
ε 0.1 Estimation
Fmax 0.8 [65]
Table B.5 Parameters used in muscle mechanics equations
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B.6 Astrocyte Model Parameters
Parameter Value Source
F 96500 C mol−1 Faraday’s Constant
Bcyt 0.0244 [20]
V RERcyt 0.185 [158]
Jmax 2880 µM s−1 [20]
KI 0.03 µM [20]
Kact 0.17 µM [20]
PL 5.2 µM s−1 [99]
Vmax 20 µM s−1 [20]
kpump 0.24 µM [20]
kon 2 µM−1s−1 [20]
Kinh 0.1 µM [20]
rh 4.8 µM s−1 Estimation
kdeg 1.25 s−1 Estimation
δ 1.235×10−3 [99]
KG 8.82 [20]
Veet 72 s−1 Estimation
keet 7.2 s−1 Estimation
ck,min 0.1 µM [20]
Cast 40 pF [124]
Table B.6 Parameters for the astrocyte equations
Parameter Value Source
gleakk 78.54 pS [61]
vleakk −70 mV [61]
gBKk 13854 pS Estimation
vBKk −95 mV [61]
eetshi f t 2 mVµM−1 Estimation – based on [104]
ψn 2.664 s−1 [61]
v4 14.5 mV [61]
v5 8 mV [61]
v6 −15 mV [61]
Ca3 0.4 µM [61]
Ca4 0.15 µM [61]
Table B.7 Parameters for the astrocyte ion channel equations
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B.7 K+/EET Model Extension Parameters
Parameter Value Source
JNaKmax 10
10 mM s−1 Estimation
KKoa 1.5 mM [124]
Naia 15 mM [124]
KNaia 10 mM [124]
vcle f t 8×10−21 L [140]
Table B.8 Parameters for synaptic cleft equations
Parameter Value Source
V Rpa 0.0009 Estimation – based on [110]
V Rps 0.1 Estimation – based on [150]
Rdecay 0.05 s−1 Estimation
Kpmin 3 mM [87]
vast 3.8×10−11 L [124]
Table B.9 Parameters for perivascular space equations
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B.8 NO Model Extension Parameters
Parameter Value Source
βA 0.41 nM [137]
βB 1.02 nM [137]
GM 46 pS [137]
PCa/PM 3.6 [137]
Caex 2 mM [137]
M 130 mM [137]
R 8.314 J mol−1K−1 [137]
T 306.15 K Assumed
V −40 mV [137]
κex 1600 s−1 [137]
Carest 0.0001 mM [137]
Λ 20 [137]
vspine 8×10−17 L [137]
Table B.10 Parameters for calcium influx into the neuron
Parameter Value Source
Q1 1.9×105 mM−1 [40]
Q2 2.1×105 mM−1 [40]
Q3 0.4×105 mM−1 [40]
Q4 0.26×105 mM−1 [40]
VmaxNOS 25 µM s
−1 Estimation
KactNOS 92.7 ×10−6 mM [35]
[CaM]thresh 25×10−6 mM Estimation
kO2 9.6×10−6 µM−2s−1 [35]
DNO 3.33×10−9 m2s−1 [35]
h1 6×10−6 m Estimation
Kdis 0.09 µM s−1 [38]
µ2 0.0167 s−1 [38]
Kenos 0.45 µM [38]
gmax 17.6 µM s−1 [38]
W0 1.4 Pa−1 [164]
δWSS 2.86 Pa [164]
h2 6×10−6 m Estimation
kdno 0.01 s−1 [35]
Table B.11 Parameters for nNOS and eNOS activation and NO diffusion
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Parameter Value Source
k1 2000 µM−1s−1 [169]
k−1 100 s−1 [169]
k2 0.1 s−1 [169]
k3 3 µM−1s−1 [169]
m 0 [169]
Vmax,sGC 1.26 µM s−1 [169]
kpde 0.0695 s−1 [169]
C4 0.4 s−1 [169]
Km,pde 2.0 µM [169]
nH,cGMP 2 [169]
Km,cGMP 0.55 µM [169]
VcGMP 68 mV Fitted to [151]
nH,NO 1 [169]
Km,NO 0.2 µM [169]
VNO 100 mV [169]
Vb 215 mV Fitted to [151]
RK f it 55 mV Fitted to [151]
kbmlcp 0.0086 s
−1 [169]
kcmlcp 0.0327 s
−1 [169]
Km,mlcp 5.5 µM [169]
nH,mlcp 2 [169]
Table B.12 Parameters for NO interactions in the SMC
Appendix C
Ion Channels and Sigmoidal Behaviour
There are many ways to mathematically represent a sigmoidal function; some use the exponen-
tial function (exp(x)) and some use the hyperbolic tan function (tanh), as shown in Figures C.1
and C.2, respectively.
Figure C.1 Sigmoidal behaviour modelled using an exponential term. Note that the function decreases in value
from left to right.
We can mathematically show how the differential equation for ion channel opening is for-
mulated by considering the following argument:
Suppose we have an ion channel that has two states:
1. open (O)
2. closed (C)
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Figure C.2 Sigmoidal behaviour modelled using a hyperbolic tangent term. This function is similar to that in
Figure C.1 except that it has been reflected about the y-axis (due to the lack of a negative sign in front of the
variable x) and now increases in value from left to right. It has also been translated (shifted along to the right
in the y-axis by the value −5) and transformed (compressed by a factor of 0.5 in the y-direction and the slope
reduced by the factor 2 in the denominator).
C
α

β
O (C.1)
with reaction rates α and β , respectively.
The “flux” of channels moving from an open to a closed state (the number of channels
changing state per unit time) is proportional to the number of open channels, and is therefore
represented by:
f lux O→C = j− = β fO (C.2)
where fO is the fraction of ion channels in the open state. Similarly, the “flux” of ions moving
from closed to open states is proportional to the number of closed channels (Equation C.3). As
there are only two states, open and closed, the proportions in each state must add up to 1, so
the proportion of channels in the closed state must be (1− fO).
f lux C→ O = j+ = α (1− fO) (C.3)
The differential equation for the rate of change in the fraction of open ion channel states is
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given by the difference between the two fluxes, j+ and j−:
d fO
dt
= rate of opening− rate of closing
= j+− j−
= −β fO+α (1− fO)
= −(β +α)
(
fO− αβ +α
)
(C.4)
Now let:
1
β +α
= τ (C.5)
where τ is a characteristic time scale, and
f∞ =
α
β +α
(C.6)
where f∞ is the fraction of open channel states at equilibrium.
Equation C.4 can then be written as:
d fO
dt
=−( fO− f∞)
τ
(C.7)
This is an example of what is known as a “reverting” differential equation; when fO < f∞,
d fO
dt > 0 and fO will revert to f∞, but when f∞ < fO,
d fO
dt < 0 and fO will still revert to f∞.
The potential difference (voltage, V) across the membrane can influence the rate of transi-
tion from O to C and C to O states, and so α and β , and hence f∞ and τ , can be rewritten in
terms of voltage. We see an example of this in Chapter 6 (in Equations 6.23 and 6.24).
f∞, when expressed as a function of voltage, tends to have a sigmoidal shape. f∞ can be
determined by fitting experimental data to a sigmoidal function. Equations A.26, A.28 and A.29
in Appendix B are examples of fitted sigmoidal functions.

Appendix D
Analysis of EET Increase With Respect to a Calcium Input
Function
We show below an argument to support the hypothesis that [EET] does increase “after” Ca2+
The differential equation for [EET] (denoted by φ (t)) is given by
dφ
dt
=V (c(t)− cmin)− kφ (D.1)
We assume that c(t)− cmin =C(t) with C(0) = 0. then
dφ
dt
+ kφ =VC(t) (D.2)
A solution to this is easily formed
ektφ(t)|t0 =V
∫ t
0
C(τ)ektdτ (D.3)
However, we do not know the exact formulation of C(t). For small values of time t we assume
that C(t)' αt then:
φ(t) = [φ(0)+ γ(t)]e−kt (D.4)
with
γ(t) =V
∫ t
0
αtektdτ (D.5)
Integrating γ(t) by parts we have that
γ(t) = αV [
τ
k
ekτ −
∫ t
0
ekτdτ] (D.6)
=
αV
k
[ekt(t−1)+1] (D.7)
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so
φ(t) =
αV
k
(t−1)+ αV
k
e−kt (D.8)
Using a Taylor expansion for e−kt we have that
φ(t) = αVt[
1
k
−1]+©(kt2) (D.9)
Clearly φ(t) increases; hence (1k −1)> 0 since all α , V and k are > 0. If φ(t) is to increase at
a slower rate than Ca2+ then
V [
1
k
−1]< 1 (D.10)
1
k
<
1
V
+1 (D.11)
So, by choosing either V or k the other is completely defined for [EET] to lag [Ca2+]. If we
choose C(t) = c˜H(t) then
φ(t) =
V
k
[1− e−kt ]⇒ φ(t)'Vt (D.12)
for small t and therefore always lags [Ca2+].
Appendix E
Source Code
All code used for the simulations presented in this thesis were developed in C++ using the Open
Source software Code::Blocks1. The attached folders are Code::Blocks “projects” and include:
• nvc keet code – code used to simulate K+/EET-mediated neurovascular coupling (Chap-
ter 7)
• nvc no code – code used to simulate NO-mediated neurovascular coupling (Chapter 8)
Both Code::Blocks projects include:
• main.cpp – file that includes all model parameters and ODEs, calls the RKSUITE solver
and defines the methods and tolerances it must use, and manages the files in which the
results will be placed
• rksuite.cpp – file containing RKSUITE, the numerical ODE solver2
• rksuite.h – the header file for RKSUITE
1A free copy of this software can be downloaded from http://www.codeblocks.org/downloads
2To obtain a copy of the RKSUITE documentation, see http://www.phy.ornl.gov/csep/ode/node9.html
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